data_5x36_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x36 _Structure_validation_residue.Date_analyzed 2017-05-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.7 p -77.31 171.41 14.9 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 111.821 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.442 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.6 t-160 -78.01 134.46 37.8 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 94.0 m-85 74.81 11.79 3.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.924 0.89 . . . . 0.0 111.596 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.37 163.82 17.91 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -77.28 122.38 25.02 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.8 p -106.8 14.96 26.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.96 85.98 0.6 Allowed Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 116.954 -2.546 . . . . 0.0 114.889 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 177.27 28.16 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 168.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.432 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 67.0 mt -65.09 111.85 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 118.129 0.965 . . . . 0.0 109.138 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.58 -9.52 21.87 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.91 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -106.42 108.57 20.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -112.62 11.64 19.64 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.943 0.401 . . . . 0.0 111.091 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.59 -147.44 1.8 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.552 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.04 98.66 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.061 2.507 . . . . 0.0 112.093 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 p -98.7 -14.78 19.64 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.036 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.49 110.93 23.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 70.8 m -69.44 157.09 37.76 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.657 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.68 147.49 49.34 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 m -60.9 126.65 28.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.524 0.678 . . . . 0.0 110.54 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.79 -20.29 24.72 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.2 p -108.14 143.25 37.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 122.403 -0.469 . . . . 0.0 109.803 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 p -107.72 137.15 46.25 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.477 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.7 t -82.08 102.22 10.88 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.96 117.96 36.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.321 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.9 t -76.63 117.91 22.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.446 HD13 ' CE1' ' A' ' 32' ' ' TYR . 83.9 mt -101.7 -42.15 6.3 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.559 0.695 . . . . 0.0 109.598 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -135.62 165.03 39.24 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.25 -27.58 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.032 1.822 . . . . 0.0 113.313 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.598 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.1 m-85 -112.49 -26.08 8.87 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.294 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.446 ' CE1' HD13 ' A' ' 28' ' ' LEU . 40.7 t80 -95.2 115.06 26.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -131.96 141.78 49.42 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -134.42 138.24 44.65 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 118.535 0.607 . . . . 0.0 112.307 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.0 m -77.32 114.7 16.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.745 179.411 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 . . . . . 0 N--CA 1.436 -1.15 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -79.32 157.49 27.67 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.74 0.781 . . . . 0.0 112.167 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.414 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.7 t-160 -67.15 132.03 46.99 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 75.44 6.05 4.07 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.975 0.91 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.75 166.78 29.18 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -78.63 130.32 35.75 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.766 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.7 p -115.23 7.0 15.15 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -173.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.82 75.26 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 117.026 -2.511 . . . . 0.0 114.458 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.94 174.06 26.19 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 172.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.428 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.2 mt -59.2 110.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 117.588 0.694 . . . . 0.0 109.694 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.9 43.68 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.815 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -89.21 109.45 20.32 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -105.23 17.62 23.71 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.165 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.25 -163.22 37.87 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.53 114.47 2.14 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.763 2.309 . . . . 0.0 111.597 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -103.28 0.33 31.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.205 0.526 . . . . 0.0 112.036 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.81 109.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 73.4 m -69.44 155.43 40.47 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.053 0.541 . . . . 0.0 111.469 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.46 147.11 49.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.046 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -57.73 123.75 16.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -14.43 28.98 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 65.3 p -117.53 145.5 44.2 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.448 -0.443 . . . . 0.0 110.117 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -111.35 138.25 48.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.504 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.441 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.9 t -78.49 109.63 12.85 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.6 mt-30 -106.28 112.5 25.55 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 99.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD13 ' CE2' ' A' ' 32' ' ' TYR . 84.2 mt -84.27 -39.23 19.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.334 -173.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' N ' HD21 ' A' ' 29' ' ' ASN . 0.5 OUTLIER -134.96 164.65 42.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.14 -34.68 88.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.818 1.679 . . . . 0.0 113.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.63 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.6 m-85 -107.46 -24.96 11.62 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.439 ' CE2' HD13 ' A' ' 28' ' ' LEU . 43.8 t80 -94.98 114.39 26.2 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -128.53 139.08 52.49 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 31.8 tt0 -133.3 137.17 45.87 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.451 0.569 . . . . 0.0 111.885 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -75.68 109.39 9.22 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.467 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.28 -2.444 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.417 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.3 tp60 . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -77.03 166.68 22.98 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.72 0.772 . . . . 0.0 111.874 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -71.22 135.76 47.68 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 73.72 8.6 4.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.801 0.84 . . . . 0.0 112.161 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.08 155.75 21.16 Favored Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.0 tt0 -69.96 125.44 26.76 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.748 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -107.52 11.33 28.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.35 72.83 0.23 Allowed Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 117.278 -2.391 . . . . 0.0 114.741 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.31 179.52 30.86 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 171.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 68.0 mt -57.93 116.28 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 118.041 0.921 . . . . 0.0 110.327 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.27 -28.5 9.62 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.608 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -78.3 111.98 14.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.91 0.386 . . . . 0.0 110.189 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -102.15 -0.32 33.46 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.925 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -163.15 10.46 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.942 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.44 123.92 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.515 2.81 . . . . 0.0 112.649 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 p -109.74 -1.57 17.89 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.377 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.24 110.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.3 m -70.64 164.61 24.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.557 0.694 . . . . 0.0 112.761 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.97 160.41 31.95 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.017 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -63.4 116.58 5.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 123.363 0.665 . . . . 0.0 110.032 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.74 -14.33 34.95 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.871 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.6 p -108.17 142.83 37.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.573 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 p -106.85 137.68 44.44 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.51 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.0 t -79.56 100.36 7.73 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -98.56 118.95 36.4 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.927 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.87 98.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.2 -35.68 28.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.581 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -146.28 165.12 21.32 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.26 -37.42 94.43 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.155 1.903 . . . . 0.0 113.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.543 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 36.3 m-85 -101.13 -26.24 13.75 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.913 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -95.59 114.3 26.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.329 0.585 . . . . 0.0 112.334 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.9 m -132.78 135.14 45.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.404 ' OE1' HD22 ' A' ' 36' ' ' LEU . 32.8 tt0 -133.84 140.54 46.94 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.956 0.343 . . . . 0.0 111.868 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.4 m -77.08 112.3 13.58 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.404 HD22 ' OE1' ' A' ' 34' ' ' GLN . 90.1 mt . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.02 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.416 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.1 tp60 . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.1 p -80.55 162.02 24.51 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.756 0.789 . . . . 0.0 111.604 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -66.04 133.22 50.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 74.5 12.54 3.84 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.841 0.856 . . . . 0.0 112.485 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -101.76 169.55 20.26 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.4 tt0 -81.42 127.41 32.75 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.763 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -110.36 8.7 23.44 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.22 80.15 0.2 Allowed Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 116.862 -2.59 . . . . 0.0 114.317 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.84 179.64 30.22 Favored Glycine 0 C--N 1.284 -2.358 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 170.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.7 mt -62.46 111.04 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 117.984 0.892 . . . . 0.0 110.733 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.92 2.28 45.74 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.032 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -91.27 109.53 20.8 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.186 -0.597 . . . . 0.0 109.659 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -97.03 12.48 32.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.393 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.55 -165.78 41.62 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.613 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.03 115.18 2.38 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.937 2.425 . . . . 0.0 112.079 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -102.82 -8.53 20.71 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.939 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.54 108.92 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 85.6 m -71.34 155.8 40.23 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.39 138.05 56.82 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.2 m -57.54 128.13 35.49 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.84 23.9 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.6 p -108.23 146.44 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.7 p -107.68 131.31 54.54 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 121.263 -0.175 . . . . 0.0 110.879 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.47 103.26 4.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -103.56 116.14 31.82 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.214 0.53 . . . . 0.0 111.29 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.3 t -72.13 107.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.549 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.73 -33.84 13.46 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.273 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.27 165.04 34.67 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.25 -30.61 93.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.723 1.615 . . . . 0.0 112.562 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.603 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.0 m-85 -105.36 -25.49 12.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.932 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -95.23 114.35 26.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -130.67 136.86 49.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.6 tt0 -132.37 137.25 47.29 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 118.304 0.502 . . . . 0.0 111.938 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -75.89 113.08 12.98 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.807 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.892 179.52 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.408 HE21 ' HA3' ' A' ' 6' ' ' GLY . 58.0 tp60 . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.7 p -75.75 158.87 31.7 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.186 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 18.7 t-160 -65.4 134.88 54.45 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 73.63 9.26 4.96 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.106 0.962 . . . . 0.0 111.584 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.408 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -97.29 161.2 21.46 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -74.95 123.57 25.36 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.75 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.2 p -107.03 16.03 24.64 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 75.49 0.31 Allowed Glycine 0 CA--C 1.483 -1.911 0 C-N-CA 117.044 -2.503 . . . . 0.0 114.705 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.15 -178.92 30.25 Favored Glycine 0 C--N 1.29 -1.986 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 169.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.4 119.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.0 -23.64 27.03 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.259 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.77 110.18 20.79 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -107.54 8.58 29.37 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.308 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.9 -162.3 25.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.881 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.64 117.83 4.57 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.202 2.601 . . . . 0.0 112.964 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 p -100.88 -13.38 18.38 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.831 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -92.53 109.58 21.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 81.8 m -73.26 159.72 32.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.277 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 138.98 58.71 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.5 m -51.94 117.93 3.09 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.448 0.467 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -2.88 28.7 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.749 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.8 p -123.98 142.21 51.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 p -109.54 131.93 54.61 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.378 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -74.18 103.66 4.69 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -103.87 113.73 27.47 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.637 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.23 104.78 4.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.03 -45.86 9.83 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.846 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.427 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -128.47 167.28 19.62 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.27 -34.86 99.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 121.545 1.497 . . . . 0.0 112.374 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.4 m-85 -100.86 -26.8 13.63 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.646 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -96.62 114.57 26.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -131.7 136.04 47.33 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -136.09 137.0 40.6 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 118.671 0.669 . . . . 0.0 112.125 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.75 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.74 109.14 9.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.287 -2.139 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.788 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 . . . . . 0 N--CA 1.426 -1.665 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.0 p -78.56 170.5 16.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.581 0.705 . . . . 0.0 111.88 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.481 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.5 t-160 -76.14 135.7 39.81 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 73.59 9.29 4.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.03 0.932 . . . . 0.0 111.963 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.85 166.88 25.15 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.058 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.1 tt0 -76.86 130.12 37.16 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.7 p -118.42 10.14 12.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.55 74.57 0.03 OUTLIER Glycine 0 CA--C 1.474 -2.479 0 C-N-CA 116.348 -2.834 . . . . 0.0 114.129 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.47 169.62 21.6 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 172.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.435 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 75.2 mt -59.55 113.49 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 117.574 0.687 . . . . 0.0 109.551 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.79 -18.75 36.93 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.323 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -73.38 114.32 11.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 109.737 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -109.67 20.28 18.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.694 0.759 . . . . 0.0 110.274 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.61 -162.45 35.02 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.079 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.85 115.92 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.702 2.268 . . . . 0.0 111.512 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -102.35 -4.13 26.03 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.945 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.31 109.65 26.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 79.1 m -71.8 152.17 42.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.724 0.409 . . . . 0.0 110.734 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.41 122.08 11.07 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -53.23 131.71 37.6 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.523 0.677 . . . . 0.0 110.806 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.15 -9.55 26.96 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -170.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -123.97 150.23 45.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -113.7 137.53 51.49 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.632 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -79.62 103.81 9.79 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.433 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 47.2 mt-30 -102.5 117.79 35.47 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.301 0.572 . . . . 0.0 111.679 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.8 t -74.48 108.41 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.518 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.5 mt -93.03 -40.08 10.73 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.627 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -138.98 165.79 29.66 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -55.46 -36.86 94.99 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.981 1.787 . . . . 0.0 113.301 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.663 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -104.06 -25.89 12.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.264 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -95.51 114.53 26.3 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.7 139.44 50.3 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -132.3 137.52 47.49 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.785 0.721 . . . . 0.0 112.452 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -75.2 109.81 9.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.433 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 98.1 mt . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.417 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.6 tp60 . . . . . 0 N--CA 1.439 -1.01 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -77.04 160.43 29.1 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.577 0.703 . . . . 0.0 112.438 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.457 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 20.4 t-160 -67.14 133.49 49.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 78.1 m-85 77.03 5.27 3.29 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.119 0.968 . . . . 0.0 112.125 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.65 161.21 22.85 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.751 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -73.36 128.72 36.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.4 p -112.48 19.25 17.74 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.64 78.38 0.56 Allowed Glycine 0 CA--C 1.479 -2.198 0 C-N-CA 117.44 -2.314 . . . . 0.0 114.478 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.96 172.59 24.73 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 106.891 -2.484 . . . . 0.0 106.891 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 70.5 mt -58.25 113.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 118.006 0.903 . . . . 0.0 109.317 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.04 -8.22 33.34 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.193 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -95.67 110.05 22.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 m -97.9 0.98 47.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.064 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.04 -158.99 11.68 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.544 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.57 114.05 2.21 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.703 2.935 . . . . 0.0 112.466 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.1 p -101.34 -13.73 17.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -88.9 110.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 73.3 m -72.07 155.63 40.09 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.986 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.11 140.26 58.85 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 125.19 16.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 123.507 0.505 . . . . 0.0 110.538 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -12.48 30.04 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.9 p -116.78 146.96 42.49 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -111.73 137.4 49.69 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.951 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.4 t -80.83 100.77 8.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -102.12 115.8 31.32 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.755 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -79.76 94.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.6 mt -76.5 -37.56 56.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.855 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.01 163.7 45.99 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.47 -35.61 92.53 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.319 2.013 . . . . 0.0 112.712 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.6 m-85 -100.61 -25.6 14.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.456 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -96.24 113.88 25.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.7 m -129.89 135.33 48.23 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.03 138.24 42.0 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.287 0.494 . . . . 0.0 111.794 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -75.62 109.09 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--N 1.294 -1.812 0 C-N-CA 123.209 0.604 . . . . 0.0 110.388 -179.521 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.405 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.0 tp60 . . . . . 0 N--CA 1.416 -2.14 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.0 p -70.18 162.42 28.38 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 122.292 1.044 . . . . 0.0 112.745 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -72.4 129.72 39.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 77.43 7.16 2.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.766 0.826 . . . . 0.0 112.169 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.405 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.7 164.9 24.32 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.664 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.6 tt0 -75.59 128.19 34.72 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.771 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -111.3 8.98 21.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -174.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.43 66.88 0.06 OUTLIER Glycine 0 CA--C 1.48 -2.134 0 C-N-CA 116.83 -2.605 . . . . 0.0 113.807 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.83 173.15 25.41 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -65.75 122.51 16.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.69 4.06 57.08 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.32 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 48.3 t80 -105.89 110.25 22.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 m -99.76 6.01 45.54 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.25 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.34 -165.59 41.21 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.96 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.24 125.86 17.31 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.834 3.023 . . . . 0.0 112.979 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 p -106.2 -2.98 21.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.02 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.57 109.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.3 m -73.19 149.13 43.14 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.396 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.67 152.82 34.29 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.22 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 m -58.98 119.98 8.24 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.302 0.572 . . . . 0.0 110.57 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.47 -11.61 30.68 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.627 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.498 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.0 p -114.27 142.61 46.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.901 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 p -112.53 133.47 54.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.172 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.27 105.07 7.11 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.13 115.15 29.9 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.966 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.61 98.92 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -81.68 -37.7 27.01 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.206 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -143.28 163.4 37.45 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.42 -38.24 89.46 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.437 2.092 . . . . 0.0 113.132 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.605 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -101.89 -26.44 13.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.921 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -96.73 114.75 26.41 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.664 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -129.46 138.79 51.62 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -132.95 137.07 46.46 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 118.896 0.771 . . . . 0.0 112.098 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.771 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.1 m -78.29 108.62 11.75 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.289 -2.032 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.712 177.798 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.41 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p -78.94 165.75 23.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.965 0.888 . . . . 0.0 112.194 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -72.31 128.24 35.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.693 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 75.85 16.0 2.46 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.232 1.013 . . . . 0.0 111.947 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.41 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -103.0 162.75 16.08 Favored Glycine 0 N--CA 1.414 -2.789 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -75.71 127.98 34.21 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 26.8 p -112.24 3.7 17.32 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.01 72.37 0.04 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 116.43 -2.795 . . . . 0.0 114.498 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 170.18 23.03 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.579 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.7 mt -58.39 122.63 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 117.828 0.814 . . . . 0.0 108.947 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -27.06 19.17 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -84.93 115.59 22.88 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.8 m -115.8 17.68 15.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.081 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 -156.46 18.06 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.459 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.08 113.81 1.74 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.21 2.607 . . . . 0.0 111.246 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -109.78 -1.61 17.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.451 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.67 110.5 31.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.499 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 85.8 m -69.16 158.04 35.69 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 159.64 20.98 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.517 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -63.86 118.21 8.05 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.25 0.548 . . . . 0.0 110.415 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.64 29.13 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.5 p -108.3 144.01 36.38 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.418 -0.46 . . . . 0.0 110.442 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.9 p -109.81 136.29 49.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.36 100.5 5.18 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -99.42 112.43 24.62 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.638 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.65 101.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.82 -39.88 17.84 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.622 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -140.18 165.86 27.58 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.15 -35.87 95.73 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.059 1.839 . . . . 0.0 113.508 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.617 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.0 m-85 -106.62 -25.42 11.79 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.262 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -95.92 114.43 26.15 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -130.81 137.91 49.64 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -133.91 138.33 45.47 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 118.262 0.483 . . . . 0.0 112.15 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -76.37 111.56 11.96 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.911 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.285 -2.228 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.329 179.53 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 120.597 0.237 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.4 p -80.13 164.54 23.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.681 0.753 . . . . 0.0 111.869 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.436 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 11.4 t-160 -71.89 135.46 46.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 73.7 4.35 4.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.271 1.028 . . . . 0.0 111.886 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.26 162.94 32.55 Favored Glycine 0 N--CA 1.421 -2.301 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.8 tt0 -79.07 120.72 24.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.752 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.0 p -99.8 15.43 26.95 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.53 86.92 0.72 Allowed Glycine 0 CA--C 1.482 -1.981 0 C-N-CA 117.64 -2.219 . . . . 0.0 114.824 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 179.2 29.17 Favored Glycine 0 C--N 1.287 -2.194 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 170.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -64.42 114.04 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 118.0 0.9 . . . . 0.0 109.153 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.82 -13.65 29.49 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.342 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -87.31 112.1 21.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 m -96.87 -4.31 40.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.878 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 -164.52 17.2 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.754 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.8 123.01 12.12 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.401 2.734 . . . . 0.0 112.422 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -105.5 -17.99 14.24 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.13 109.56 18.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -69.17 146.46 52.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 123.263 0.352 . . . . 0.0 111.165 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.64 133.96 54.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.411 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 m -47.29 127.89 11.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.631 0.729 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.71 -19.72 25.59 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.774 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.4 p -113.8 153.03 29.79 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 122.429 -0.454 . . . . 0.0 109.917 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -113.54 138.33 50.3 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.895 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -83.09 110.24 17.83 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -108.46 114.5 28.38 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.63 97.82 2.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.78 -38.16 29.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.417 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -142.64 168.66 12.67 Favored Pre-proline 0 C--N 1.297 -1.692 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.59 -35.16 98.9 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.826 1.684 . . . . 0.0 113.198 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.1 m-85 -108.6 -25.46 10.88 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.493 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -96.14 115.25 27.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -132.89 141.03 48.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -136.27 139.56 42.77 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.741 0.7 . . . . 0.0 112.229 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.752 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.1 m -78.05 113.35 15.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.434 175.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.289 -2.039 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.908 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.532 ' OE1' ' HG2' ' A' ' 16' ' ' PRO . 52.0 tp60 . . . . . 0 N--CA 1.433 -1.298 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.8 p -80.62 167.69 19.75 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.067 0.937 . . . . 0.0 112.759 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -71.89 128.48 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.999 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 76.19 6.87 3.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.453 1.101 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.413 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.72 161.7 22.05 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.638 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.6 tt0 -77.85 121.44 24.12 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.706 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.1 p -106.76 16.19 24.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 123.93 76.64 0.32 Allowed Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 116.354 -2.832 . . . . 0.0 114.885 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.79 176.33 28.39 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 170.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 72.6 mt -60.47 113.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 118.177 0.988 . . . . 0.0 110.666 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.4 -11.56 21.68 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.167 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.442 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 51.5 t80 -91.97 132.23 36.68 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.1 m -128.49 13.32 6.51 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.84 -142.16 10.6 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.638 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.532 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -71.76 113.94 3.8 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.25 1.967 . . . . 0.0 111.282 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -102.79 -0.59 31.22 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.855 0.836 . . . . 0.0 112.098 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -106.96 118.99 55.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 74.2 m -73.29 160.24 32.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.4 0.619 . . . . 0.0 112.2 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 144.9 56.09 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.104 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -62.44 124.77 21.81 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.63 -14.55 27.21 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -173.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.2 p -119.59 147.73 44.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -113.76 138.08 50.75 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.881 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.8 t -78.86 98.17 6.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.3 mt-30 -96.89 113.85 25.43 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.64 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.4 96.26 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.0 mt -79.92 -38.36 32.64 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.049 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -135.48 165.02 39.43 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -55.86 -34.31 91.12 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.809 1.673 . . . . 0.0 113.187 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.618 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.7 m-85 -106.04 -25.25 12.15 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.274 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -95.09 115.06 26.95 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -130.84 134.54 46.91 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -133.41 137.44 45.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 118.446 0.566 . . . . 0.0 111.974 -175.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.706 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.8 m -76.8 110.03 11.07 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.999 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.286 -2.183 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.414 HE21 ' HA3' ' A' ' 6' ' ' GLY . 52.0 tp60 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -76.65 159.16 30.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.736 0.779 . . . . 0.0 112.283 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.414 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.4 t-160 -66.49 134.53 52.62 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 76.34 0.32 3.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.163 0.985 . . . . 0.0 112.72 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.414 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -89.31 161.81 30.36 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.609 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -75.18 123.39 25.17 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.739 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -105.63 11.46 32.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.53 88.36 0.84 Allowed Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 116.926 -2.559 . . . . 0.0 114.937 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.56 -178.03 31.14 Favored Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 169.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.4 113.27 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 118.12 0.96 . . . . 0.0 109.099 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.81 -16.37 28.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -82.77 110.26 17.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 m -98.8 2.55 46.94 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.571 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.18 -164.66 13.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.154 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.62 116.53 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.88 2.387 . . . . 0.0 111.873 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.9 p -104.84 -4.81 21.8 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.098 0.475 . . . . 0.0 112.042 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.33 109.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.496 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.8 m -65.29 154.09 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 123.762 0.825 . . . . 0.0 112.35 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 146.9 52.31 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.417 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -50.21 122.74 7.25 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.107 0.963 . . . . 0.0 111.684 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.81 -20.12 24.88 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.132 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 78.7 p -108.31 159.68 16.45 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 122.463 -0.433 . . . . 0.0 111.178 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -119.66 142.27 48.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.9 t -82.23 110.31 17.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -107.7 117.58 34.49 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.93 101.78 3.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' C ' HD21 ' A' ' 29' ' ' ASN . 90.3 mt -86.85 -39.75 15.56 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.859 0.837 . . . . 0.0 109.62 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.404 HD21 ' C ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -133.34 162.93 54.66 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -57.98 -27.26 78.49 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.858 1.705 . . . . 0.0 113.137 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.496 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.5 m-85 -110.36 -25.19 10.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.321 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -94.51 114.02 25.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.609 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.02 139.55 51.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -134.47 137.79 44.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 117.967 0.349 . . . . 0.0 111.448 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.739 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -74.03 116.31 14.51 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.009 -179.34 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.0 p -73.07 166.1 23.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.51 1.148 . . . . 0.0 113.15 -174.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 14.4 t-160 -75.2 134.02 41.29 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 72.9 m-85 75.08 7.62 4.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.876 0.871 . . . . 0.0 111.081 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -93.5 167.61 28.79 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -81.72 135.39 35.5 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.684 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.2 p -124.74 8.2 8.19 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.35 68.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 116.337 -2.84 . . . . 0.0 115.198 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.04 169.77 22.17 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.588 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.8 mt -58.95 111.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 117.492 0.646 . . . . 0.0 109.492 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.86 -1.8 52.07 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.067 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -84.09 109.84 18.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 117.282 0.541 . . . . 0.0 110.393 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.5 m -93.92 7.01 46.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.48 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.37 -176.36 48.69 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.471 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.12 125.1 14.01 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.581 2.188 . . . . 0.0 110.662 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -99.23 -8.31 25.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.57 0.7 . . . . 0.0 111.006 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.91 109.49 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 58.9 m -76.13 160.69 29.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.052 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.7 121.08 11.36 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 m -53.68 136.68 38.98 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.608 0.718 . . . . 0.0 111.547 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.28 -20.39 23.47 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.2 p -108.53 147.49 31.65 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -107.06 132.04 53.41 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.352 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.9 t -76.0 106.67 7.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -105.48 115.77 30.82 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.29 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -73.85 104.71 2.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.67 -45.23 9.0 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.804 -175.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.406 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -130.01 167.5 20.36 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.428 ' O ' HG13 ' A' ' 11' ' ' ILE . 49.1 Cg_exo -60.63 -28.7 87.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.566 1.511 . . . . 0.0 113.198 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.631 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 32.3 m-85 -110.25 -26.04 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -95.17 114.64 26.46 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.1 m -131.31 136.64 48.31 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' OE1' HD22 ' A' ' 36' ' ' LEU . 32.3 tt0 -131.52 139.43 49.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 118.601 0.637 . . . . 0.0 112.457 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 38.1 m -78.56 109.25 12.59 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.533 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.468 HD22 ' OE1' ' A' ' 34' ' ' GLN . 95.3 mt . . . . . 0 C--N 1.294 -1.82 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.491 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.9 p -68.5 158.16 34.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.945 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -64.46 132.83 51.09 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 76.49 4.06 3.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.015 0.926 . . . . 0.0 112.35 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.52 154.18 24.78 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -71.17 124.42 24.42 Favored 'General case' 0 C--O 1.202 -1.434 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.751 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.1 p -106.17 14.73 27.25 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -173.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.3 80.71 0.46 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 116.828 -2.606 . . . . 0.0 114.963 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.66 177.45 29.36 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 106.881 -2.487 . . . . 0.0 106.881 170.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.11 114.2 2.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 118.27 1.035 . . . . 0.0 108.971 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.51 -6.49 26.38 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.748 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -97.37 109.82 22.5 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.366 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -100.89 18.74 18.76 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.498 0.666 . . . . 0.0 110.765 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.63 -165.27 38.43 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -58.18 114.9 2.18 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.904 2.403 . . . . 0.0 111.915 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -104.55 -2.83 24.65 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.847 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.6 113.29 43.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 81.7 m -70.91 156.26 39.81 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 154.1 38.39 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.499 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -54.77 118.79 4.53 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.021 0.528 . . . . 0.0 110.831 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.84 26.26 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.139 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.6 p -108.78 143.83 37.41 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.456 -0.438 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.6 p -110.78 145.32 38.34 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.862 -0.154 . . . . 0.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.5 t -84.76 110.51 18.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -107.38 111.89 24.44 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.814 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.6 100.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 32' ' ' TYR . 79.9 mt -82.78 -40.74 20.04 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.028 -174.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -136.07 162.94 53.74 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.06 -28.14 68.14 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.02 1.813 . . . . 0.0 113.463 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.545 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 40.9 m-85 -111.34 -25.51 9.62 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.617 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' HD12 ' A' ' 28' ' ' LEU . 38.8 t80 -96.6 115.0 26.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -129.95 140.01 50.99 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -133.05 138.82 46.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 118.903 0.774 . . . . 0.0 112.034 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.751 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.1 m -76.21 114.24 14.66 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.064 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.286 -2.16 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.879 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.413 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.4 tp60 . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.3 p -75.69 162.43 28.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.982 0.896 . . . . 0.0 112.13 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -68.77 133.44 48.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 74.35 6.84 4.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.987 0.915 . . . . 0.0 112.19 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.413 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.61 160.89 22.78 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.5 tt0 -74.4 129.54 37.97 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.795 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.9 p -111.58 5.12 19.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.13 82.77 0.1 Allowed Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 116.78 -2.629 . . . . 0.0 114.51 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.25 174.52 26.29 Favored Glycine 0 N--CA 1.417 -2.605 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 170.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.3 mt -59.55 118.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 117.788 0.794 . . . . 0.0 109.61 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.41 63.07 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.487 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -76.87 111.54 12.52 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.28 -0.541 . . . . 0.0 110.488 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -94.65 2.98 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.938 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.1 -174.28 50.27 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.525 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -62.32 127.84 22.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.177 2.585 . . . . 0.0 112.617 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.5 p -105.96 -5.67 19.42 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -99.29 109.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 99.4 m -66.44 154.52 40.0 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.64 0.587 . . . . 0.0 112.304 -178.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 150.1 45.07 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.389 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -59.72 124.37 19.92 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.247 0.546 . . . . 0.0 110.822 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.23 -18.42 28.19 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.8 p -108.32 149.98 27.94 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.8 p -114.43 140.41 48.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -80.73 103.37 10.52 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.66 114.24 28.3 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.172 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -73.16 106.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.8 mt -92.38 -33.29 14.63 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.961 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -143.97 161.85 43.6 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.09 -31.32 89.94 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.891 1.727 . . . . 0.0 112.87 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.555 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 64.8 m-85 -105.71 -26.08 11.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.938 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' CE2' HD12 ' A' ' 28' ' ' LEU . 51.5 t80 -96.69 114.56 26.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -132.75 136.47 46.37 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -131.02 138.29 49.58 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.795 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -75.72 109.11 9.04 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--N 1.293 -1.868 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.834 178.935 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.406 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.0 tp60 . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.1 p -76.03 160.98 29.28 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.075 0.941 . . . . 0.0 112.858 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 17.1 t-160 -66.06 133.04 49.92 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 82.6 m-85 76.9 3.61 3.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.243 1.017 . . . . 0.0 111.591 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.406 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -93.75 163.44 25.91 Favored Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -77.05 123.83 26.93 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 19.4 p -105.64 6.98 32.51 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -175.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.34 85.4 0.42 Allowed Glycine 0 CA--C 1.476 -2.388 0 C-N-CA 116.512 -2.756 . . . . 0.0 114.909 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.73 -176.87 31.0 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 107.019 -2.432 . . . . 0.0 107.019 169.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.09 118.24 6.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.854 0.827 . . . . 0.0 109.577 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.5 9.0 59.31 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.293 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -80.56 115.32 20.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.393 0.597 . . . . 0.0 110.508 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -84.63 -3.45 58.5 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.923 0.889 . . . . 0.0 113.326 -176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.06 -167.23 33.03 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.245 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.52 130.06 21.45 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.381 2.721 . . . . 0.0 112.098 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -104.4 -6.47 20.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.917 0.865 . . . . 0.0 111.866 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.57 109.04 22.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 87.9 m -68.45 156.22 38.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 123.612 0.57 . . . . 0.0 112.423 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 148.22 43.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.943 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -59.06 120.72 9.65 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -13.65 28.09 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.84 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.5 p -116.88 150.48 38.36 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.371 -0.488 . . . . 0.0 110.077 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -116.58 144.48 44.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.1 t -79.2 112.17 16.15 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.487 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.1 mt-30 -106.45 116.61 32.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.333 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -73.01 111.08 6.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.1 mt -97.0 -31.61 12.43 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.56 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -149.63 166.14 15.93 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.32 -36.22 96.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.19 1.927 . . . . 0.0 113.627 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.583 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.61 -25.73 12.15 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.281 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -95.93 114.96 26.73 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.596 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.2 m -129.33 143.55 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.7 tt0 -132.04 137.51 47.84 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.688 0.676 . . . . 0.0 111.952 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.818 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -74.93 111.64 10.34 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.042 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.487 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.0 mt . . . . . 0 C--N 1.291 -1.969 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.482 ' OE1' ' HG2' ' A' ' 16' ' ' PRO . 56.4 tp60 . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.1 p -73.6 167.87 20.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.045 0.926 . . . . 0.0 112.722 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -73.49 132.96 43.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.506 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 75.35 2.76 3.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.29 1.036 . . . . 0.0 112.135 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.412 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -91.43 161.81 27.73 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.4 tt0 -75.68 123.32 25.36 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.81 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.4 p -103.63 -3.62 24.91 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.74 83.57 0.12 Allowed Glycine 0 CA--C 1.479 -2.183 0 C-N-CA 116.334 -2.841 . . . . 0.0 114.966 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -173.25 29.89 Favored Glycine 0 C--N 1.284 -2.34 0 N-CA-C 107.925 -2.07 . . . . 0.0 107.925 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 78.6 mt -64.41 116.37 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.2 54.77 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.025 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -91.91 109.73 21.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.159 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 m -89.47 -5.6 57.19 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.839 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.15 -160.23 26.64 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.41 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 39.9 Cg_endo -72.14 131.53 18.12 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.1 2.533 . . . . 0.0 112.59 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.0 p -107.57 3.07 24.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -105.59 109.71 28.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 75.5 m -67.62 150.38 48.84 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.815 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 156.06 24.02 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.165 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -58.52 119.34 6.84 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.458 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -11.9 30.3 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.907 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.41 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.1 p -118.62 146.27 44.78 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.512 -0.404 . . . . 0.0 110.345 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 p -114.22 142.17 46.61 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.5 t -79.88 112.17 16.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 73.6 mt-30 -110.59 114.22 27.45 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.235 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 t -77.49 104.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 32' ' ' TYR . 86.6 mt -89.57 -34.16 16.45 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.528 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 37.2 m-80 -143.42 167.41 15.79 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.91 -41.5 74.37 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.149 1.899 . . . . 0.0 113.62 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.4 m-85 -101.7 -25.04 13.99 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.199 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 41.7 t80 -95.04 115.42 27.41 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.7 m -131.5 140.04 49.45 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -134.31 138.4 44.93 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.244 0.475 . . . . 0.0 111.839 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.81 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.0 m -76.86 107.44 9.18 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.951 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.423 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.2 mt . . . . . 0 C--N 1.282 -2.339 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.413 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.1 p -77.27 168.01 20.76 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 112.145 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -71.21 135.28 47.44 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 73.71 9.7 4.85 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.954 0.901 . . . . 0.0 112.651 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.413 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.19 154.17 22.22 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.845 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.7 tt0 -70.14 123.27 21.2 Favored 'General case' 0 C--O 1.205 -1.241 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.9 p -102.21 13.01 35.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -171.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.71 63.22 0.18 Allowed Glycine 0 CA--C 1.48 -2.114 0 C-N-CA 117.047 -2.502 . . . . 0.0 114.876 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -85.19 173.24 48.22 Favored Glycine 0 N--CA 1.421 -2.317 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.453 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 63.9 mt -56.73 111.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 117.919 0.86 . . . . 0.0 109.951 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.82 -13.72 34.83 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.8 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -85.51 109.15 18.29 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 m -107.43 30.24 6.43 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.422 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.06 -160.67 28.46 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.06 118.68 5.58 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.944 2.429 . . . . 0.0 111.014 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -107.55 0.56 22.75 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.415 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.48 109.55 28.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 68.9 m -71.38 155.75 40.28 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 123.158 0.583 . . . . 0.0 112.051 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.54 147.63 50.91 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.046 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.7 m -57.6 122.62 13.17 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -10.08 30.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.3 p -118.67 141.84 48.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -108.35 129.12 55.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.422 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.84 98.54 3.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -98.94 117.03 32.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.268 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.4 t -78.43 93.95 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.3 -41.97 32.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.875 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 39.8 m-80 -139.91 166.53 23.23 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.04 -43.03 63.32 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.265 1.976 . . . . 0.0 112.866 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.632 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -99.64 -26.37 14.09 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.009 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 31.9 t80 -94.94 113.95 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.456 0.646 . . . . 0.0 111.722 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -135.49 137.18 41.89 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -137.05 141.3 42.43 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.872 0.76 . . . . 0.0 111.75 -172.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.9 m -78.96 107.12 11.47 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.276 -2.602 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.202 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.402 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.4 tp60 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 172.68 13.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.011 0.91 . . . . 0.0 112.189 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -78.58 133.46 37.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 74.04 6.34 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.909 0.884 . . . . 0.0 111.818 -175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.402 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.78 160.45 25.29 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.1 tt0 -78.84 127.41 32.0 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.0 p -106.68 9.37 31.25 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.65 80.57 0.48 Allowed Glycine 0 CA--C 1.489 -1.576 0 C-N-CA 117.252 -2.404 . . . . 0.0 115.207 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.24 -179.15 30.08 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 168.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 71.4 mt -62.78 114.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 117.854 0.827 . . . . 0.0 108.859 175.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.74 2.43 32.38 Favored Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.664 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -98.08 133.3 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -117.86 10.68 13.28 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.097 0.475 . . . . 0.0 111.133 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.08 -164.6 35.15 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.069 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.37 124.66 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.174 2.582 . . . . 0.0 112.159 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.8 p -106.09 -7.83 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.771 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -99.33 111.9 30.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 82.2 m -73.53 159.93 32.44 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.521 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 151.52 43.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.77 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -60.6 121.54 12.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.018 0.437 . . . . 0.0 109.861 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -19.81 24.77 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.586 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.7 p -107.62 140.77 40.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 27.6 p -105.24 136.33 44.95 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.359 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.1 t -79.91 99.03 7.38 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -98.55 116.73 31.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.588 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.92 93.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.51 -34.22 58.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.542 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -142.92 165.28 27.14 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 -32.51 93.65 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 121.453 1.435 . . . . 0.0 112.557 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.565 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.0 m-85 -107.76 -26.83 10.61 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.411 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -96.68 115.24 27.09 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -124.63 142.47 51.35 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -135.7 141.06 44.88 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 118.762 0.71 . . . . 0.0 112.334 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -82.03 107.46 14.75 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.073 176.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 85.6 mt . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.389 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.417 HE21 ' HA3' ' A' ' 6' ' ' GLY . 59.9 tp60 . . . . . 0 N--CA 1.41 -2.445 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.2 p -79.08 172.28 14.02 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.922 0.867 . . . . 0.0 111.163 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -72.66 135.07 45.36 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.259 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 73.77 6.38 4.92 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.319 1.048 . . . . 0.0 112.075 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.15 166.8 29.92 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.662 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -79.81 128.66 33.71 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.791 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 16.2 p -110.57 15.48 22.05 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.63 84.42 0.51 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 117.109 -2.472 . . . . 0.0 114.412 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.32 -179.4 29.89 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 169.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.66 109.62 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 117.826 0.813 . . . . 0.0 109.199 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.65 -11.12 32.77 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.12 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -79.12 110.15 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.025 0.441 . . . . 0.0 109.904 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 p -93.78 0.61 56.4 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.936 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.42 -168.55 40.65 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.305 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.86 122.37 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.845 2.364 . . . . 0.0 112.511 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 p -102.6 -15.72 16.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.657 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.43 108.97 20.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 77.9 m -68.92 153.11 44.37 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.094 0.473 . . . . 0.0 111.587 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.61 146.94 47.35 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -60.66 120.49 10.14 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.944 0.402 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.58 -10.66 30.43 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.486 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 71.1 p -114.31 143.83 44.24 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -108.7 132.72 53.65 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.227 0.329 . . . . 0.0 110.634 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.1 t -78.81 100.75 7.28 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -100.2 110.89 23.15 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.59 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.32 102.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.71 -39.4 16.04 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.437 -177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -139.41 162.79 49.66 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.7 -32.88 85.66 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.108 1.872 . . . . 0.0 113.041 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.573 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.7 m-85 -106.28 -26.16 11.64 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.491 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -96.79 114.45 26.08 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -131.74 139.35 48.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -135.08 138.36 43.77 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 118.55 0.614 . . . . 0.0 112.45 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.791 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -79.41 107.63 12.32 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.291 -1.966 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.235 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 120.718 0.294 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 49.5 tp60 -74.21 145.28 44.27 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.7 p -77.31 171.41 14.9 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 111.821 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.442 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.6 t-160 -78.01 134.46 37.8 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 94.0 m-85 74.81 11.79 3.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.924 0.89 . . . . 0.0 111.596 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.37 163.82 17.91 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -77.28 122.38 25.02 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.8 p -106.8 14.96 26.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.96 85.98 0.6 Allowed Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 116.954 -2.546 . . . . 0.0 114.889 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 177.27 28.16 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 168.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.432 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 67.0 mt -65.09 111.85 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 118.129 0.965 . . . . 0.0 109.138 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.58 -9.52 21.87 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.91 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -106.42 108.57 20.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -112.62 11.64 19.64 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.943 0.401 . . . . 0.0 111.091 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.59 -147.44 1.8 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.552 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.04 98.66 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.061 2.507 . . . . 0.0 112.093 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 p -98.7 -14.78 19.64 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.036 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.49 110.93 23.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 70.8 m -69.44 157.09 37.76 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.657 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.68 147.49 49.34 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 m -60.9 126.65 28.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.524 0.678 . . . . 0.0 110.54 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.79 -20.29 24.72 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.2 p -108.14 143.25 37.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 122.403 -0.469 . . . . 0.0 109.803 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 p -107.72 137.15 46.25 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.477 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.7 t -82.08 102.22 10.88 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.96 117.96 36.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.321 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.9 t -76.63 117.91 22.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.446 HD13 ' CE1' ' A' ' 32' ' ' TYR . 83.9 mt -101.7 -42.15 6.3 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.559 0.695 . . . . 0.0 109.598 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -135.62 165.03 39.24 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.25 -27.58 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.032 1.822 . . . . 0.0 113.313 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.598 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.1 m-85 -112.49 -26.08 8.87 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.294 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.446 ' CE1' HD13 ' A' ' 28' ' ' LEU . 40.7 t80 -95.2 115.06 26.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -131.96 141.78 49.42 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -134.42 138.24 44.65 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 118.535 0.607 . . . . 0.0 112.307 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.0 m -77.32 114.7 16.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.745 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.507 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 C--O 1.241 0.647 0 CA-C-O 120.871 0.367 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -70.87 142.57 51.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.966 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -79.32 157.49 27.67 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.74 0.781 . . . . 0.0 112.167 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.414 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.7 t-160 -67.15 132.03 46.99 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 75.44 6.05 4.07 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.975 0.91 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.75 166.78 29.18 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -78.63 130.32 35.75 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.766 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.7 p -115.23 7.0 15.15 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -173.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.82 75.26 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 117.026 -2.511 . . . . 0.0 114.458 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.94 174.06 26.19 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 172.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.428 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.2 mt -59.2 110.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 117.588 0.694 . . . . 0.0 109.694 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.9 43.68 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.815 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -89.21 109.45 20.32 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -105.23 17.62 23.71 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.165 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.25 -163.22 37.87 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.53 114.47 2.14 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.763 2.309 . . . . 0.0 111.597 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -103.28 0.33 31.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.205 0.526 . . . . 0.0 112.036 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.81 109.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 73.4 m -69.44 155.43 40.47 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.053 0.541 . . . . 0.0 111.469 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.46 147.11 49.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.046 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -57.73 123.75 16.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -14.43 28.98 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 65.3 p -117.53 145.5 44.2 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.448 -0.443 . . . . 0.0 110.117 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -111.35 138.25 48.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.504 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.441 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.9 t -78.49 109.63 12.85 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.6 mt-30 -106.28 112.5 25.55 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 99.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD13 ' CE2' ' A' ' 32' ' ' TYR . 84.2 mt -84.27 -39.23 19.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.334 -173.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' N ' HD21 ' A' ' 29' ' ' ASN . 0.5 OUTLIER -134.96 164.65 42.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.14 -34.68 88.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.818 1.679 . . . . 0.0 113.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.63 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.6 m-85 -107.46 -24.96 11.62 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.439 ' CE2' HD13 ' A' ' 28' ' ' LEU . 43.8 t80 -94.98 114.39 26.2 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -128.53 139.08 52.49 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 31.8 tt0 -133.3 137.17 45.87 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.451 0.569 . . . . 0.0 111.885 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -75.68 109.39 9.22 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.467 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.28 -2.444 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 54.3 tp60 -70.84 140.3 51.11 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -77.03 166.68 22.98 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.72 0.772 . . . . 0.0 111.874 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -71.22 135.76 47.68 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 73.72 8.6 4.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.801 0.84 . . . . 0.0 112.161 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.08 155.75 21.16 Favored Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.0 tt0 -69.96 125.44 26.76 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.748 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -107.52 11.33 28.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.35 72.83 0.23 Allowed Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 117.278 -2.391 . . . . 0.0 114.741 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.31 179.52 30.86 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 171.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 68.0 mt -57.93 116.28 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 118.041 0.921 . . . . 0.0 110.327 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.27 -28.5 9.62 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.608 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -78.3 111.98 14.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.91 0.386 . . . . 0.0 110.189 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -102.15 -0.32 33.46 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.925 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -163.15 10.46 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.942 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.44 123.92 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.515 2.81 . . . . 0.0 112.649 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 p -109.74 -1.57 17.89 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.377 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.24 110.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.3 m -70.64 164.61 24.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.557 0.694 . . . . 0.0 112.761 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.97 160.41 31.95 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.017 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -63.4 116.58 5.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 123.363 0.665 . . . . 0.0 110.032 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.74 -14.33 34.95 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.871 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.6 p -108.17 142.83 37.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.573 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 p -106.85 137.68 44.44 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.51 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.0 t -79.56 100.36 7.73 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -98.56 118.95 36.4 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.927 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.87 98.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.2 -35.68 28.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.581 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -146.28 165.12 21.32 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.26 -37.42 94.43 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.155 1.903 . . . . 0.0 113.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.543 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 36.3 m-85 -101.13 -26.24 13.75 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.913 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -95.59 114.3 26.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.329 0.585 . . . . 0.0 112.334 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.9 m -132.78 135.14 45.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.404 ' OE1' HD22 ' A' ' 36' ' ' LEU . 32.8 tt0 -133.84 140.54 46.94 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.956 0.343 . . . . 0.0 111.868 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.4 m -77.08 112.3 13.58 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.404 HD22 ' OE1' ' A' ' 34' ' ' GLN . 90.1 mt . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.02 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.439 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.44 -0.962 0 CA-C-O 120.85 0.357 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.416 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.1 tp60 -77.7 141.01 39.6 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 174.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.1 p -80.55 162.02 24.51 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.756 0.789 . . . . 0.0 111.604 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -66.04 133.22 50.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 74.5 12.54 3.84 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.841 0.856 . . . . 0.0 112.485 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -101.76 169.55 20.26 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.4 tt0 -81.42 127.41 32.75 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.763 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -110.36 8.7 23.44 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.22 80.15 0.2 Allowed Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 116.862 -2.59 . . . . 0.0 114.317 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.84 179.64 30.22 Favored Glycine 0 C--N 1.284 -2.358 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 170.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.7 mt -62.46 111.04 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 117.984 0.892 . . . . 0.0 110.733 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.92 2.28 45.74 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.032 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -91.27 109.53 20.8 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.186 -0.597 . . . . 0.0 109.659 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -97.03 12.48 32.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.393 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.55 -165.78 41.62 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.613 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.03 115.18 2.38 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.937 2.425 . . . . 0.0 112.079 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -102.82 -8.53 20.71 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.939 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.54 108.92 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 85.6 m -71.34 155.8 40.23 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.39 138.05 56.82 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.2 m -57.54 128.13 35.49 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.84 23.9 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.6 p -108.23 146.44 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.7 p -107.68 131.31 54.54 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 121.263 -0.175 . . . . 0.0 110.879 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.47 103.26 4.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -103.56 116.14 31.82 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.214 0.53 . . . . 0.0 111.29 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.3 t -72.13 107.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.549 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.73 -33.84 13.46 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.273 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.27 165.04 34.67 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.25 -30.61 93.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.723 1.615 . . . . 0.0 112.562 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.603 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.0 m-85 -105.36 -25.49 12.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.932 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -95.23 114.35 26.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -130.67 136.86 49.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.6 tt0 -132.37 137.25 47.29 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 118.304 0.502 . . . . 0.0 111.938 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -75.89 113.08 12.98 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.807 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.892 179.52 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.247 0.967 0 CA-C-O 120.575 0.226 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.408 HE21 ' HA3' ' A' ' 6' ' ' GLY . 58.0 tp60 -70.43 138.06 50.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.7 p -75.75 158.87 31.7 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.186 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 18.7 t-160 -65.4 134.88 54.45 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 73.63 9.26 4.96 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.106 0.962 . . . . 0.0 111.584 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -97.29 161.2 21.46 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -74.95 123.57 25.36 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.75 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.2 p -107.03 16.03 24.64 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 75.49 0.31 Allowed Glycine 0 CA--C 1.483 -1.911 0 C-N-CA 117.044 -2.503 . . . . 0.0 114.705 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.15 -178.92 30.25 Favored Glycine 0 C--N 1.29 -1.986 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 169.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.4 119.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.0 -23.64 27.03 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.259 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.77 110.18 20.79 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -107.54 8.58 29.37 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.308 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.9 -162.3 25.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.881 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.64 117.83 4.57 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.202 2.601 . . . . 0.0 112.964 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 p -100.88 -13.38 18.38 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.831 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -92.53 109.58 21.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 81.8 m -73.26 159.72 32.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.277 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 138.98 58.71 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.5 m -51.94 117.93 3.09 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.448 0.467 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -2.88 28.7 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.749 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.8 p -123.98 142.21 51.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 p -109.54 131.93 54.61 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.378 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -74.18 103.66 4.69 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -103.87 113.73 27.47 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.637 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.23 104.78 4.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.03 -45.86 9.83 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.846 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.427 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -128.47 167.28 19.62 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.27 -34.86 99.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 121.545 1.497 . . . . 0.0 112.374 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.4 m-85 -100.86 -26.8 13.63 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.646 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -96.62 114.57 26.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -131.7 136.04 47.33 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -136.09 137.0 40.6 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 118.671 0.669 . . . . 0.0 112.125 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.75 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.74 109.14 9.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.287 -2.139 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.788 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -84.25 145.34 28.37 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.0 p -78.56 170.5 16.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.581 0.705 . . . . 0.0 111.88 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.481 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.5 t-160 -76.14 135.7 39.81 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 73.59 9.29 4.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.03 0.932 . . . . 0.0 111.963 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.85 166.88 25.15 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.058 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.1 tt0 -76.86 130.12 37.16 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.7 p -118.42 10.14 12.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.55 74.57 0.03 OUTLIER Glycine 0 CA--C 1.474 -2.479 0 C-N-CA 116.348 -2.834 . . . . 0.0 114.129 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.47 169.62 21.6 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 172.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.435 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 75.2 mt -59.55 113.49 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 117.574 0.687 . . . . 0.0 109.551 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.79 -18.75 36.93 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.323 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -73.38 114.32 11.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 109.737 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -109.67 20.28 18.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.694 0.759 . . . . 0.0 110.274 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.61 -162.45 35.02 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.079 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.85 115.92 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.702 2.268 . . . . 0.0 111.512 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -102.35 -4.13 26.03 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.945 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.31 109.65 26.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 79.1 m -71.8 152.17 42.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.724 0.409 . . . . 0.0 110.734 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.41 122.08 11.07 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -53.23 131.71 37.6 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.523 0.677 . . . . 0.0 110.806 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.15 -9.55 26.96 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -170.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -123.97 150.23 45.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -113.7 137.53 51.49 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.632 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -79.62 103.81 9.79 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.433 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 47.2 mt-30 -102.5 117.79 35.47 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.301 0.572 . . . . 0.0 111.679 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.8 t -74.48 108.41 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.518 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.5 mt -93.03 -40.08 10.73 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.627 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -138.98 165.79 29.66 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -55.46 -36.86 94.99 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.981 1.787 . . . . 0.0 113.301 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.663 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -104.06 -25.89 12.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.264 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -95.51 114.53 26.3 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.7 139.44 50.3 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -132.3 137.52 47.49 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.785 0.721 . . . . 0.0 112.452 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -75.2 109.81 9.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.433 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 98.1 mt . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.417 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.6 tp60 -76.04 141.36 42.11 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.077 0.551 . . . . 0.0 110.172 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -77.04 160.43 29.1 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.577 0.703 . . . . 0.0 112.438 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.457 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 20.4 t-160 -67.14 133.49 49.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 78.1 m-85 77.03 5.27 3.29 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.119 0.968 . . . . 0.0 112.125 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.65 161.21 22.85 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.751 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -73.36 128.72 36.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.4 p -112.48 19.25 17.74 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.64 78.38 0.56 Allowed Glycine 0 CA--C 1.479 -2.198 0 C-N-CA 117.44 -2.314 . . . . 0.0 114.478 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.96 172.59 24.73 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 106.891 -2.484 . . . . 0.0 106.891 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 70.5 mt -58.25 113.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 118.006 0.903 . . . . 0.0 109.317 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.04 -8.22 33.34 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.193 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -95.67 110.05 22.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 m -97.9 0.98 47.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.064 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.04 -158.99 11.68 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.544 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.57 114.05 2.21 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.703 2.935 . . . . 0.0 112.466 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.1 p -101.34 -13.73 17.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -88.9 110.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 73.3 m -72.07 155.63 40.09 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.986 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.11 140.26 58.85 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 125.19 16.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 123.507 0.505 . . . . 0.0 110.538 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -12.48 30.04 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.9 p -116.78 146.96 42.49 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -111.73 137.4 49.69 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.951 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.4 t -80.83 100.77 8.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -102.12 115.8 31.32 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.755 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -79.76 94.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.6 mt -76.5 -37.56 56.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.855 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.01 163.7 45.99 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.47 -35.61 92.53 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.319 2.013 . . . . 0.0 112.712 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.6 m-85 -100.61 -25.6 14.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.456 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -96.24 113.88 25.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.7 m -129.89 135.33 48.23 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.03 138.24 42.0 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.287 0.494 . . . . 0.0 111.794 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -75.62 109.09 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--N 1.294 -1.812 0 C-N-CA 123.209 0.604 . . . . 0.0 110.388 -179.521 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.438 -1.048 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.405 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.0 tp60 -82.5 138.35 34.35 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 174.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.0 p -70.18 162.42 28.38 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 122.292 1.044 . . . . 0.0 112.745 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -72.4 129.72 39.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 77.43 7.16 2.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.766 0.826 . . . . 0.0 112.169 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.7 164.9 24.32 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.664 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.6 tt0 -75.59 128.19 34.72 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.771 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -111.3 8.98 21.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -174.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.43 66.88 0.06 OUTLIER Glycine 0 CA--C 1.48 -2.134 0 C-N-CA 116.83 -2.605 . . . . 0.0 113.807 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.83 173.15 25.41 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -65.75 122.51 16.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.69 4.06 57.08 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.32 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 48.3 t80 -105.89 110.25 22.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 m -99.76 6.01 45.54 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.25 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.34 -165.59 41.21 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.96 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.24 125.86 17.31 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.834 3.023 . . . . 0.0 112.979 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 p -106.2 -2.98 21.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.02 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.57 109.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.3 m -73.19 149.13 43.14 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.396 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.67 152.82 34.29 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.22 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 m -58.98 119.98 8.24 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.302 0.572 . . . . 0.0 110.57 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.47 -11.61 30.68 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.627 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.498 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.0 p -114.27 142.61 46.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.901 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 p -112.53 133.47 54.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.172 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.27 105.07 7.11 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.13 115.15 29.9 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.966 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.61 98.92 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -81.68 -37.7 27.01 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.206 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -143.28 163.4 37.45 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.42 -38.24 89.46 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.437 2.092 . . . . 0.0 113.132 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.605 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -101.89 -26.44 13.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.921 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -96.73 114.75 26.41 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.664 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -129.46 138.79 51.62 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -132.95 137.07 46.46 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 118.896 0.771 . . . . 0.0 112.098 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.771 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.1 m -78.29 108.62 11.75 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.289 -2.032 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.712 177.798 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 120.943 0.401 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.471 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 56.5 tp60 -76.63 140.97 41.19 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.562 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p -78.94 165.75 23.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.965 0.888 . . . . 0.0 112.194 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -72.31 128.24 35.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.693 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 75.85 16.0 2.46 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.232 1.013 . . . . 0.0 111.947 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.435 ' HA3' ' H3 ' ' A' ' 101' ' ' MAN . . . -103.0 162.75 16.08 Favored Glycine 0 N--CA 1.414 -2.789 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -75.71 127.98 34.21 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 26.8 p -112.24 3.7 17.32 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.01 72.37 0.04 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 116.43 -2.795 . . . . 0.0 114.498 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 170.18 23.03 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.579 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.7 mt -58.39 122.63 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 117.828 0.814 . . . . 0.0 108.947 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -27.06 19.17 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -84.93 115.59 22.88 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.8 m -115.8 17.68 15.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.081 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 -156.46 18.06 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.459 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.08 113.81 1.74 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.21 2.607 . . . . 0.0 111.246 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -109.78 -1.61 17.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.451 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.67 110.5 31.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.499 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 85.8 m -69.16 158.04 35.69 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 159.64 20.98 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.517 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -63.86 118.21 8.05 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.25 0.548 . . . . 0.0 110.415 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.64 29.13 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.5 p -108.3 144.01 36.38 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.418 -0.46 . . . . 0.0 110.442 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.9 p -109.81 136.29 49.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.36 100.5 5.18 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -99.42 112.43 24.62 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.638 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.65 101.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.82 -39.88 17.84 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.622 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -140.18 165.86 27.58 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.15 -35.87 95.73 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.059 1.839 . . . . 0.0 113.508 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.617 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.0 m-85 -106.62 -25.42 11.79 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.262 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -95.92 114.43 26.15 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -130.81 137.91 49.64 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -133.91 138.33 45.47 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 118.262 0.483 . . . . 0.0 112.15 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -76.37 111.56 11.96 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.911 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.285 -2.228 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.329 179.53 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.471 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.462 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 54.0 tp60 -77.9 143.08 38.01 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.597 0.237 . . . . 0.0 110.652 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.4 p -80.13 164.54 23.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.681 0.753 . . . . 0.0 111.869 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.436 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 11.4 t-160 -71.89 135.46 46.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 73.7 4.35 4.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.271 1.028 . . . . 0.0 111.886 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.26 162.94 32.55 Favored Glycine 0 N--CA 1.421 -2.301 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.8 tt0 -79.07 120.72 24.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.752 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.0 p -99.8 15.43 26.95 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.53 86.92 0.72 Allowed Glycine 0 CA--C 1.482 -1.981 0 C-N-CA 117.64 -2.219 . . . . 0.0 114.824 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 179.2 29.17 Favored Glycine 0 C--N 1.287 -2.194 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 170.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -64.42 114.04 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 118.0 0.9 . . . . 0.0 109.153 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.82 -13.65 29.49 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.342 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -87.31 112.1 21.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 m -96.87 -4.31 40.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.878 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 -164.52 17.2 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.754 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.8 123.01 12.12 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.401 2.734 . . . . 0.0 112.422 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -105.5 -17.99 14.24 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.13 109.56 18.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -69.17 146.46 52.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 123.263 0.352 . . . . 0.0 111.165 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.64 133.96 54.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.411 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 m -47.29 127.89 11.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.631 0.729 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.71 -19.72 25.59 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.774 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.4 p -113.8 153.03 29.79 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 122.429 -0.454 . . . . 0.0 109.917 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -113.54 138.33 50.3 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.895 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -83.09 110.24 17.83 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -108.46 114.5 28.38 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.63 97.82 2.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.78 -38.16 29.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.417 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -142.64 168.66 12.67 Favored Pre-proline 0 C--N 1.297 -1.692 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.59 -35.16 98.9 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.826 1.684 . . . . 0.0 113.198 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.1 m-85 -108.6 -25.46 10.88 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.493 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -96.14 115.25 27.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -132.89 141.03 48.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -136.27 139.56 42.77 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.741 0.7 . . . . 0.0 112.229 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.752 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.1 m -78.05 113.35 15.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.434 175.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.289 -2.039 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.908 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.462 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.532 ' OE1' ' HG2' ' A' ' 16' ' ' PRO . 52.0 tp60 -86.51 144.43 27.25 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.8 p -80.62 167.69 19.75 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.067 0.937 . . . . 0.0 112.759 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -71.89 128.48 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.999 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 76.19 6.87 3.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.453 1.101 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.413 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.72 161.7 22.05 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.638 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.6 tt0 -77.85 121.44 24.12 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.706 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.1 p -106.76 16.19 24.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 123.93 76.64 0.32 Allowed Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 116.354 -2.832 . . . . 0.0 114.885 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.79 176.33 28.39 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 170.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 72.6 mt -60.47 113.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 118.177 0.988 . . . . 0.0 110.666 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.4 -11.56 21.68 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.167 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.442 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 51.5 t80 -91.97 132.23 36.68 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.1 m -128.49 13.32 6.51 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.84 -142.16 10.6 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.638 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.532 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -71.76 113.94 3.8 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.25 1.967 . . . . 0.0 111.282 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -102.79 -0.59 31.22 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.855 0.836 . . . . 0.0 112.098 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -106.96 118.99 55.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 74.2 m -73.29 160.24 32.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.4 0.619 . . . . 0.0 112.2 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 144.9 56.09 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.104 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -62.44 124.77 21.81 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.63 -14.55 27.21 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -173.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.2 p -119.59 147.73 44.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -113.76 138.08 50.75 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.881 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.8 t -78.86 98.17 6.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.3 mt-30 -96.89 113.85 25.43 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.64 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.4 96.26 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.0 mt -79.92 -38.36 32.64 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.049 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -135.48 165.02 39.43 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -55.86 -34.31 91.12 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.809 1.673 . . . . 0.0 113.187 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.618 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.7 m-85 -106.04 -25.25 12.15 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.274 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -95.09 115.06 26.95 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -130.84 134.54 46.91 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -133.41 137.44 45.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 118.446 0.566 . . . . 0.0 111.974 -175.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.706 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.8 m -76.8 110.03 11.07 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.999 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.286 -2.183 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.438 -1.072 0 CA-C-O 120.639 0.257 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.414 HE21 ' HA3' ' A' ' 6' ' ' GLY . 52.0 tp60 -74.03 138.82 44.32 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 123.192 0.597 . . . . 0.0 109.663 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -76.65 159.16 30.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.736 0.779 . . . . 0.0 112.283 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.414 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.4 t-160 -66.49 134.53 52.62 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 76.34 0.32 3.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.163 0.985 . . . . 0.0 112.72 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -89.31 161.81 30.36 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.609 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -75.18 123.39 25.17 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.739 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -105.63 11.46 32.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.53 88.36 0.84 Allowed Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 116.926 -2.559 . . . . 0.0 114.937 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.56 -178.03 31.14 Favored Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 169.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.4 113.27 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 118.12 0.96 . . . . 0.0 109.099 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.81 -16.37 28.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -82.77 110.26 17.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 m -98.8 2.55 46.94 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.571 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.18 -164.66 13.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.154 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.62 116.53 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.88 2.387 . . . . 0.0 111.873 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.9 p -104.84 -4.81 21.8 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.098 0.475 . . . . 0.0 112.042 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.33 109.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.496 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.8 m -65.29 154.09 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 123.762 0.825 . . . . 0.0 112.35 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 146.9 52.31 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.417 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -50.21 122.74 7.25 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.107 0.963 . . . . 0.0 111.684 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.81 -20.12 24.88 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.132 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 78.7 p -108.31 159.68 16.45 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 122.463 -0.433 . . . . 0.0 111.178 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -119.66 142.27 48.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.9 t -82.23 110.31 17.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -107.7 117.58 34.49 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.93 101.78 3.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' C ' HD21 ' A' ' 29' ' ' ASN . 90.3 mt -86.85 -39.75 15.56 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.859 0.837 . . . . 0.0 109.62 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.404 HD21 ' C ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -133.34 162.93 54.66 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -57.98 -27.26 78.49 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.858 1.705 . . . . 0.0 113.137 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.496 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.5 m-85 -110.36 -25.19 10.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.321 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -94.51 114.02 25.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.609 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.02 139.55 51.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -134.47 137.79 44.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 117.967 0.349 . . . . 0.0 111.448 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.739 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -74.03 116.31 14.51 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.009 -179.34 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.635 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 56.5 tp60 -79.19 141.77 36.89 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.0 p -73.07 166.1 23.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.51 1.148 . . . . 0.0 113.15 -174.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 14.4 t-160 -75.2 134.02 41.29 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 72.9 m-85 75.08 7.62 4.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.876 0.871 . . . . 0.0 111.081 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -93.5 167.61 28.79 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -81.72 135.39 35.5 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.684 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.2 p -124.74 8.2 8.19 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.35 68.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 116.337 -2.84 . . . . 0.0 115.198 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.04 169.77 22.17 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.588 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.8 mt -58.95 111.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 117.492 0.646 . . . . 0.0 109.492 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.86 -1.8 52.07 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.067 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -84.09 109.84 18.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 117.282 0.541 . . . . 0.0 110.393 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.5 m -93.92 7.01 46.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.48 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.37 -176.36 48.69 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.471 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.12 125.1 14.01 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.581 2.188 . . . . 0.0 110.662 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -99.23 -8.31 25.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.57 0.7 . . . . 0.0 111.006 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.91 109.49 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 58.9 m -76.13 160.69 29.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.052 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.7 121.08 11.36 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 m -53.68 136.68 38.98 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.608 0.718 . . . . 0.0 111.547 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.28 -20.39 23.47 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.2 p -108.53 147.49 31.65 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -107.06 132.04 53.41 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.352 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.9 t -76.0 106.67 7.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -105.48 115.77 30.82 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.29 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -73.85 104.71 2.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.67 -45.23 9.0 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.804 -175.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.406 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -130.01 167.5 20.36 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.428 ' O ' HG13 ' A' ' 11' ' ' ILE . 49.1 Cg_exo -60.63 -28.7 87.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.566 1.511 . . . . 0.0 113.198 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.631 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 32.3 m-85 -110.25 -26.04 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -95.17 114.64 26.46 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.1 m -131.31 136.64 48.31 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' OE1' HD22 ' A' ' 36' ' ' LEU . 32.3 tt0 -131.52 139.43 49.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 118.601 0.637 . . . . 0.0 112.457 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 38.1 m -78.56 109.25 12.59 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.533 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.468 HD22 ' OE1' ' A' ' 34' ' ' GLN . 95.3 mt . . . . . 0 C--N 1.294 -1.82 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.491 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.635 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 120.791 0.329 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.416 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 18.2 tp60 -98.01 133.9 41.85 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.9 p -68.5 158.16 34.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.945 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -64.46 132.83 51.09 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 76.49 4.06 3.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.015 0.926 . . . . 0.0 112.35 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.52 154.18 24.78 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -71.17 124.42 24.42 Favored 'General case' 0 C--O 1.202 -1.434 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.751 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.1 p -106.17 14.73 27.25 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -173.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.3 80.71 0.46 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 116.828 -2.606 . . . . 0.0 114.963 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.66 177.45 29.36 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 106.881 -2.487 . . . . 0.0 106.881 170.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.11 114.2 2.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 118.27 1.035 . . . . 0.0 108.971 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.51 -6.49 26.38 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.748 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -97.37 109.82 22.5 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.366 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -100.89 18.74 18.76 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.498 0.666 . . . . 0.0 110.765 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.63 -165.27 38.43 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -58.18 114.9 2.18 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.904 2.403 . . . . 0.0 111.915 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -104.55 -2.83 24.65 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.847 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.6 113.29 43.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 81.7 m -70.91 156.26 39.81 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 154.1 38.39 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.499 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -54.77 118.79 4.53 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.021 0.528 . . . . 0.0 110.831 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.84 26.26 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.139 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.6 p -108.78 143.83 37.41 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.456 -0.438 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.6 p -110.78 145.32 38.34 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.862 -0.154 . . . . 0.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.5 t -84.76 110.51 18.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -107.38 111.89 24.44 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.814 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.6 100.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 32' ' ' TYR . 79.9 mt -82.78 -40.74 20.04 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.028 -174.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -136.07 162.94 53.74 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.06 -28.14 68.14 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.02 1.813 . . . . 0.0 113.463 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.545 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 40.9 m-85 -111.34 -25.51 9.62 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.617 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' HD12 ' A' ' 28' ' ' LEU . 38.8 t80 -96.6 115.0 26.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -129.95 140.01 50.99 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -133.05 138.82 46.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 118.903 0.774 . . . . 0.0 112.034 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.751 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.1 m -76.21 114.24 14.66 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.064 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.286 -2.16 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.879 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.416 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 120.885 0.374 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.413 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.4 tp60 -85.9 139.77 30.95 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.3 p -75.69 162.43 28.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.982 0.896 . . . . 0.0 112.13 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -68.77 133.44 48.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 74.35 6.84 4.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.987 0.915 . . . . 0.0 112.19 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.413 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.61 160.89 22.78 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.5 tt0 -74.4 129.54 37.97 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.795 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.9 p -111.58 5.12 19.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.13 82.77 0.1 Allowed Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 116.78 -2.629 . . . . 0.0 114.51 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.25 174.52 26.29 Favored Glycine 0 N--CA 1.417 -2.605 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 170.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.3 mt -59.55 118.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 117.788 0.794 . . . . 0.0 109.61 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.41 63.07 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.487 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -76.87 111.54 12.52 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.28 -0.541 . . . . 0.0 110.488 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -94.65 2.98 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.938 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.1 -174.28 50.27 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.525 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -62.32 127.84 22.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.177 2.585 . . . . 0.0 112.617 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.5 p -105.96 -5.67 19.42 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -99.29 109.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 99.4 m -66.44 154.52 40.0 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.64 0.587 . . . . 0.0 112.304 -178.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 150.1 45.07 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.389 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -59.72 124.37 19.92 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.247 0.546 . . . . 0.0 110.822 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.23 -18.42 28.19 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.8 p -108.32 149.98 27.94 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.8 p -114.43 140.41 48.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -80.73 103.37 10.52 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.66 114.24 28.3 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.172 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -73.16 106.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.8 mt -92.38 -33.29 14.63 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.961 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -143.97 161.85 43.6 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.09 -31.32 89.94 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.891 1.727 . . . . 0.0 112.87 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.555 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 64.8 m-85 -105.71 -26.08 11.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.938 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' CE2' HD12 ' A' ' 28' ' ' LEU . 51.5 t80 -96.69 114.56 26.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -132.75 136.47 46.37 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -131.02 138.29 49.58 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.795 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -75.72 109.11 9.04 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--N 1.293 -1.868 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.834 178.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.434 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 56.0 tp60 -87.29 137.05 32.68 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.1 p -76.03 160.98 29.28 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.075 0.941 . . . . 0.0 112.858 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 17.1 t-160 -66.06 133.04 49.92 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 82.6 m-85 76.9 3.61 3.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.243 1.017 . . . . 0.0 111.591 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.406 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -93.75 163.44 25.91 Favored Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -77.05 123.83 26.93 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 19.4 p -105.64 6.98 32.51 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -175.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.34 85.4 0.42 Allowed Glycine 0 CA--C 1.476 -2.388 0 C-N-CA 116.512 -2.756 . . . . 0.0 114.909 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.73 -176.87 31.0 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 107.019 -2.432 . . . . 0.0 107.019 169.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.09 118.24 6.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.854 0.827 . . . . 0.0 109.577 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.5 9.0 59.31 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.293 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -80.56 115.32 20.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.393 0.597 . . . . 0.0 110.508 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -84.63 -3.45 58.5 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.923 0.889 . . . . 0.0 113.326 -176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.06 -167.23 33.03 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.245 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.52 130.06 21.45 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.381 2.721 . . . . 0.0 112.098 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -104.4 -6.47 20.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.917 0.865 . . . . 0.0 111.866 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.57 109.04 22.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 87.9 m -68.45 156.22 38.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 123.612 0.57 . . . . 0.0 112.423 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 148.22 43.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.943 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -59.06 120.72 9.65 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -13.65 28.09 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.84 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.5 p -116.88 150.48 38.36 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.371 -0.488 . . . . 0.0 110.077 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -116.58 144.48 44.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.1 t -79.2 112.17 16.15 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.487 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.1 mt-30 -106.45 116.61 32.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.333 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -73.01 111.08 6.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.1 mt -97.0 -31.61 12.43 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.56 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -149.63 166.14 15.93 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.32 -36.22 96.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.19 1.927 . . . . 0.0 113.627 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.583 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.61 -25.73 12.15 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.281 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -95.93 114.96 26.73 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.596 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.2 m -129.33 143.55 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.7 tt0 -132.04 137.51 47.84 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.688 0.676 . . . . 0.0 111.952 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.818 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -74.93 111.64 10.34 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.042 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.487 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.0 mt . . . . . 0 C--N 1.291 -1.969 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.434 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.438 -1.071 0 CA-C-O 120.821 0.343 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.482 ' OE1' ' HG2' ' A' ' 16' ' ' PRO . 56.4 tp60 -85.07 141.92 29.91 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.1 p -73.6 167.87 20.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.045 0.926 . . . . 0.0 112.722 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -73.49 132.96 43.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.506 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 75.35 2.76 3.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.29 1.036 . . . . 0.0 112.135 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -91.43 161.81 27.73 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.4 tt0 -75.68 123.32 25.36 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.81 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.4 p -103.63 -3.62 24.91 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.74 83.57 0.12 Allowed Glycine 0 CA--C 1.479 -2.183 0 C-N-CA 116.334 -2.841 . . . . 0.0 114.966 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -173.25 29.89 Favored Glycine 0 C--N 1.284 -2.34 0 N-CA-C 107.925 -2.07 . . . . 0.0 107.925 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 78.6 mt -64.41 116.37 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.2 54.77 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.025 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -91.91 109.73 21.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.159 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 m -89.47 -5.6 57.19 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.839 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.15 -160.23 26.64 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.41 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 39.9 Cg_endo -72.14 131.53 18.12 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.1 2.533 . . . . 0.0 112.59 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.0 p -107.57 3.07 24.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -105.59 109.71 28.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 75.5 m -67.62 150.38 48.84 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.815 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 156.06 24.02 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.165 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -58.52 119.34 6.84 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.458 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -11.9 30.3 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.907 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.41 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.1 p -118.62 146.27 44.78 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.512 -0.404 . . . . 0.0 110.345 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 p -114.22 142.17 46.61 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.5 t -79.88 112.17 16.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 73.6 mt-30 -110.59 114.22 27.45 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.235 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 t -77.49 104.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 32' ' ' TYR . 86.6 mt -89.57 -34.16 16.45 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.528 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 37.2 m-80 -143.42 167.41 15.79 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.91 -41.5 74.37 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.149 1.899 . . . . 0.0 113.62 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.4 m-85 -101.7 -25.04 13.99 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.199 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 41.7 t80 -95.04 115.42 27.41 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.7 m -131.5 140.04 49.45 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -134.31 138.4 44.93 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.244 0.475 . . . . 0.0 111.839 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.81 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.0 m -76.86 107.44 9.18 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.951 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.423 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.2 mt . . . . . 0 C--N 1.282 -2.339 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.437 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.413 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 -69.48 142.4 53.76 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.1 p -77.27 168.01 20.76 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 112.145 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -71.21 135.28 47.44 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 73.71 9.7 4.85 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.954 0.901 . . . . 0.0 112.651 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.413 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.19 154.17 22.22 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.845 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.7 tt0 -70.14 123.27 21.2 Favored 'General case' 0 C--O 1.205 -1.241 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.9 p -102.21 13.01 35.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -171.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.71 63.22 0.18 Allowed Glycine 0 CA--C 1.48 -2.114 0 C-N-CA 117.047 -2.502 . . . . 0.0 114.876 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -85.19 173.24 48.22 Favored Glycine 0 N--CA 1.421 -2.317 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.453 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 63.9 mt -56.73 111.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 117.919 0.86 . . . . 0.0 109.951 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.82 -13.72 34.83 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.8 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -85.51 109.15 18.29 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 m -107.43 30.24 6.43 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.422 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.06 -160.67 28.46 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.06 118.68 5.58 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.944 2.429 . . . . 0.0 111.014 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -107.55 0.56 22.75 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.415 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.48 109.55 28.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 68.9 m -71.38 155.75 40.28 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 123.158 0.583 . . . . 0.0 112.051 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.54 147.63 50.91 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.046 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.7 m -57.6 122.62 13.17 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -10.08 30.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.3 p -118.67 141.84 48.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -108.35 129.12 55.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.422 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.84 98.54 3.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -98.94 117.03 32.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.268 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.4 t -78.43 93.95 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.3 -41.97 32.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.875 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 39.8 m-80 -139.91 166.53 23.23 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.04 -43.03 63.32 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.265 1.976 . . . . 0.0 112.866 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.632 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -99.64 -26.37 14.09 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.009 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 31.9 t80 -94.94 113.95 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.456 0.646 . . . . 0.0 111.722 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -135.49 137.18 41.89 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -137.05 141.3 42.43 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.872 0.76 . . . . 0.0 111.75 -172.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.9 m -78.96 107.12 11.47 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.276 -2.602 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.202 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.241 0.641 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.553 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 54.4 tp60 -68.42 141.88 55.55 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 172.68 13.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.011 0.91 . . . . 0.0 112.189 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -78.58 133.46 37.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 74.04 6.34 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.909 0.884 . . . . 0.0 111.818 -175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.78 160.45 25.29 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.1 tt0 -78.84 127.41 32.0 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.0 p -106.68 9.37 31.25 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.65 80.57 0.48 Allowed Glycine 0 CA--C 1.489 -1.576 0 C-N-CA 117.252 -2.404 . . . . 0.0 115.207 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.24 -179.15 30.08 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 168.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 71.4 mt -62.78 114.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 117.854 0.827 . . . . 0.0 108.859 175.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.74 2.43 32.38 Favored Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.664 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -98.08 133.3 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -117.86 10.68 13.28 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.097 0.475 . . . . 0.0 111.133 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.08 -164.6 35.15 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.069 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.37 124.66 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.174 2.582 . . . . 0.0 112.159 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.8 p -106.09 -7.83 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.771 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -99.33 111.9 30.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 82.2 m -73.53 159.93 32.44 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.521 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 151.52 43.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.77 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -60.6 121.54 12.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.018 0.437 . . . . 0.0 109.861 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -19.81 24.77 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.586 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.7 p -107.62 140.77 40.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 27.6 p -105.24 136.33 44.95 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.359 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.1 t -79.91 99.03 7.38 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -98.55 116.73 31.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.588 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.92 93.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.51 -34.22 58.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.542 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -142.92 165.28 27.14 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 -32.51 93.65 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 121.453 1.435 . . . . 0.0 112.557 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.565 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.0 m-85 -107.76 -26.83 10.61 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.411 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -96.68 115.24 27.09 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -124.63 142.47 51.35 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -135.7 141.06 44.88 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 118.762 0.71 . . . . 0.0 112.334 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -82.03 107.46 14.75 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.073 176.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 85.6 mt . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.389 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.553 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.438 -1.059 0 CA-C-O 121.203 0.525 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.491 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 59.9 tp60 -96.7 144.99 26.2 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.2 p -79.08 172.28 14.02 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.922 0.867 . . . . 0.0 111.163 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -72.66 135.07 45.36 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.259 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 73.77 6.38 4.92 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.319 1.048 . . . . 0.0 112.075 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.15 166.8 29.92 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.662 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -79.81 128.66 33.71 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.791 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 16.2 p -110.57 15.48 22.05 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.63 84.42 0.51 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 117.109 -2.472 . . . . 0.0 114.412 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.32 -179.4 29.89 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 169.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.66 109.62 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 117.826 0.813 . . . . 0.0 109.199 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.65 -11.12 32.77 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.12 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -79.12 110.15 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.025 0.441 . . . . 0.0 109.904 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 p -93.78 0.61 56.4 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.936 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.42 -168.55 40.65 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.305 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.86 122.37 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.845 2.364 . . . . 0.0 112.511 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 p -102.6 -15.72 16.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.657 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 1' ' ' THR . 47.2 t -90.43 108.97 20.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -176.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 77.9 m -68.92 153.11 44.37 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.094 0.473 . . . . 0.0 111.587 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.61 146.94 47.35 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -60.66 120.49 10.14 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.944 0.402 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.58 -10.66 30.43 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.486 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 71.1 p -114.31 143.83 44.24 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -108.7 132.72 53.65 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.227 0.329 . . . . 0.0 110.634 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.1 t -78.81 100.75 7.28 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -100.2 110.89 23.15 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.59 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.32 102.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.71 -39.4 16.04 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.437 -177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -139.41 162.79 49.66 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.7 -32.88 85.66 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.108 1.872 . . . . 0.0 113.041 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.573 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.7 m-85 -106.28 -26.16 11.64 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.491 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -96.79 114.45 26.08 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -131.74 139.35 48.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -135.08 138.36 43.77 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 118.55 0.614 . . . . 0.0 112.45 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.791 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -79.41 107.63 12.32 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.291 -1.966 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.235 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.491 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.51 HE21 ' HA3' ' A' ' 6' ' ' GLY . 49.5 tp60 . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.7 p -77.31 171.41 14.9 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 111.821 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.441 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.6 t-160 -78.01 134.46 37.8 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 74.81 11.79 3.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.924 0.89 . . . . 0.0 111.596 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.51 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -101.37 163.82 17.91 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.642 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -77.28 122.38 25.02 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.8 p -106.8 14.96 26.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.96 85.98 0.6 Allowed Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 116.954 -2.546 . . . . 0.0 114.889 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 177.27 28.16 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 168.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.433 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 67.0 mt -65.09 111.85 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 118.129 0.965 . . . . 0.0 109.138 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.58 -9.52 21.87 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.91 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -106.42 108.57 20.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -112.62 11.64 19.64 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.943 0.401 . . . . 0.0 111.091 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.59 -147.44 1.8 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.552 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.04 98.66 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.061 2.507 . . . . 0.0 112.093 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 p -98.7 -14.78 19.64 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.036 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.49 110.93 23.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.531 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 70.8 m -69.44 157.09 37.76 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.657 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.68 147.49 49.34 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 m -60.9 126.65 28.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.524 0.678 . . . . 0.0 110.54 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.79 -20.29 24.72 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.2 p -108.14 143.25 37.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 122.403 -0.469 . . . . 0.0 109.803 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 p -107.72 137.15 46.25 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.477 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.7 t -82.08 102.22 10.88 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.96 117.96 36.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.321 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.9 t -76.63 117.91 22.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD12 ' CE1' ' A' ' 32' ' ' TYR . 83.9 mt -101.7 -42.15 6.3 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.559 0.695 . . . . 0.0 109.598 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 20.5 m120 -135.62 165.03 39.24 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.25 -27.58 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.032 1.822 . . . . 0.0 113.313 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.607 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.1 m-85 -112.49 -26.08 8.87 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.294 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CE1' HD12 ' A' ' 28' ' ' LEU . 40.7 t80 -95.2 115.06 26.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -131.96 141.78 49.42 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 33.7 tt0 -134.42 138.24 44.65 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 118.535 0.607 . . . . 0.0 112.307 -175.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.0 m -77.32 114.7 16.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.745 179.411 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.515 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.1 tp60 . . . . . 0 N--CA 1.436 -1.15 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -79.32 157.49 27.67 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.74 0.781 . . . . 0.0 112.167 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -67.15 132.03 46.99 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 75.44 6.05 4.07 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.975 0.91 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.515 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.75 166.78 29.18 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -78.63 130.32 35.75 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.779 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.7 p -115.23 7.0 15.15 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -173.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.82 75.26 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 117.026 -2.511 . . . . 0.0 114.458 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.94 174.06 26.19 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 172.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.2 mt -59.2 110.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 117.588 0.694 . . . . 0.0 109.694 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.9 43.68 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.815 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -89.21 109.45 20.32 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -105.23 17.62 23.71 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.165 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.25 -163.22 37.87 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.53 114.47 2.14 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.763 2.309 . . . . 0.0 111.597 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -103.28 0.33 31.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.205 0.526 . . . . 0.0 112.036 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.81 109.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 73.4 m -69.44 155.43 40.47 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.053 0.541 . . . . 0.0 111.469 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.46 147.11 49.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.046 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -57.73 123.75 16.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -14.43 28.98 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 65.3 p -117.53 145.5 44.2 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.448 -0.443 . . . . 0.0 110.117 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -111.35 138.25 48.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.504 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.9 t -78.49 109.63 12.85 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.6 mt-30 -106.28 112.5 25.55 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 99.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.47 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.2 mt -84.27 -39.23 19.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.334 -173.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -134.96 164.65 42.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.14 -34.68 88.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.818 1.679 . . . . 0.0 113.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.642 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.6 m-85 -107.46 -24.96 11.62 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CE2' HD12 ' A' ' 28' ' ' LEU . 43.8 t80 -94.98 114.39 26.2 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -128.53 139.08 52.49 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 31.8 tt0 -133.3 137.17 45.87 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.451 0.569 . . . . 0.0 111.885 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -75.68 109.39 9.22 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.48 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.28 -2.444 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.554 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.3 tp60 . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -77.03 166.68 22.98 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.72 0.772 . . . . 0.0 111.874 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -71.22 135.76 47.68 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 73.72 8.6 4.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.801 0.84 . . . . 0.0 112.161 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.08 155.75 21.16 Favored Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.0 tt0 -69.96 125.44 26.76 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.76 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -107.52 11.33 28.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.35 72.83 0.23 Allowed Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 117.278 -2.391 . . . . 0.0 114.741 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.31 179.52 30.86 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 171.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 68.0 mt -57.93 116.28 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 118.041 0.921 . . . . 0.0 110.327 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.27 -28.5 9.62 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.608 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -78.3 111.98 14.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.91 0.386 . . . . 0.0 110.189 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -102.15 -0.32 33.46 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.925 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -163.15 10.46 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.942 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.44 123.92 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.515 2.81 . . . . 0.0 112.649 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 p -109.74 -1.57 17.89 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.377 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.24 110.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.3 m -70.64 164.61 24.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.557 0.694 . . . . 0.0 112.761 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.97 160.41 31.95 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.017 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -63.4 116.58 5.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 123.363 0.665 . . . . 0.0 110.032 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.74 -14.33 34.95 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.871 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 60.6 p -108.17 142.83 37.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.573 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 p -106.85 137.68 44.44 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.51 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.0 t -79.56 100.36 7.73 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -98.56 118.95 36.4 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.927 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.87 98.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.2 -35.68 28.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.581 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 19.7 m120 -146.28 165.12 21.32 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.26 -37.42 94.43 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.155 1.903 . . . . 0.0 113.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.534 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 36.3 m-85 -101.13 -26.24 13.75 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.913 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 19.9 t80 -95.59 114.3 26.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.329 0.585 . . . . 0.0 112.334 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.9 m -132.78 135.14 45.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' OE1' HD21 ' A' ' 36' ' ' LEU . 32.8 tt0 -133.84 140.54 46.94 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.956 0.343 . . . . 0.0 111.868 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.4 m -77.08 112.3 13.58 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.426 HD21 ' OE1' ' A' ' 34' ' ' GLN . 90.1 mt . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.02 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.582 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.1 tp60 . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.1 p -80.55 162.02 24.51 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.756 0.789 . . . . 0.0 111.604 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -66.04 133.22 50.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 74.5 12.54 3.84 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.841 0.856 . . . . 0.0 112.485 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.582 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -101.76 169.55 20.26 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.629 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.4 tt0 -81.42 127.41 32.75 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.773 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -110.36 8.7 23.44 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.22 80.15 0.2 Allowed Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 116.862 -2.59 . . . . 0.0 114.317 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.84 179.64 30.22 Favored Glycine 0 C--N 1.284 -2.358 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 170.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 66.7 mt -62.46 111.04 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 117.984 0.892 . . . . 0.0 110.733 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.92 2.28 45.74 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.032 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -91.27 109.53 20.8 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.186 -0.597 . . . . 0.0 109.659 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -97.03 12.48 32.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.393 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.55 -165.78 41.62 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.613 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.03 115.18 2.38 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.937 2.425 . . . . 0.0 112.079 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -102.82 -8.53 20.71 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.939 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.54 108.92 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 85.6 m -71.34 155.8 40.23 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.39 138.05 56.82 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.2 m -57.54 128.13 35.49 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.84 23.9 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.6 p -108.23 146.44 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.7 p -107.68 131.31 54.54 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 121.263 -0.175 . . . . 0.0 110.879 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.47 103.26 4.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -103.56 116.14 31.82 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.214 0.53 . . . . 0.0 111.29 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.3 t -72.13 107.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.549 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.73 -33.84 13.46 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.273 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 1.9 m120 -139.27 165.04 34.67 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.25 -30.61 93.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.723 1.615 . . . . 0.0 112.562 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.606 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.0 m-85 -105.36 -25.49 12.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.932 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 32.2 t80 -95.23 114.35 26.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -130.67 136.86 49.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.6 tt0 -132.37 137.25 47.29 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 118.304 0.502 . . . . 0.0 111.938 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -75.89 113.08 12.98 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.807 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.892 179.52 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.554 HE21 ' HA3' ' A' ' 6' ' ' GLY . 58.0 tp60 . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.7 p -75.75 158.87 31.7 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.186 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.447 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 18.7 t-160 -65.4 134.88 54.45 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 73.63 9.26 4.96 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.106 0.962 . . . . 0.0 111.584 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -97.29 161.2 21.46 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.675 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -74.95 123.57 25.36 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.2 p -107.03 16.03 24.64 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 75.49 0.31 Allowed Glycine 0 CA--C 1.483 -1.911 0 C-N-CA 117.044 -2.503 . . . . 0.0 114.705 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.15 -178.92 30.25 Favored Glycine 0 C--N 1.29 -1.986 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 169.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.4 119.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.0 -23.64 27.03 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.259 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.77 110.18 20.79 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -107.54 8.58 29.37 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.308 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.9 -162.3 25.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.881 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.64 117.83 4.57 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.202 2.601 . . . . 0.0 112.964 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 p -100.88 -13.38 18.38 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.831 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -92.53 109.58 21.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 81.8 m -73.26 159.72 32.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.277 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 138.98 58.71 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.5 m -51.94 117.93 3.09 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.448 0.467 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -2.88 28.7 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.749 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.8 p -123.98 142.21 51.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 p -109.54 131.93 54.61 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.378 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -74.18 103.66 4.69 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -103.87 113.73 27.47 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.637 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.23 104.78 4.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.03 -45.86 9.83 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.846 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.445 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 1.6 m-20 -128.47 167.28 19.62 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.27 -34.86 99.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 121.545 1.497 . . . . 0.0 112.374 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.557 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.4 m-85 -100.86 -26.8 13.63 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.646 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 25.4 t80 -96.62 114.57 26.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -131.7 136.04 47.33 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' OE1' HD21 ' A' ' 36' ' ' LEU . 30.9 tt0 -136.09 137.0 40.6 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 118.671 0.669 . . . . 0.0 112.125 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.74 109.14 9.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.422 HD21 ' OE1' ' A' ' 34' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.287 -2.139 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.516 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.7 tp60 . . . . . 0 N--CA 1.426 -1.665 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.0 p -78.56 170.5 16.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.581 0.705 . . . . 0.0 111.88 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.479 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.5 t-160 -76.14 135.7 39.81 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 73.59 9.29 4.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.03 0.932 . . . . 0.0 111.963 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.516 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.85 166.88 25.15 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.058 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.1 tt0 -76.86 130.12 37.16 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.7 p -118.42 10.14 12.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.55 74.57 0.03 OUTLIER Glycine 0 CA--C 1.474 -2.479 0 C-N-CA 116.348 -2.834 . . . . 0.0 114.129 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.47 169.62 21.6 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 172.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 75.2 mt -59.55 113.49 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 117.574 0.687 . . . . 0.0 109.551 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.79 -18.75 36.93 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.323 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -73.38 114.32 11.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 109.737 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -109.67 20.28 18.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.694 0.759 . . . . 0.0 110.274 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.61 -162.45 35.02 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.079 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.85 115.92 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.702 2.268 . . . . 0.0 111.512 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -102.35 -4.13 26.03 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.945 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.31 109.65 26.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 79.1 m -71.8 152.17 42.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.724 0.409 . . . . 0.0 110.734 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.41 122.08 11.07 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -53.23 131.71 37.6 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.523 0.677 . . . . 0.0 110.806 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.15 -9.55 26.96 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -170.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -123.97 150.23 45.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -113.7 137.53 51.49 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.632 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -79.62 103.81 9.79 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -102.5 117.79 35.47 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.301 0.572 . . . . 0.0 111.679 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.8 t -74.48 108.41 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.518 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.5 mt -93.03 -40.08 10.73 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.627 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 22.3 m120 -138.98 165.79 29.66 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -55.46 -36.86 94.99 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.981 1.787 . . . . 0.0 113.301 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.677 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -104.06 -25.89 12.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.264 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.5 t80 -95.51 114.53 26.3 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.7 139.44 50.3 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -132.3 137.52 47.49 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.785 0.721 . . . . 0.0 112.452 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -75.2 109.81 9.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.128 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.611 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.6 tp60 . . . . . 0 N--CA 1.439 -1.01 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -77.04 160.43 29.1 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.577 0.703 . . . . 0.0 112.438 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.455 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 20.4 t-160 -67.14 133.49 49.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 77.03 5.27 3.29 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.119 0.968 . . . . 0.0 112.125 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.611 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.65 161.21 22.85 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.751 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -73.36 128.72 36.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.4 p -112.48 19.25 17.74 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.64 78.38 0.56 Allowed Glycine 0 CA--C 1.479 -2.198 0 C-N-CA 117.44 -2.314 . . . . 0.0 114.478 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.96 172.59 24.73 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 106.891 -2.484 . . . . 0.0 106.891 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.479 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 70.5 mt -58.25 113.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 118.006 0.903 . . . . 0.0 109.317 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.04 -8.22 33.34 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.193 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -95.67 110.05 22.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 m -97.9 0.98 47.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.064 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.04 -158.99 11.68 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.544 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.57 114.05 2.21 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.703 2.935 . . . . 0.0 112.466 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.1 p -101.34 -13.73 17.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -88.9 110.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 73.3 m -72.07 155.63 40.09 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.986 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.11 140.26 58.85 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 125.19 16.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 123.507 0.505 . . . . 0.0 110.538 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -12.48 30.04 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.9 p -116.78 146.96 42.49 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -111.73 137.4 49.69 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.951 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.4 t -80.83 100.77 8.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -102.12 115.8 31.32 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.755 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -79.76 94.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.6 mt -76.5 -37.56 56.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.855 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -138.01 163.7 45.99 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.47 -35.61 92.53 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.319 2.013 . . . . 0.0 112.712 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.6 m-85 -100.61 -25.6 14.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.456 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -96.24 113.88 25.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.636 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.7 m -129.89 135.33 48.23 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.03 138.24 42.0 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.287 0.494 . . . . 0.0 111.794 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -75.62 109.09 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--N 1.294 -1.812 0 C-N-CA 123.209 0.604 . . . . 0.0 110.388 -179.521 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.538 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.0 tp60 . . . . . 0 N--CA 1.416 -2.14 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.0 p -70.18 162.42 28.38 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 122.292 1.044 . . . . 0.0 112.745 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -72.4 129.72 39.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 77.43 7.16 2.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.766 0.826 . . . . 0.0 112.169 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.538 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.7 164.9 24.32 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.692 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.6 tt0 -75.59 128.19 34.72 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -111.3 8.98 21.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -174.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.43 66.88 0.06 OUTLIER Glycine 0 CA--C 1.48 -2.134 0 C-N-CA 116.83 -2.605 . . . . 0.0 113.807 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.83 173.15 25.41 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' H ' ' HA ' ' A' ' 31' ' ' TYR . 76.6 mt -65.75 122.51 16.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.69 4.06 57.08 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.32 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.421 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 48.3 t80 -105.89 110.25 22.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 m -99.76 6.01 45.54 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.25 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.34 -165.59 41.21 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.96 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.24 125.86 17.31 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.834 3.023 . . . . 0.0 112.979 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 p -106.2 -2.98 21.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.02 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.57 109.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 71.3 m -73.19 149.13 43.14 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.396 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.67 152.82 34.29 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.22 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 m -58.98 119.98 8.24 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.302 0.572 . . . . 0.0 110.57 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.47 -11.61 30.68 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.627 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.0 p -114.27 142.61 46.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.901 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 p -112.53 133.47 54.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.172 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.513 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.27 105.07 7.11 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.13 115.15 29.9 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.966 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.61 98.92 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -81.68 -37.7 27.01 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.206 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -143.28 163.4 37.45 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.42 -38.24 89.46 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.437 2.092 . . . . 0.0 113.132 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -101.89 -26.44 13.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.921 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -96.73 114.75 26.41 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -129.46 138.79 51.62 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.7 tt0 -132.95 137.07 46.46 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 118.896 0.771 . . . . 0.0 112.098 -175.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.1 m -78.29 108.62 11.75 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.289 -2.032 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.712 177.798 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.54 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p -78.94 165.75 23.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.965 0.888 . . . . 0.0 112.194 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -72.31 128.24 35.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.693 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 75.85 16.0 2.46 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.232 1.013 . . . . 0.0 111.947 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.54 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -103.0 162.75 16.08 Favored Glycine 0 N--CA 1.414 -2.789 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -75.71 127.98 34.21 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 26.8 p -112.24 3.7 17.32 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.01 72.37 0.04 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 116.43 -2.795 . . . . 0.0 114.498 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 170.18 23.03 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.588 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.7 mt -58.39 122.63 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 117.828 0.814 . . . . 0.0 108.947 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -27.06 19.17 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -84.93 115.59 22.88 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.8 m -115.8 17.68 15.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.081 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 -156.46 18.06 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.459 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.08 113.81 1.74 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.21 2.607 . . . . 0.0 111.246 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -109.78 -1.61 17.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.451 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.67 110.5 31.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.523 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 85.8 m -69.16 158.04 35.69 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 159.64 20.98 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.517 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -63.86 118.21 8.05 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.25 0.548 . . . . 0.0 110.415 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.64 29.13 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.5 p -108.3 144.01 36.38 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.418 -0.46 . . . . 0.0 110.442 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.9 p -109.81 136.29 49.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.36 100.5 5.18 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -99.42 112.43 24.62 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.638 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.65 101.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.82 -39.88 17.84 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.622 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 18.9 m120 -140.18 165.86 27.58 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.15 -35.87 95.73 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.059 1.839 . . . . 0.0 113.508 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.621 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.0 m-85 -106.62 -25.42 11.79 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.262 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 41.2 t80 -95.92 114.43 26.15 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 177.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.595 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -130.81 137.91 49.64 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -133.91 138.33 45.47 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 118.262 0.483 . . . . 0.0 112.15 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -76.37 111.56 11.96 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.911 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.285 -2.228 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.329 179.53 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.514 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.0 tp60 . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 120.597 0.237 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.4 p -80.13 164.54 23.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.681 0.753 . . . . 0.0 111.869 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.432 ' CE1' ' O ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -71.89 135.46 46.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 73.7 4.35 4.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.271 1.028 . . . . 0.0 111.886 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.514 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -88.26 162.94 32.55 Favored Glycine 0 N--CA 1.421 -2.301 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.8 tt0 -79.07 120.72 24.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.0 p -99.8 15.43 26.95 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.53 86.92 0.72 Allowed Glycine 0 CA--C 1.482 -1.981 0 C-N-CA 117.64 -2.219 . . . . 0.0 114.824 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 179.2 29.17 Favored Glycine 0 C--N 1.287 -2.194 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 170.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -64.42 114.04 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 118.0 0.9 . . . . 0.0 109.153 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.82 -13.65 29.49 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.342 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -87.31 112.1 21.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 m -96.87 -4.31 40.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.878 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 -164.52 17.2 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.754 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.8 123.01 12.12 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.401 2.734 . . . . 0.0 112.422 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -105.5 -17.99 14.24 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.13 109.56 18.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -69.17 146.46 52.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 123.263 0.352 . . . . 0.0 111.165 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.64 133.96 54.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.411 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 m -47.29 127.89 11.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.631 0.729 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.71 -19.72 25.59 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.774 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.4 p -113.8 153.03 29.79 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 122.429 -0.454 . . . . 0.0 109.917 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -113.54 138.33 50.3 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.895 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -83.09 110.24 17.83 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -108.46 114.5 28.38 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.63 97.82 2.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.78 -38.16 29.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.417 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.64 168.66 12.67 Favored Pre-proline 0 C--N 1.297 -1.692 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.59 -35.16 98.9 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.826 1.684 . . . . 0.0 113.198 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.608 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.1 m-85 -108.6 -25.46 10.88 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.493 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -96.14 115.25 27.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -132.89 141.03 48.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -136.27 139.56 42.77 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.741 0.7 . . . . 0.0 112.229 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.1 m -78.05 113.35 15.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.434 175.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.432 ' O ' ' CE1' ' A' ' 4' ' ' HIS . 91.7 mt . . . . . 0 C--N 1.289 -2.039 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.552 ' OE1' ' HG2' ' A' ' 16' ' ' PRO . 52.0 tp60 . . . . . 0 N--CA 1.433 -1.298 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.8 p -80.62 167.69 19.75 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.067 0.937 . . . . 0.0 112.759 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -71.89 128.48 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.999 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 76.19 6.87 3.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.453 1.101 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.524 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.72 161.7 22.05 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.6 tt0 -77.85 121.44 24.12 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.713 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.1 p -106.76 16.19 24.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 123.93 76.64 0.32 Allowed Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 116.354 -2.832 . . . . 0.0 114.885 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.79 176.33 28.39 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 170.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.6 mt -60.47 113.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 118.177 0.988 . . . . 0.0 110.666 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.4 -11.56 21.68 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.167 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.481 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 51.5 t80 -91.97 132.23 36.68 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.1 m -128.49 13.32 6.51 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.84 -142.16 10.6 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.638 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -71.76 113.94 3.8 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.25 1.967 . . . . 0.0 111.282 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -102.79 -0.59 31.22 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.855 0.836 . . . . 0.0 112.098 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -106.96 118.99 55.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 74.2 m -73.29 160.24 32.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.4 0.619 . . . . 0.0 112.2 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 144.9 56.09 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.104 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -62.44 124.77 21.81 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.63 -14.55 27.21 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -173.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.2 p -119.59 147.73 44.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -113.76 138.08 50.75 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.881 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.8 t -78.86 98.17 6.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.3 mt-30 -96.89 113.85 25.43 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.64 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.4 96.26 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 32' ' ' TYR . 82.0 mt -79.92 -38.36 32.64 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.049 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -135.48 165.02 39.43 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -55.86 -34.31 91.12 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.809 1.673 . . . . 0.0 113.187 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.61 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.7 m-85 -106.04 -25.25 12.15 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.274 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 28' ' ' LEU . 44.8 t80 -95.09 115.06 26.95 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -130.84 134.54 46.91 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -133.41 137.44 45.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 118.446 0.566 . . . . 0.0 111.974 -175.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.8 m -76.8 110.03 11.07 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.999 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.286 -2.183 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.555 HE21 ' HA3' ' A' ' 6' ' ' GLY . 52.0 tp60 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -76.65 159.16 30.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.736 0.779 . . . . 0.0 112.283 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.4 t-160 -66.49 134.53 52.62 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 76.34 0.32 3.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.163 0.985 . . . . 0.0 112.72 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -89.31 161.81 30.36 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -75.18 123.39 25.17 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.754 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -105.63 11.46 32.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.53 88.36 0.84 Allowed Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 116.926 -2.559 . . . . 0.0 114.937 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.56 -178.03 31.14 Favored Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 169.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.4 113.27 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 118.12 0.96 . . . . 0.0 109.099 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.81 -16.37 28.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -82.77 110.26 17.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 m -98.8 2.55 46.94 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.571 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.18 -164.66 13.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.154 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.62 116.53 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.88 2.387 . . . . 0.0 111.873 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.9 p -104.84 -4.81 21.8 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.098 0.475 . . . . 0.0 112.042 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.33 109.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.511 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.8 m -65.29 154.09 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 123.762 0.825 . . . . 0.0 112.35 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 146.9 52.31 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.417 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -50.21 122.74 7.25 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.107 0.963 . . . . 0.0 111.684 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.81 -20.12 24.88 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.132 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 78.7 p -108.31 159.68 16.45 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 122.463 -0.433 . . . . 0.0 111.178 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -119.66 142.27 48.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.9 t -82.23 110.31 17.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -107.7 117.58 34.49 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.93 101.78 3.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.85 -39.75 15.56 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.859 0.837 . . . . 0.0 109.62 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 1.7 m-20 -133.34 162.93 54.66 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -57.98 -27.26 78.49 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.858 1.705 . . . . 0.0 113.137 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.51 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.5 m-85 -110.36 -25.19 10.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.321 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.443 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 39.5 t80 -94.51 114.02 25.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.02 139.55 51.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' OE1' HD21 ' A' ' 36' ' ' LEU . 30.2 tt0 -134.47 137.79 44.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 117.967 0.349 . . . . 0.0 111.448 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -74.03 116.31 14.51 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.418 HD21 ' OE1' ' A' ' 34' ' ' GLN . 89.9 mt . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.009 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.0 p -73.07 166.1 23.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.51 1.148 . . . . 0.0 113.15 -174.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -75.2 134.02 41.29 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 75.08 7.62 4.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.876 0.871 . . . . 0.0 111.081 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -93.5 167.61 28.79 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -81.72 135.39 35.5 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.692 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.2 p -124.74 8.2 8.19 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.35 68.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 116.337 -2.84 . . . . 0.0 115.198 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.04 169.77 22.17 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.6 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.8 mt -58.95 111.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 117.492 0.646 . . . . 0.0 109.492 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.86 -1.8 52.07 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.067 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -84.09 109.84 18.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 117.282 0.541 . . . . 0.0 110.393 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.5 m -93.92 7.01 46.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.48 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.37 -176.36 48.69 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.471 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.12 125.1 14.01 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.581 2.188 . . . . 0.0 110.662 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -99.23 -8.31 25.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.57 0.7 . . . . 0.0 111.006 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.91 109.49 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 58.9 m -76.13 160.69 29.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.052 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.7 121.08 11.36 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 m -53.68 136.68 38.98 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.608 0.718 . . . . 0.0 111.547 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.28 -20.39 23.47 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.2 p -108.53 147.49 31.65 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -107.06 132.04 53.41 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.352 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.9 t -76.0 106.67 7.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.436 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -105.48 115.77 30.82 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.29 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -73.85 104.71 2.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.67 -45.23 9.0 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.804 -175.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -130.01 167.5 20.36 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' O ' HG13 ' A' ' 11' ' ' ILE . 49.1 Cg_exo -60.63 -28.7 87.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.566 1.511 . . . . 0.0 113.198 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.647 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 32.3 m-85 -110.25 -26.04 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -95.17 114.64 26.46 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.1 m -131.31 136.64 48.31 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.475 ' OE1' HD21 ' A' ' 36' ' ' LEU . 32.3 tt0 -131.52 139.43 49.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 118.601 0.637 . . . . 0.0 112.457 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 38.1 m -78.56 109.25 12.59 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.533 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.475 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.3 mt . . . . . 0 C--N 1.294 -1.82 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.491 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.9 p -68.5 158.16 34.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.945 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -64.46 132.83 51.09 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 76.49 4.06 3.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.015 0.926 . . . . 0.0 112.35 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.52 154.18 24.78 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -71.17 124.42 24.42 Favored 'General case' 0 C--O 1.202 -1.434 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.1 p -106.17 14.73 27.25 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -173.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.3 80.71 0.46 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 116.828 -2.606 . . . . 0.0 114.963 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.66 177.45 29.36 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 106.881 -2.487 . . . . 0.0 106.881 170.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.11 114.2 2.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 118.27 1.035 . . . . 0.0 108.971 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.51 -6.49 26.38 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.748 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -97.37 109.82 22.5 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.366 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -100.89 18.74 18.76 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.498 0.666 . . . . 0.0 110.765 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.63 -165.27 38.43 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -58.18 114.9 2.18 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.904 2.403 . . . . 0.0 111.915 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -104.55 -2.83 24.65 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.847 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.6 113.29 43.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 81.7 m -70.91 156.26 39.81 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 154.1 38.39 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.499 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -54.77 118.79 4.53 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.021 0.528 . . . . 0.0 110.831 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.84 26.26 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.139 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.6 p -108.78 143.83 37.41 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.456 -0.438 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.6 p -110.78 145.32 38.34 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.862 -0.154 . . . . 0.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.5 t -84.76 110.51 18.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -107.38 111.89 24.44 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.814 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.6 100.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.427 HD12 ' CE1' ' A' ' 32' ' ' TYR . 79.9 mt -82.78 -40.74 20.04 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.028 -174.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -136.07 162.94 53.74 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.06 -28.14 68.14 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.02 1.813 . . . . 0.0 113.463 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 40.9 m-85 -111.34 -25.51 9.62 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.617 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' CE1' HD12 ' A' ' 28' ' ' LEU . 38.8 t80 -96.6 115.0 26.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -129.95 140.01 50.99 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -133.05 138.82 46.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 118.903 0.774 . . . . 0.0 112.034 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.1 m -76.21 114.24 14.66 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.064 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.286 -2.16 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.879 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.547 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.4 tp60 . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.3 p -75.69 162.43 28.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.982 0.896 . . . . 0.0 112.13 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -68.77 133.44 48.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 74.35 6.84 4.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.987 0.915 . . . . 0.0 112.19 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.547 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.61 160.89 22.78 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.5 tt0 -74.4 129.54 37.97 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.9 p -111.58 5.12 19.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.13 82.77 0.1 Allowed Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 116.78 -2.629 . . . . 0.0 114.51 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.25 174.52 26.29 Favored Glycine 0 N--CA 1.417 -2.605 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 170.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.505 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.3 mt -59.55 118.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 117.788 0.794 . . . . 0.0 109.61 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.41 63.07 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.487 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -76.87 111.54 12.52 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.28 -0.541 . . . . 0.0 110.488 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -94.65 2.98 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.938 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.1 -174.28 50.27 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.525 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -62.32 127.84 22.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.177 2.585 . . . . 0.0 112.617 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 p -105.96 -5.67 19.42 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -99.29 109.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 99.4 m -66.44 154.52 40.0 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.64 0.587 . . . . 0.0 112.304 -178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 150.1 45.07 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.389 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -59.72 124.37 19.92 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.247 0.546 . . . . 0.0 110.822 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.23 -18.42 28.19 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.8 p -108.32 149.98 27.94 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.8 p -114.43 140.41 48.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -80.73 103.37 10.52 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.66 114.24 28.3 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.172 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -73.16 106.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.8 mt -92.38 -33.29 14.63 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.961 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 18.4 m120 -143.97 161.85 43.6 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.09 -31.32 89.94 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.891 1.727 . . . . 0.0 112.87 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.573 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 64.8 m-85 -105.71 -26.08 11.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.938 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' CE2' HD12 ' A' ' 28' ' ' LEU . 51.5 t80 -96.69 114.56 26.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -132.75 136.47 46.37 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -131.02 138.29 49.58 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -75.72 109.11 9.04 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--N 1.293 -1.868 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.834 178.935 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.1 p -76.03 160.98 29.28 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.075 0.941 . . . . 0.0 112.858 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -66.06 133.04 49.92 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 76.9 3.61 3.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.243 1.017 . . . . 0.0 111.591 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -93.75 163.44 25.91 Favored Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -77.05 123.83 26.93 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.828 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 19.4 p -105.64 6.98 32.51 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -175.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.34 85.4 0.42 Allowed Glycine 0 CA--C 1.476 -2.388 0 C-N-CA 116.512 -2.756 . . . . 0.0 114.909 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.73 -176.87 31.0 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 107.019 -2.432 . . . . 0.0 107.019 169.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.09 118.24 6.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.854 0.827 . . . . 0.0 109.577 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.5 9.0 59.31 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.293 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -80.56 115.32 20.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.393 0.597 . . . . 0.0 110.508 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -84.63 -3.45 58.5 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.923 0.889 . . . . 0.0 113.326 -176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.06 -167.23 33.03 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.245 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.52 130.06 21.45 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.381 2.721 . . . . 0.0 112.098 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -104.4 -6.47 20.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.917 0.865 . . . . 0.0 111.866 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.57 109.04 22.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 87.9 m -68.45 156.22 38.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 123.612 0.57 . . . . 0.0 112.423 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 148.22 43.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.943 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -59.06 120.72 9.65 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -13.65 28.09 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.84 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.5 p -116.88 150.48 38.36 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.371 -0.488 . . . . 0.0 110.077 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -116.58 144.48 44.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.1 t -79.2 112.17 16.15 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.1 mt-30 -106.45 116.61 32.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.333 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -73.01 111.08 6.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 32' ' ' TYR . 94.1 mt -97.0 -31.61 12.43 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.56 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -149.63 166.14 15.93 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.32 -36.22 96.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.19 1.927 . . . . 0.0 113.627 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.61 -25.73 12.15 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.281 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CE1' HD12 ' A' ' 28' ' ' LEU . 58.3 t80 -95.93 114.96 26.73 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.2 m -129.33 143.55 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.7 tt0 -132.04 137.51 47.84 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.688 0.676 . . . . 0.0 111.952 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.828 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -74.93 111.64 10.34 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.042 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.502 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.0 mt . . . . . 0 C--N 1.291 -1.969 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.531 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.4 tp60 . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.1 p -73.6 167.87 20.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.045 0.926 . . . . 0.0 112.722 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -73.49 132.96 43.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.506 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 75.35 2.76 3.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.29 1.036 . . . . 0.0 112.135 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.531 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -91.43 161.81 27.73 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.4 tt0 -75.68 123.32 25.36 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.817 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.4 p -103.63 -3.62 24.91 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 137.74 83.57 0.12 Allowed Glycine 0 CA--C 1.479 -2.183 0 C-N-CA 116.334 -2.841 . . . . 0.0 114.966 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -173.25 29.89 Favored Glycine 0 C--N 1.284 -2.34 0 N-CA-C 107.925 -2.07 . . . . 0.0 107.925 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 78.6 mt -64.41 116.37 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.2 54.77 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.025 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 53.5 t80 -91.91 109.73 21.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.159 177.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 m -89.47 -5.6 57.19 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.839 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.15 -160.23 26.64 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.41 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.506 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 39.9 Cg_endo -72.14 131.53 18.12 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.1 2.533 . . . . 0.0 112.59 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.0 p -107.57 3.07 24.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -105.59 109.71 28.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 75.5 m -67.62 150.38 48.84 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.815 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 156.06 24.02 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.165 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -58.52 119.34 6.84 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.458 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -11.9 30.3 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.907 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.1 p -118.62 146.27 44.78 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.512 -0.404 . . . . 0.0 110.345 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 p -114.22 142.17 46.61 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.5 t -79.88 112.17 16.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.437 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 73.6 mt-30 -110.59 114.22 27.45 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.235 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 t -77.49 104.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD12 ' CE2' ' A' ' 32' ' ' TYR . 86.6 mt -89.57 -34.16 16.45 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.528 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 20.0 m120 -143.42 167.41 15.79 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.91 -41.5 74.37 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.149 1.899 . . . . 0.0 113.62 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.512 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.4 m-85 -101.7 -25.04 13.99 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.199 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 41.7 t80 -95.04 115.42 27.41 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.7 m -131.5 140.04 49.45 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -134.31 138.4 44.93 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.244 0.475 . . . . 0.0 111.839 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.817 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.0 m -76.86 107.44 9.18 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.951 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.437 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.2 mt . . . . . 0 C--N 1.282 -2.339 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.555 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.1 p -77.27 168.01 20.76 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 112.145 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -71.21 135.28 47.44 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 73.71 9.7 4.85 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.954 0.901 . . . . 0.0 112.651 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.19 154.17 22.22 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.845 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.7 tt0 -70.14 123.27 21.2 Favored 'General case' 0 C--O 1.205 -1.241 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.726 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.9 p -102.21 13.01 35.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -171.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.71 63.22 0.18 Allowed Glycine 0 CA--C 1.48 -2.114 0 C-N-CA 117.047 -2.502 . . . . 0.0 114.876 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -85.19 173.24 48.22 Favored Glycine 0 N--CA 1.421 -2.317 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 63.9 mt -56.73 111.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 117.919 0.86 . . . . 0.0 109.951 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.82 -13.72 34.83 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.8 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -85.51 109.15 18.29 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 m -107.43 30.24 6.43 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.422 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.06 -160.67 28.46 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.06 118.68 5.58 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.944 2.429 . . . . 0.0 111.014 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -107.55 0.56 22.75 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.415 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.48 109.55 28.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 68.9 m -71.38 155.75 40.28 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 123.158 0.583 . . . . 0.0 112.051 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.54 147.63 50.91 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.046 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.7 m -57.6 122.62 13.17 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -10.08 30.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.3 p -118.67 141.84 48.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -108.35 129.12 55.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.422 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.84 98.54 3.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -98.94 117.03 32.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.268 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.4 t -78.43 93.95 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.3 -41.97 32.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.875 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 20.0 m120 -139.91 166.53 23.23 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.04 -43.03 63.32 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.265 1.976 . . . . 0.0 112.866 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.634 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -99.64 -26.37 14.09 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.009 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 31.9 t80 -94.94 113.95 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.456 0.646 . . . . 0.0 111.722 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -135.49 137.18 41.89 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -137.05 141.3 42.43 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.872 0.76 . . . . 0.0 111.75 -172.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.9 m -78.96 107.12 11.47 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.276 -2.602 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.202 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.505 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.4 tp60 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 172.68 13.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.011 0.91 . . . . 0.0 112.189 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -78.58 133.46 37.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 74.04 6.34 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.909 0.884 . . . . 0.0 111.818 -175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.505 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.78 160.45 25.29 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.638 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.1 tt0 -78.84 127.41 32.0 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.793 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.0 p -106.68 9.37 31.25 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.65 80.57 0.48 Allowed Glycine 0 CA--C 1.489 -1.576 0 C-N-CA 117.252 -2.404 . . . . 0.0 115.207 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.24 -179.15 30.08 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 168.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.433 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 71.4 mt -62.78 114.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 117.854 0.827 . . . . 0.0 108.859 175.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.74 2.43 32.38 Favored Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.664 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -98.08 133.3 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -117.86 10.68 13.28 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.097 0.475 . . . . 0.0 111.133 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.08 -164.6 35.15 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.069 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.37 124.66 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.174 2.582 . . . . 0.0 112.159 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.8 p -106.09 -7.83 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.771 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -99.33 111.9 30.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 82.2 m -73.53 159.93 32.44 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.521 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 151.52 43.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.77 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -60.6 121.54 12.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.018 0.437 . . . . 0.0 109.861 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -19.81 24.77 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.586 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.7 p -107.62 140.77 40.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 27.6 p -105.24 136.33 44.95 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.359 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.1 t -79.91 99.03 7.38 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -98.55 116.73 31.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.588 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.92 93.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.51 -34.22 58.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.542 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -142.92 165.28 27.14 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 -32.51 93.65 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 121.453 1.435 . . . . 0.0 112.557 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.553 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.0 m-85 -107.76 -26.83 10.61 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.411 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -96.68 115.24 27.09 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -124.63 142.47 51.35 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -135.7 141.06 44.88 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 118.762 0.71 . . . . 0.0 112.334 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -82.03 107.46 14.75 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.073 176.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.488 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 85.6 mt . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.389 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.563 HE21 ' HA3' ' A' ' 6' ' ' GLY . 59.9 tp60 . . . . . 0 N--CA 1.41 -2.445 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.2 p -79.08 172.28 14.02 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.922 0.867 . . . . 0.0 111.163 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -72.66 135.07 45.36 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.259 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 73.77 6.38 4.92 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.319 1.048 . . . . 0.0 112.075 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.563 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.15 166.8 29.92 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.662 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.619 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -79.81 128.66 33.71 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.797 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 16.2 p -110.57 15.48 22.05 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.63 84.42 0.51 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 117.109 -2.472 . . . . 0.0 114.412 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.32 -179.4 29.89 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 169.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.66 109.62 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 117.826 0.813 . . . . 0.0 109.199 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.65 -11.12 32.77 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.12 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -79.12 110.15 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.025 0.441 . . . . 0.0 109.904 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 p -93.78 0.61 56.4 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.936 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.42 -168.55 40.65 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.305 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.86 122.37 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.845 2.364 . . . . 0.0 112.511 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 p -102.6 -15.72 16.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.657 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.43 108.97 20.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 77.9 m -68.92 153.11 44.37 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.094 0.473 . . . . 0.0 111.587 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.61 146.94 47.35 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -60.66 120.49 10.14 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.944 0.402 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.58 -10.66 30.43 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 71.1 p -114.31 143.83 44.24 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -108.7 132.72 53.65 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.227 0.329 . . . . 0.0 110.634 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.1 t -78.81 100.75 7.28 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -100.2 110.89 23.15 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.59 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.32 102.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.71 -39.4 16.04 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.437 -177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -139.41 162.79 49.66 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.7 -32.88 85.66 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.108 1.872 . . . . 0.0 113.041 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.7 m-85 -106.28 -26.16 11.64 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.491 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -96.79 114.45 26.08 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -131.74 139.35 48.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.3 tt0 -135.08 138.36 43.77 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 118.55 0.614 . . . . 0.0 112.45 -174.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -79.41 107.63 12.32 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.291 -1.966 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.235 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 120.718 0.294 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.51 HE21 ' HA3' ' A' ' 6' ' ' GLY . 49.5 tp60 -74.21 145.28 44.27 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.7 p -77.31 171.41 14.9 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 111.821 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.441 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.6 t-160 -78.01 134.46 37.8 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 74.81 11.79 3.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.924 0.89 . . . . 0.0 111.596 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.51 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -101.37 163.82 17.91 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.642 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -77.28 122.38 25.02 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.8 p -106.8 14.96 26.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.96 85.98 0.6 Allowed Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 116.954 -2.546 . . . . 0.0 114.889 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 177.27 28.16 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 168.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.433 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 67.0 mt -65.09 111.85 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 118.129 0.965 . . . . 0.0 109.138 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.58 -9.52 21.87 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.91 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -106.42 108.57 20.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -112.62 11.64 19.64 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.943 0.401 . . . . 0.0 111.091 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.59 -147.44 1.8 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.552 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.04 98.66 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.061 2.507 . . . . 0.0 112.093 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 p -98.7 -14.78 19.64 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.036 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.49 110.93 23.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.531 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 70.8 m -69.44 157.09 37.76 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.657 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.68 147.49 49.34 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 m -60.9 126.65 28.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.524 0.678 . . . . 0.0 110.54 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.79 -20.29 24.72 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.2 p -108.14 143.25 37.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 122.403 -0.469 . . . . 0.0 109.803 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 p -107.72 137.15 46.25 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.477 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.7 t -82.08 102.22 10.88 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.96 117.96 36.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.321 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.9 t -76.63 117.91 22.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.459 HD12 ' CE1' ' A' ' 32' ' ' TYR . 83.9 mt -101.7 -42.15 6.3 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.559 0.695 . . . . 0.0 109.598 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 20.5 m120 -135.62 165.03 39.24 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.25 -27.58 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.032 1.822 . . . . 0.0 113.313 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.607 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.1 m-85 -112.49 -26.08 8.87 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.294 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CE1' HD12 ' A' ' 28' ' ' LEU . 40.7 t80 -95.2 115.06 26.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -131.96 141.78 49.42 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 33.7 tt0 -134.42 138.24 44.65 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 118.535 0.607 . . . . 0.0 112.307 -175.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.0 m -77.32 114.7 16.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.745 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.494 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 C--O 1.241 0.647 0 CA-C-O 120.871 0.367 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.515 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.1 tp60 -70.87 142.57 51.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.966 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -79.32 157.49 27.67 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.74 0.781 . . . . 0.0 112.167 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -67.15 132.03 46.99 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 75.44 6.05 4.07 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.975 0.91 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.515 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.75 166.78 29.18 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -78.63 130.32 35.75 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.779 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.7 p -115.23 7.0 15.15 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -173.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.82 75.26 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 117.026 -2.511 . . . . 0.0 114.458 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.94 174.06 26.19 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 172.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.2 mt -59.2 110.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 117.588 0.694 . . . . 0.0 109.694 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.9 43.68 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.815 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -89.21 109.45 20.32 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -105.23 17.62 23.71 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.165 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.25 -163.22 37.87 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.53 114.47 2.14 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.763 2.309 . . . . 0.0 111.597 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -103.28 0.33 31.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.205 0.526 . . . . 0.0 112.036 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.81 109.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 73.4 m -69.44 155.43 40.47 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.053 0.541 . . . . 0.0 111.469 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.46 147.11 49.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.046 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -57.73 123.75 16.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -14.43 28.98 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 65.3 p -117.53 145.5 44.2 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.448 -0.443 . . . . 0.0 110.117 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -111.35 138.25 48.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.504 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.9 t -78.49 109.63 12.85 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.6 mt-30 -106.28 112.5 25.55 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 99.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.47 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.2 mt -84.27 -39.23 19.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.334 -173.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -134.96 164.65 42.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.14 -34.68 88.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.818 1.679 . . . . 0.0 113.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.642 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.6 m-85 -107.46 -24.96 11.62 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CE2' HD12 ' A' ' 28' ' ' LEU . 43.8 t80 -94.98 114.39 26.2 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -128.53 139.08 52.49 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 31.8 tt0 -133.3 137.17 45.87 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.451 0.569 . . . . 0.0 111.885 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -75.68 109.39 9.22 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.48 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.28 -2.444 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.683 HE21 ' HB2' ' A' ' 16' ' ' PRO . 9.8 tp-100 -70.84 140.3 51.11 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -77.03 166.68 22.98 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.72 0.772 . . . . 0.0 111.874 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -71.22 135.76 47.68 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 73.72 8.6 4.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.801 0.84 . . . . 0.0 112.161 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.467 ' HA3' ' H3 ' ' A' ' 101' ' ' MAN . . . -96.08 155.75 21.16 Favored Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.0 tt0 -69.96 125.44 26.76 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.76 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -107.52 11.33 28.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.35 72.83 0.23 Allowed Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 117.278 -2.391 . . . . 0.0 114.741 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.31 179.52 30.86 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 171.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 68.0 mt -57.93 116.28 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 118.041 0.921 . . . . 0.0 110.327 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.27 -28.5 9.62 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.608 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -78.3 111.98 14.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.91 0.386 . . . . 0.0 110.189 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -102.15 -0.32 33.46 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.925 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -163.15 10.46 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.942 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.683 ' HB2' HE21 ' A' ' 2' ' ' GLN . 52.2 Cg_exo -58.44 123.92 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.515 2.81 . . . . 0.0 112.649 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 p -109.74 -1.57 17.89 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.377 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.24 110.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.3 m -70.64 164.61 24.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.557 0.694 . . . . 0.0 112.761 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.97 160.41 31.95 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.017 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -63.4 116.58 5.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 123.363 0.665 . . . . 0.0 110.032 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.74 -14.33 34.95 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.871 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 60.6 p -108.17 142.83 37.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.573 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 p -106.85 137.68 44.44 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.51 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.0 t -79.56 100.36 7.73 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -98.56 118.95 36.4 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.927 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.87 98.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.2 -35.68 28.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.581 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 19.7 m120 -146.28 165.12 21.32 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.26 -37.42 94.43 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.155 1.903 . . . . 0.0 113.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.534 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 36.3 m-85 -101.13 -26.24 13.75 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.913 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 19.9 t80 -95.59 114.3 26.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.329 0.585 . . . . 0.0 112.334 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.9 m -132.78 135.14 45.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' OE1' HD21 ' A' ' 36' ' ' LEU . 32.8 tt0 -133.84 140.54 46.94 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.956 0.343 . . . . 0.0 111.868 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.4 m -77.08 112.3 13.58 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.426 HD21 ' OE1' ' A' ' 34' ' ' GLN . 90.1 mt . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.02 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.467 ' H3 ' ' HA3' ' A' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.44 -0.962 0 CA-C-O 120.85 0.357 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.582 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.1 tp60 -77.7 141.01 39.6 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 174.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.1 p -80.55 162.02 24.51 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.756 0.789 . . . . 0.0 111.604 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -66.04 133.22 50.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 74.5 12.54 3.84 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.841 0.856 . . . . 0.0 112.485 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.582 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -101.76 169.55 20.26 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.629 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.4 tt0 -81.42 127.41 32.75 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.773 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -110.36 8.7 23.44 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.22 80.15 0.2 Allowed Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 116.862 -2.59 . . . . 0.0 114.317 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.84 179.64 30.22 Favored Glycine 0 C--N 1.284 -2.358 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 170.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 66.7 mt -62.46 111.04 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 117.984 0.892 . . . . 0.0 110.733 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.92 2.28 45.74 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.032 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -91.27 109.53 20.8 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.186 -0.597 . . . . 0.0 109.659 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -97.03 12.48 32.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.393 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.55 -165.78 41.62 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.613 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.03 115.18 2.38 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.937 2.425 . . . . 0.0 112.079 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -102.82 -8.53 20.71 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.939 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.54 108.92 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 85.6 m -71.34 155.8 40.23 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.39 138.05 56.82 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.2 m -57.54 128.13 35.49 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.84 23.9 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.6 p -108.23 146.44 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.7 p -107.68 131.31 54.54 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 121.263 -0.175 . . . . 0.0 110.879 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.47 103.26 4.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -103.56 116.14 31.82 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.214 0.53 . . . . 0.0 111.29 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.3 t -72.13 107.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.549 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.73 -33.84 13.46 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.273 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 1.9 m120 -139.27 165.04 34.67 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.25 -30.61 93.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.723 1.615 . . . . 0.0 112.562 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.606 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.0 m-85 -105.36 -25.49 12.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.932 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 32.2 t80 -95.23 114.35 26.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -130.67 136.86 49.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.6 tt0 -132.37 137.25 47.29 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 118.304 0.502 . . . . 0.0 111.938 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -75.89 113.08 12.98 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.807 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.892 179.52 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.247 0.967 0 CA-C-O 120.575 0.226 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.554 HE21 ' HA3' ' A' ' 6' ' ' GLY . 58.0 tp60 -70.43 138.06 50.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.7 p -75.75 158.87 31.7 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.186 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.447 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 18.7 t-160 -65.4 134.88 54.45 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 73.63 9.26 4.96 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.106 0.962 . . . . 0.0 111.584 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -97.29 161.2 21.46 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.675 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -74.95 123.57 25.36 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.2 p -107.03 16.03 24.64 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 75.49 0.31 Allowed Glycine 0 CA--C 1.483 -1.911 0 C-N-CA 117.044 -2.503 . . . . 0.0 114.705 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.15 -178.92 30.25 Favored Glycine 0 C--N 1.29 -1.986 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 169.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.4 119.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.0 -23.64 27.03 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.259 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.77 110.18 20.79 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -107.54 8.58 29.37 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.308 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.9 -162.3 25.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.881 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.64 117.83 4.57 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.202 2.601 . . . . 0.0 112.964 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 p -100.88 -13.38 18.38 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.831 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -92.53 109.58 21.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.469 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 81.8 m -73.26 159.72 32.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.277 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 138.98 58.71 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.5 m -51.94 117.93 3.09 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.448 0.467 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -2.88 28.7 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.749 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.8 p -123.98 142.21 51.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 p -109.54 131.93 54.61 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.378 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -74.18 103.66 4.69 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -103.87 113.73 27.47 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.637 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.23 104.78 4.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.03 -45.86 9.83 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.846 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.445 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 1.6 m-20 -128.47 167.28 19.62 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.27 -34.86 99.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 121.545 1.497 . . . . 0.0 112.374 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.557 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.4 m-85 -100.86 -26.8 13.63 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.646 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.445 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 25.4 t80 -96.62 114.57 26.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -131.7 136.04 47.33 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' OE1' HD21 ' A' ' 36' ' ' LEU . 30.9 tt0 -136.09 137.0 40.6 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 118.671 0.669 . . . . 0.0 112.125 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.74 109.14 9.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.422 HD21 ' OE1' ' A' ' 34' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.287 -2.139 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.516 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.7 tp60 -84.25 145.34 28.37 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.0 p -78.56 170.5 16.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.581 0.705 . . . . 0.0 111.88 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.479 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.5 t-160 -76.14 135.7 39.81 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 73.59 9.29 4.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.03 0.932 . . . . 0.0 111.963 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.516 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.85 166.88 25.15 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.058 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.1 tt0 -76.86 130.12 37.16 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.7 p -118.42 10.14 12.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.55 74.57 0.03 OUTLIER Glycine 0 CA--C 1.474 -2.479 0 C-N-CA 116.348 -2.834 . . . . 0.0 114.129 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.47 169.62 21.6 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 172.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 75.2 mt -59.55 113.49 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 117.574 0.687 . . . . 0.0 109.551 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.79 -18.75 36.93 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.323 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -73.38 114.32 11.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 109.737 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -109.67 20.28 18.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.694 0.759 . . . . 0.0 110.274 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.61 -162.45 35.02 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.079 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.85 115.92 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.702 2.268 . . . . 0.0 111.512 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -102.35 -4.13 26.03 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.945 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.31 109.65 26.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 79.1 m -71.8 152.17 42.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.724 0.409 . . . . 0.0 110.734 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.41 122.08 11.07 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -53.23 131.71 37.6 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.523 0.677 . . . . 0.0 110.806 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.15 -9.55 26.96 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -170.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -123.97 150.23 45.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -113.7 137.53 51.49 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.632 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -79.62 103.81 9.79 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -102.5 117.79 35.47 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.301 0.572 . . . . 0.0 111.679 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.8 t -74.48 108.41 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.518 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.5 mt -93.03 -40.08 10.73 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.627 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 22.3 m120 -138.98 165.79 29.66 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -55.46 -36.86 94.99 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.981 1.787 . . . . 0.0 113.301 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.677 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -104.06 -25.89 12.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.264 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.5 t80 -95.51 114.53 26.3 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.7 139.44 50.3 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -132.3 137.52 47.49 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.785 0.721 . . . . 0.0 112.452 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -75.2 109.81 9.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.128 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.611 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.6 tp60 -76.04 141.36 42.11 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.077 0.551 . . . . 0.0 110.172 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -77.04 160.43 29.1 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.577 0.703 . . . . 0.0 112.438 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.455 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 20.4 t-160 -67.14 133.49 49.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 77.03 5.27 3.29 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.119 0.968 . . . . 0.0 112.125 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.611 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.65 161.21 22.85 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.751 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -73.36 128.72 36.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.4 p -112.48 19.25 17.74 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.64 78.38 0.56 Allowed Glycine 0 CA--C 1.479 -2.198 0 C-N-CA 117.44 -2.314 . . . . 0.0 114.478 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.96 172.59 24.73 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 106.891 -2.484 . . . . 0.0 106.891 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.479 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 70.5 mt -58.25 113.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 118.006 0.903 . . . . 0.0 109.317 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.04 -8.22 33.34 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.193 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -95.67 110.05 22.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 m -97.9 0.98 47.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.064 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.04 -158.99 11.68 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.544 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.57 114.05 2.21 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.703 2.935 . . . . 0.0 112.466 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.1 p -101.34 -13.73 17.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -88.9 110.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 73.3 m -72.07 155.63 40.09 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.986 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.11 140.26 58.85 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 125.19 16.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 123.507 0.505 . . . . 0.0 110.538 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -12.48 30.04 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.9 p -116.78 146.96 42.49 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -111.73 137.4 49.69 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.951 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.4 t -80.83 100.77 8.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -102.12 115.8 31.32 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.755 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -79.76 94.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.6 mt -76.5 -37.56 56.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.855 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -138.01 163.7 45.99 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.47 -35.61 92.53 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.319 2.013 . . . . 0.0 112.712 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.6 m-85 -100.61 -25.6 14.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.456 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -96.24 113.88 25.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.636 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.7 m -129.89 135.33 48.23 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.03 138.24 42.0 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.287 0.494 . . . . 0.0 111.794 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -75.62 109.09 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--N 1.294 -1.812 0 C-N-CA 123.209 0.604 . . . . 0.0 110.388 -179.521 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.438 -1.048 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.527 HE21 ' HB2' ' A' ' 16' ' ' PRO . 9.8 tp-100 -82.5 138.35 34.35 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 174.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.0 p -70.18 162.42 28.38 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 122.292 1.044 . . . . 0.0 112.745 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -72.4 129.72 39.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 77.43 7.16 2.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.766 0.826 . . . . 0.0 112.169 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -95.7 164.9 24.32 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.692 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.6 tt0 -75.59 128.19 34.72 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -111.3 8.98 21.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -174.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.43 66.88 0.06 OUTLIER Glycine 0 CA--C 1.48 -2.134 0 C-N-CA 116.83 -2.605 . . . . 0.0 113.807 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.83 173.15 25.41 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' H ' ' HA ' ' A' ' 31' ' ' TYR . 76.6 mt -65.75 122.51 16.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.69 4.06 57.08 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.32 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.421 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 48.3 t80 -105.89 110.25 22.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 m -99.76 6.01 45.54 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.25 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.34 -165.59 41.21 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.96 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HB2' HE21 ' A' ' 2' ' ' GLN . 39.0 Cg_exo -62.24 125.86 17.31 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.834 3.023 . . . . 0.0 112.979 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 p -106.2 -2.98 21.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.02 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.57 109.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 71.3 m -73.19 149.13 43.14 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.396 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.67 152.82 34.29 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.22 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 m -58.98 119.98 8.24 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.302 0.572 . . . . 0.0 110.57 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.47 -11.61 30.68 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.627 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.0 p -114.27 142.61 46.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.901 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 p -112.53 133.47 54.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.172 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.513 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.27 105.07 7.11 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.13 115.15 29.9 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.966 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.61 98.92 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -81.68 -37.7 27.01 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.206 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -143.28 163.4 37.45 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.42 -38.24 89.46 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.437 2.092 . . . . 0.0 113.132 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -101.89 -26.44 13.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.921 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -96.73 114.75 26.41 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -129.46 138.79 51.62 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.7 tt0 -132.95 137.07 46.46 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 118.896 0.771 . . . . 0.0 112.098 -175.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.1 m -78.29 108.62 11.75 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.289 -2.032 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.712 177.798 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 120.943 0.401 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.54 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 -76.63 140.97 41.19 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.562 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p -78.94 165.75 23.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.965 0.888 . . . . 0.0 112.194 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -72.31 128.24 35.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.693 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 75.85 16.0 2.46 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.232 1.013 . . . . 0.0 111.947 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.54 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -103.0 162.75 16.08 Favored Glycine 0 N--CA 1.414 -2.789 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -75.71 127.98 34.21 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 26.8 p -112.24 3.7 17.32 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.01 72.37 0.04 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 116.43 -2.795 . . . . 0.0 114.498 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 170.18 23.03 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.588 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.7 mt -58.39 122.63 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 117.828 0.814 . . . . 0.0 108.947 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -27.06 19.17 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -84.93 115.59 22.88 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.8 m -115.8 17.68 15.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.081 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 -156.46 18.06 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.459 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.08 113.81 1.74 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.21 2.607 . . . . 0.0 111.246 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -109.78 -1.61 17.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.451 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.67 110.5 31.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.523 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 85.8 m -69.16 158.04 35.69 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 159.64 20.98 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.517 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -63.86 118.21 8.05 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.25 0.548 . . . . 0.0 110.415 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.64 29.13 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.5 p -108.3 144.01 36.38 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.418 -0.46 . . . . 0.0 110.442 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.9 p -109.81 136.29 49.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.36 100.5 5.18 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -99.42 112.43 24.62 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.638 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.65 101.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.82 -39.88 17.84 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.622 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 18.9 m120 -140.18 165.86 27.58 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.15 -35.87 95.73 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.059 1.839 . . . . 0.0 113.508 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.0 m-85 -106.62 -25.42 11.79 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.262 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 41.2 t80 -95.92 114.43 26.15 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 177.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.595 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -130.81 137.91 49.64 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -133.91 138.33 45.47 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 118.262 0.483 . . . . 0.0 112.15 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -76.37 111.56 11.96 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.911 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.285 -2.228 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.329 179.53 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.519 ' H3 ' ' HA3' ' A' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.514 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.0 tp60 -77.9 143.08 38.01 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.597 0.237 . . . . 0.0 110.652 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.4 p -80.13 164.54 23.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.681 0.753 . . . . 0.0 111.869 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.432 ' CE1' ' O ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -71.89 135.46 46.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 73.7 4.35 4.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.271 1.028 . . . . 0.0 111.886 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.514 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -88.26 162.94 32.55 Favored Glycine 0 N--CA 1.421 -2.301 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.8 tt0 -79.07 120.72 24.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.0 p -99.8 15.43 26.95 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.53 86.92 0.72 Allowed Glycine 0 CA--C 1.482 -1.981 0 C-N-CA 117.64 -2.219 . . . . 0.0 114.824 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 179.2 29.17 Favored Glycine 0 C--N 1.287 -2.194 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 170.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -64.42 114.04 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 118.0 0.9 . . . . 0.0 109.153 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.82 -13.65 29.49 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.342 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -87.31 112.1 21.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 m -96.87 -4.31 40.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.878 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 -164.52 17.2 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.754 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.8 123.01 12.12 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.401 2.734 . . . . 0.0 112.422 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -105.5 -17.99 14.24 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.13 109.56 18.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -69.17 146.46 52.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 123.263 0.352 . . . . 0.0 111.165 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.64 133.96 54.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.411 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 m -47.29 127.89 11.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.631 0.729 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.71 -19.72 25.59 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.774 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.4 p -113.8 153.03 29.79 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 122.429 -0.454 . . . . 0.0 109.917 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -113.54 138.33 50.3 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.895 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -83.09 110.24 17.83 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -108.46 114.5 28.38 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.63 97.82 2.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.78 -38.16 29.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.417 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.64 168.66 12.67 Favored Pre-proline 0 C--N 1.297 -1.692 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.59 -35.16 98.9 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.826 1.684 . . . . 0.0 113.198 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.608 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.1 m-85 -108.6 -25.46 10.88 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.493 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -96.14 115.25 27.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -132.89 141.03 48.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -136.27 139.56 42.77 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.741 0.7 . . . . 0.0 112.229 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.1 m -78.05 113.35 15.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.434 175.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.432 ' O ' ' CE1' ' A' ' 4' ' ' HIS . 91.7 mt . . . . . 0 C--N 1.289 -2.039 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.451 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.552 ' OE1' ' HG2' ' A' ' 16' ' ' PRO . 52.0 tp60 -86.51 144.43 27.25 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.8 p -80.62 167.69 19.75 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.067 0.937 . . . . 0.0 112.759 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -71.89 128.48 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.999 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 76.19 6.87 3.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.453 1.101 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.524 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.72 161.7 22.05 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.6 tt0 -77.85 121.44 24.12 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.713 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.1 p -106.76 16.19 24.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 123.93 76.64 0.32 Allowed Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 116.354 -2.832 . . . . 0.0 114.885 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.79 176.33 28.39 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 170.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.6 mt -60.47 113.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 118.177 0.988 . . . . 0.0 110.666 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.4 -11.56 21.68 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.167 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.481 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 51.5 t80 -91.97 132.23 36.68 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.1 m -128.49 13.32 6.51 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.84 -142.16 10.6 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.638 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -71.76 113.94 3.8 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.25 1.967 . . . . 0.0 111.282 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -102.79 -0.59 31.22 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.855 0.836 . . . . 0.0 112.098 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -106.96 118.99 55.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 74.2 m -73.29 160.24 32.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.4 0.619 . . . . 0.0 112.2 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 144.9 56.09 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.104 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -62.44 124.77 21.81 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.63 -14.55 27.21 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -173.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.2 p -119.59 147.73 44.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -113.76 138.08 50.75 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.881 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.8 t -78.86 98.17 6.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.3 mt-30 -96.89 113.85 25.43 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.64 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.4 96.26 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 32' ' ' TYR . 82.0 mt -79.92 -38.36 32.64 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.049 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -135.48 165.02 39.43 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -55.86 -34.31 91.12 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.809 1.673 . . . . 0.0 113.187 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.61 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.7 m-85 -106.04 -25.25 12.15 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.274 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 28' ' ' LEU . 44.8 t80 -95.09 115.06 26.95 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -130.84 134.54 46.91 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -133.41 137.44 45.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 118.446 0.566 . . . . 0.0 111.974 -175.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.8 m -76.8 110.03 11.07 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.999 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.286 -2.183 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.438 -1.072 0 CA-C-O 120.639 0.257 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.555 HE21 ' HA3' ' A' ' 6' ' ' GLY . 52.0 tp60 -74.03 138.82 44.32 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 123.192 0.597 . . . . 0.0 109.663 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -76.65 159.16 30.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.736 0.779 . . . . 0.0 112.283 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.4 t-160 -66.49 134.53 52.62 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 76.34 0.32 3.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.163 0.985 . . . . 0.0 112.72 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -89.31 161.81 30.36 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -75.18 123.39 25.17 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.754 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -105.63 11.46 32.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.53 88.36 0.84 Allowed Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 116.926 -2.559 . . . . 0.0 114.937 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.56 -178.03 31.14 Favored Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 169.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.4 113.27 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 118.12 0.96 . . . . 0.0 109.099 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.81 -16.37 28.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -82.77 110.26 17.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 m -98.8 2.55 46.94 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.571 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.18 -164.66 13.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.154 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.62 116.53 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.88 2.387 . . . . 0.0 111.873 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.9 p -104.84 -4.81 21.8 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.098 0.475 . . . . 0.0 112.042 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.33 109.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.511 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.8 m -65.29 154.09 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 123.762 0.825 . . . . 0.0 112.35 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 146.9 52.31 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.417 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -50.21 122.74 7.25 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.107 0.963 . . . . 0.0 111.684 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.81 -20.12 24.88 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.132 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 78.7 p -108.31 159.68 16.45 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 122.463 -0.433 . . . . 0.0 111.178 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -119.66 142.27 48.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.9 t -82.23 110.31 17.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -107.7 117.58 34.49 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.93 101.78 3.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.85 -39.75 15.56 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.859 0.837 . . . . 0.0 109.62 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 1.7 m-20 -133.34 162.93 54.66 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -57.98 -27.26 78.49 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.858 1.705 . . . . 0.0 113.137 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.51 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.5 m-85 -110.36 -25.19 10.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.321 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.443 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 39.5 t80 -94.51 114.02 25.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.02 139.55 51.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' OE1' HD21 ' A' ' 36' ' ' LEU . 30.2 tt0 -134.47 137.79 44.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 117.967 0.349 . . . . 0.0 111.448 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -74.03 116.31 14.51 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.418 HD21 ' OE1' ' A' ' 34' ' ' GLN . 89.9 mt . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.009 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' OE1' ' H3 ' ' A' ' 101' ' ' MAN . 10.1 tp-100 -79.19 141.77 36.89 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.0 p -73.07 166.1 23.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.51 1.148 . . . . 0.0 113.15 -174.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -75.2 134.02 41.29 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 75.08 7.62 4.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.876 0.871 . . . . 0.0 111.081 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -93.5 167.61 28.79 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -81.72 135.39 35.5 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.692 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.2 p -124.74 8.2 8.19 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.35 68.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 116.337 -2.84 . . . . 0.0 115.198 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.04 169.77 22.17 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.6 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.8 mt -58.95 111.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 117.492 0.646 . . . . 0.0 109.492 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.86 -1.8 52.07 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.067 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -84.09 109.84 18.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 117.282 0.541 . . . . 0.0 110.393 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.5 m -93.92 7.01 46.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.48 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.37 -176.36 48.69 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.471 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.12 125.1 14.01 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.581 2.188 . . . . 0.0 110.662 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -99.23 -8.31 25.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.57 0.7 . . . . 0.0 111.006 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.91 109.49 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 58.9 m -76.13 160.69 29.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.052 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.7 121.08 11.36 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 m -53.68 136.68 38.98 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.608 0.718 . . . . 0.0 111.547 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.28 -20.39 23.47 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.2 p -108.53 147.49 31.65 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -107.06 132.04 53.41 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.352 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.9 t -76.0 106.67 7.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.436 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -105.48 115.77 30.82 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.29 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -73.85 104.71 2.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.67 -45.23 9.0 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.804 -175.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -130.01 167.5 20.36 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' O ' HG13 ' A' ' 11' ' ' ILE . 49.1 Cg_exo -60.63 -28.7 87.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.566 1.511 . . . . 0.0 113.198 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.647 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 32.3 m-85 -110.25 -26.04 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -95.17 114.64 26.46 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.1 m -131.31 136.64 48.31 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' OE1' HD21 ' A' ' 36' ' ' LEU . 32.3 tt0 -131.52 139.43 49.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 118.601 0.637 . . . . 0.0 112.457 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 38.1 m -78.56 109.25 12.59 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.533 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.475 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.3 mt . . . . . 0 C--N 1.294 -1.82 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.491 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.465 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 120.791 0.329 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.419 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 18.2 tp60 -98.01 133.9 41.85 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.9 p -68.5 158.16 34.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.945 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -64.46 132.83 51.09 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 76.49 4.06 3.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.015 0.926 . . . . 0.0 112.35 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.52 154.18 24.78 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -71.17 124.42 24.42 Favored 'General case' 0 C--O 1.202 -1.434 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.1 p -106.17 14.73 27.25 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -173.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.3 80.71 0.46 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 116.828 -2.606 . . . . 0.0 114.963 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.66 177.45 29.36 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 106.881 -2.487 . . . . 0.0 106.881 170.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.11 114.2 2.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 118.27 1.035 . . . . 0.0 108.971 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.51 -6.49 26.38 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.748 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -97.37 109.82 22.5 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.366 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -100.89 18.74 18.76 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.498 0.666 . . . . 0.0 110.765 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.63 -165.27 38.43 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -58.18 114.9 2.18 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.904 2.403 . . . . 0.0 111.915 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -104.55 -2.83 24.65 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.847 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.6 113.29 43.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 81.7 m -70.91 156.26 39.81 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 154.1 38.39 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.499 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -54.77 118.79 4.53 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.021 0.528 . . . . 0.0 110.831 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.84 26.26 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.139 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.6 p -108.78 143.83 37.41 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.456 -0.438 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.6 p -110.78 145.32 38.34 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.862 -0.154 . . . . 0.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.5 t -84.76 110.51 18.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -107.38 111.89 24.44 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.814 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.6 100.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.427 HD12 ' CE1' ' A' ' 32' ' ' TYR . 79.9 mt -82.78 -40.74 20.04 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.028 -174.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -136.07 162.94 53.74 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.06 -28.14 68.14 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.02 1.813 . . . . 0.0 113.463 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 40.9 m-85 -111.34 -25.51 9.62 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.617 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' CE1' HD12 ' A' ' 28' ' ' LEU . 38.8 t80 -96.6 115.0 26.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -129.95 140.01 50.99 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -133.05 138.82 46.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 118.903 0.774 . . . . 0.0 112.034 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.1 m -76.21 114.24 14.66 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.064 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.286 -2.16 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.879 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.419 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 120.885 0.374 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.547 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.4 tp60 -85.9 139.77 30.95 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.3 p -75.69 162.43 28.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.982 0.896 . . . . 0.0 112.13 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -68.77 133.44 48.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 74.35 6.84 4.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.987 0.915 . . . . 0.0 112.19 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.547 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.61 160.89 22.78 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.5 tt0 -74.4 129.54 37.97 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.9 p -111.58 5.12 19.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.13 82.77 0.1 Allowed Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 116.78 -2.629 . . . . 0.0 114.51 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.25 174.52 26.29 Favored Glycine 0 N--CA 1.417 -2.605 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 170.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.505 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.3 mt -59.55 118.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 117.788 0.794 . . . . 0.0 109.61 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.41 63.07 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.487 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -76.87 111.54 12.52 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.28 -0.541 . . . . 0.0 110.488 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -94.65 2.98 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.938 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.1 -174.28 50.27 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.525 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -62.32 127.84 22.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.177 2.585 . . . . 0.0 112.617 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 p -105.96 -5.67 19.42 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -99.29 109.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 99.4 m -66.44 154.52 40.0 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.64 0.587 . . . . 0.0 112.304 -178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 150.1 45.07 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.389 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -59.72 124.37 19.92 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.247 0.546 . . . . 0.0 110.822 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.23 -18.42 28.19 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.8 p -108.32 149.98 27.94 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.8 p -114.43 140.41 48.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -80.73 103.37 10.52 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.66 114.24 28.3 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.172 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -73.16 106.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.8 mt -92.38 -33.29 14.63 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.961 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 18.4 m120 -143.97 161.85 43.6 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.09 -31.32 89.94 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.891 1.727 . . . . 0.0 112.87 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.573 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 64.8 m-85 -105.71 -26.08 11.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.938 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.445 ' CE2' HD12 ' A' ' 28' ' ' LEU . 51.5 t80 -96.69 114.56 26.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -132.75 136.47 46.37 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -131.02 138.29 49.58 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -75.72 109.11 9.04 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--N 1.293 -1.868 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.834 178.935 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -87.29 137.05 32.68 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.1 p -76.03 160.98 29.28 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.075 0.941 . . . . 0.0 112.858 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -66.06 133.04 49.92 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 76.9 3.61 3.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.243 1.017 . . . . 0.0 111.591 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -93.75 163.44 25.91 Favored Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -77.05 123.83 26.93 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.828 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 19.4 p -105.64 6.98 32.51 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -175.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.34 85.4 0.42 Allowed Glycine 0 CA--C 1.476 -2.388 0 C-N-CA 116.512 -2.756 . . . . 0.0 114.909 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.73 -176.87 31.0 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 107.019 -2.432 . . . . 0.0 107.019 169.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.09 118.24 6.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.854 0.827 . . . . 0.0 109.577 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.5 9.0 59.31 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.293 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -80.56 115.32 20.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.393 0.597 . . . . 0.0 110.508 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -84.63 -3.45 58.5 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.923 0.889 . . . . 0.0 113.326 -176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.06 -167.23 33.03 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.245 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.52 130.06 21.45 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.381 2.721 . . . . 0.0 112.098 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -104.4 -6.47 20.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.917 0.865 . . . . 0.0 111.866 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.57 109.04 22.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 87.9 m -68.45 156.22 38.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 123.612 0.57 . . . . 0.0 112.423 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 148.22 43.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.943 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -59.06 120.72 9.65 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -13.65 28.09 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.84 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.5 p -116.88 150.48 38.36 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.371 -0.488 . . . . 0.0 110.077 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -116.58 144.48 44.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.1 t -79.2 112.17 16.15 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.1 mt-30 -106.45 116.61 32.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.333 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -73.01 111.08 6.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 32' ' ' TYR . 94.1 mt -97.0 -31.61 12.43 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.56 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -149.63 166.14 15.93 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.32 -36.22 96.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.19 1.927 . . . . 0.0 113.627 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.61 -25.73 12.15 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.281 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CE1' HD12 ' A' ' 28' ' ' LEU . 58.3 t80 -95.93 114.96 26.73 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.2 m -129.33 143.55 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.7 tt0 -132.04 137.51 47.84 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.688 0.676 . . . . 0.0 111.952 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.828 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -74.93 111.64 10.34 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.042 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.502 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.0 mt . . . . . 0 C--N 1.291 -1.969 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.438 -1.071 0 CA-C-O 120.821 0.343 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.531 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.4 tp60 -85.07 141.92 29.91 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.1 p -73.6 167.87 20.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.045 0.926 . . . . 0.0 112.722 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -73.49 132.96 43.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.506 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 75.35 2.76 3.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.29 1.036 . . . . 0.0 112.135 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.531 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -91.43 161.81 27.73 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.4 tt0 -75.68 123.32 25.36 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.817 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.4 p -103.63 -3.62 24.91 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 137.74 83.57 0.12 Allowed Glycine 0 CA--C 1.479 -2.183 0 C-N-CA 116.334 -2.841 . . . . 0.0 114.966 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -173.25 29.89 Favored Glycine 0 C--N 1.284 -2.34 0 N-CA-C 107.925 -2.07 . . . . 0.0 107.925 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 78.6 mt -64.41 116.37 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.2 54.77 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.025 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 53.5 t80 -91.91 109.73 21.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.159 177.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 m -89.47 -5.6 57.19 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.839 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.15 -160.23 26.64 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.41 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.506 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 39.9 Cg_endo -72.14 131.53 18.12 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.1 2.533 . . . . 0.0 112.59 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.0 p -107.57 3.07 24.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -105.59 109.71 28.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 75.5 m -67.62 150.38 48.84 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.815 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 156.06 24.02 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.165 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -58.52 119.34 6.84 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.458 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -11.9 30.3 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.907 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.1 p -118.62 146.27 44.78 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.512 -0.404 . . . . 0.0 110.345 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 p -114.22 142.17 46.61 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.5 t -79.88 112.17 16.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.437 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 73.6 mt-30 -110.59 114.22 27.45 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.235 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 t -77.49 104.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD12 ' CE2' ' A' ' 32' ' ' TYR . 86.6 mt -89.57 -34.16 16.45 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.528 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 20.0 m120 -143.42 167.41 15.79 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.91 -41.5 74.37 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.149 1.899 . . . . 0.0 113.62 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.512 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.4 m-85 -101.7 -25.04 13.99 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.199 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 41.7 t80 -95.04 115.42 27.41 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.7 m -131.5 140.04 49.45 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -134.31 138.4 44.93 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.244 0.475 . . . . 0.0 111.839 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.817 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.0 m -76.86 107.44 9.18 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.951 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.437 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.2 mt . . . . . 0 C--N 1.282 -2.339 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.42 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.784 HE21 ' HB2' ' A' ' 16' ' ' PRO . 10.2 tp-100 -69.48 142.4 53.76 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.1 p -77.27 168.01 20.76 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 112.145 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -71.21 135.28 47.44 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 73.71 9.7 4.85 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.954 0.901 . . . . 0.0 112.651 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.19 154.17 22.22 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.845 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.7 tt0 -70.14 123.27 21.2 Favored 'General case' 0 C--O 1.205 -1.241 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.726 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.9 p -102.21 13.01 35.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -171.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.71 63.22 0.18 Allowed Glycine 0 CA--C 1.48 -2.114 0 C-N-CA 117.047 -2.502 . . . . 0.0 114.876 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -85.19 173.24 48.22 Favored Glycine 0 N--CA 1.421 -2.317 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 63.9 mt -56.73 111.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 117.919 0.86 . . . . 0.0 109.951 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.82 -13.72 34.83 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.8 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -85.51 109.15 18.29 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 m -107.43 30.24 6.43 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.422 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.06 -160.67 28.46 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.784 ' HB2' HE21 ' A' ' 2' ' ' GLN . 31.8 Cg_exo -62.06 118.68 5.58 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.944 2.429 . . . . 0.0 111.014 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -107.55 0.56 22.75 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.415 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.48 109.55 28.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 68.9 m -71.38 155.75 40.28 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 123.158 0.583 . . . . 0.0 112.051 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.54 147.63 50.91 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.046 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.7 m -57.6 122.62 13.17 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -10.08 30.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.3 p -118.67 141.84 48.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -108.35 129.12 55.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.422 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.84 98.54 3.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -98.94 117.03 32.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.268 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.4 t -78.43 93.95 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.3 -41.97 32.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.875 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 20.0 m120 -139.91 166.53 23.23 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.04 -43.03 63.32 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.265 1.976 . . . . 0.0 112.866 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.634 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -99.64 -26.37 14.09 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.009 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 31.9 t80 -94.94 113.95 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.456 0.646 . . . . 0.0 111.722 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -135.49 137.18 41.89 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -137.05 141.3 42.43 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.872 0.76 . . . . 0.0 111.75 -172.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.9 m -78.96 107.12 11.47 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.276 -2.602 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.202 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.241 0.641 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.552 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 54.4 tp60 -68.42 141.88 55.55 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 172.68 13.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.011 0.91 . . . . 0.0 112.189 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -78.58 133.46 37.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 74.04 6.34 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.909 0.884 . . . . 0.0 111.818 -175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.505 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.78 160.45 25.29 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.638 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.1 tt0 -78.84 127.41 32.0 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.793 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.0 p -106.68 9.37 31.25 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.65 80.57 0.48 Allowed Glycine 0 CA--C 1.489 -1.576 0 C-N-CA 117.252 -2.404 . . . . 0.0 115.207 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.24 -179.15 30.08 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 168.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.433 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 71.4 mt -62.78 114.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 117.854 0.827 . . . . 0.0 108.859 175.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.74 2.43 32.38 Favored Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.664 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -98.08 133.3 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -117.86 10.68 13.28 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.097 0.475 . . . . 0.0 111.133 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.08 -164.6 35.15 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.069 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.37 124.66 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.174 2.582 . . . . 0.0 112.159 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.8 p -106.09 -7.83 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.771 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -99.33 111.9 30.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 82.2 m -73.53 159.93 32.44 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.521 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 151.52 43.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.77 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -60.6 121.54 12.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.018 0.437 . . . . 0.0 109.861 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -19.81 24.77 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.586 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.7 p -107.62 140.77 40.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 27.6 p -105.24 136.33 44.95 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.359 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.1 t -79.91 99.03 7.38 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -98.55 116.73 31.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.588 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.92 93.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.51 -34.22 58.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.542 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -142.92 165.28 27.14 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 -32.51 93.65 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 121.453 1.435 . . . . 0.0 112.557 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.553 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.0 m-85 -107.76 -26.83 10.61 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.411 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -96.68 115.24 27.09 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -124.63 142.47 51.35 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -135.7 141.06 44.88 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 118.762 0.71 . . . . 0.0 112.334 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -82.03 107.46 14.75 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.073 176.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.488 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 85.6 mt . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.389 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.552 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.438 -1.059 0 CA-C-O 121.203 0.525 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.573 HE21 ' HB2' ' A' ' 16' ' ' PRO . 10.7 tp-100 -96.7 144.99 26.2 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.2 p -79.08 172.28 14.02 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.922 0.867 . . . . 0.0 111.163 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -72.66 135.07 45.36 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.259 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 73.77 6.38 4.92 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.319 1.048 . . . . 0.0 112.075 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -92.15 166.8 29.92 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.662 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.619 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -79.81 128.66 33.71 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.797 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 16.2 p -110.57 15.48 22.05 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.63 84.42 0.51 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 117.109 -2.472 . . . . 0.0 114.412 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.32 -179.4 29.89 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 169.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.66 109.62 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 117.826 0.813 . . . . 0.0 109.199 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.65 -11.12 32.77 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.12 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -79.12 110.15 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.025 0.441 . . . . 0.0 109.904 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 p -93.78 0.61 56.4 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.936 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.42 -168.55 40.65 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.305 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HB2' HE21 ' A' ' 2' ' ' GLN . 31.6 Cg_exo -61.86 122.37 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.845 2.364 . . . . 0.0 112.511 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 p -102.6 -15.72 16.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.657 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 1' ' ' THR . 47.2 t -90.43 108.97 20.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -176.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 77.9 m -68.92 153.11 44.37 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.094 0.473 . . . . 0.0 111.587 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.61 146.94 47.35 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -60.66 120.49 10.14 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.944 0.402 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.58 -10.66 30.43 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 71.1 p -114.31 143.83 44.24 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -108.7 132.72 53.65 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.227 0.329 . . . . 0.0 110.634 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.1 t -78.81 100.75 7.28 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -100.2 110.89 23.15 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.59 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.32 102.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.71 -39.4 16.04 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.437 -177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -139.41 162.79 49.66 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.7 -32.88 85.66 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.108 1.872 . . . . 0.0 113.041 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.7 m-85 -106.28 -26.16 11.64 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.491 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -96.79 114.45 26.08 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -131.74 139.35 48.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.3 tt0 -135.08 138.36 43.77 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 118.55 0.614 . . . . 0.0 112.45 -174.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -79.41 107.63 12.32 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.291 -1.966 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.235 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.51 HE21 ' HA3' ' A' ' 6' ' ' GLY . 49.5 tp60 . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.7 p -77.31 171.41 14.9 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 111.821 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.441 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.6 t-160 -78.01 134.46 37.8 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 74.81 11.79 3.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.924 0.89 . . . . 0.0 111.596 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.51 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -101.37 163.82 17.91 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.642 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -77.28 122.38 25.02 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.8 p -106.8 14.96 26.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.96 85.98 0.6 Allowed Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 116.954 -2.546 . . . . 0.0 114.889 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 177.27 28.16 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 168.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.433 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 67.0 mt -65.09 111.85 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 118.129 0.965 . . . . 0.0 109.138 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.58 -9.52 21.87 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.91 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -106.42 108.57 20.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -112.62 11.64 19.64 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.943 0.401 . . . . 0.0 111.091 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.59 -147.44 1.8 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.552 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.04 98.66 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.061 2.507 . . . . 0.0 112.093 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 p -98.7 -14.78 19.64 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.036 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.49 110.93 23.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.531 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 70.8 m -69.44 157.09 37.76 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.657 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.68 147.49 49.34 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 m -60.9 126.65 28.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.524 0.678 . . . . 0.0 110.54 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.79 -20.29 24.72 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.2 p -108.14 143.25 37.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 122.403 -0.469 . . . . 0.0 109.803 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 p -107.72 137.15 46.25 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.477 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.7 t -82.08 102.22 10.88 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.96 117.96 36.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.321 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.9 t -76.63 117.91 22.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD12 ' CE1' ' A' ' 32' ' ' TYR . 83.9 mt -101.7 -42.15 6.3 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.559 0.695 . . . . 0.0 109.598 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 40.8 m-80 -135.62 165.03 39.24 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.25 -27.58 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.032 1.822 . . . . 0.0 113.313 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.607 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.1 m-85 -112.49 -26.08 8.87 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.294 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CE1' HD12 ' A' ' 28' ' ' LEU . 40.7 t80 -95.2 115.06 26.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -131.96 141.78 49.42 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 33.7 tt0 -134.42 138.24 44.65 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 118.535 0.607 . . . . 0.0 112.307 -175.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.0 m -77.32 114.7 16.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.745 179.411 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.515 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.1 tp60 . . . . . 0 N--CA 1.436 -1.15 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -79.32 157.49 27.67 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.74 0.781 . . . . 0.0 112.167 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.416 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.7 t-160 -67.15 132.03 46.99 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 75.44 6.05 4.07 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.975 0.91 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.515 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.75 166.78 29.18 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -78.63 130.32 35.75 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.779 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.7 p -115.23 7.0 15.15 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -173.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.82 75.26 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 117.026 -2.511 . . . . 0.0 114.458 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.94 174.06 26.19 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 172.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.2 mt -59.2 110.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 117.588 0.694 . . . . 0.0 109.694 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.9 43.68 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.815 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -89.21 109.45 20.32 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -105.23 17.62 23.71 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.165 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.25 -163.22 37.87 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.53 114.47 2.14 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.763 2.309 . . . . 0.0 111.597 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -103.28 0.33 31.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.205 0.526 . . . . 0.0 112.036 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.81 109.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 73.4 m -69.44 155.43 40.47 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.053 0.541 . . . . 0.0 111.469 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.46 147.11 49.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.046 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -57.73 123.75 16.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -14.43 28.98 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 65.3 p -117.53 145.5 44.2 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.448 -0.443 . . . . 0.0 110.117 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -111.35 138.25 48.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.504 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.9 t -78.49 109.63 12.85 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.6 mt-30 -106.28 112.5 25.55 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 99.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.47 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.2 mt -84.27 -39.23 19.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.334 -173.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.422 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -134.96 164.65 42.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.14 -34.68 88.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.818 1.679 . . . . 0.0 113.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.642 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.6 m-85 -107.46 -24.96 11.62 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CE2' HD12 ' A' ' 28' ' ' LEU . 43.8 t80 -94.98 114.39 26.2 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -128.53 139.08 52.49 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 31.8 tt0 -133.3 137.17 45.87 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.451 0.569 . . . . 0.0 111.885 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -75.68 109.39 9.22 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.48 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.28 -2.444 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.554 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.3 tp60 . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -77.03 166.68 22.98 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.72 0.772 . . . . 0.0 111.874 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -71.22 135.76 47.68 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 73.72 8.6 4.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.801 0.84 . . . . 0.0 112.161 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.08 155.75 21.16 Favored Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.0 tt0 -69.96 125.44 26.76 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.76 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -107.52 11.33 28.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.35 72.83 0.23 Allowed Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 117.278 -2.391 . . . . 0.0 114.741 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.31 179.52 30.86 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 171.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 68.0 mt -57.93 116.28 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 118.041 0.921 . . . . 0.0 110.327 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.27 -28.5 9.62 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.608 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -78.3 111.98 14.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.91 0.386 . . . . 0.0 110.189 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -102.15 -0.32 33.46 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.925 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -163.15 10.46 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.942 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.44 123.92 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.515 2.81 . . . . 0.0 112.649 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 p -109.74 -1.57 17.89 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.377 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.24 110.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.3 m -70.64 164.61 24.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.557 0.694 . . . . 0.0 112.761 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.97 160.41 31.95 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.017 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -63.4 116.58 5.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 123.363 0.665 . . . . 0.0 110.032 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.74 -14.33 34.95 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.871 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 60.6 p -108.17 142.83 37.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.573 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 p -106.85 137.68 44.44 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.51 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.0 t -79.56 100.36 7.73 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -98.56 118.95 36.4 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.927 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.87 98.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.2 -35.68 28.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.581 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 37.9 m-80 -146.28 165.12 21.32 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.26 -37.42 94.43 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.155 1.903 . . . . 0.0 113.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.534 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 36.3 m-85 -101.13 -26.24 13.75 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.913 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 19.9 t80 -95.59 114.3 26.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.329 0.585 . . . . 0.0 112.334 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.9 m -132.78 135.14 45.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' OE1' HD21 ' A' ' 36' ' ' LEU . 32.8 tt0 -133.84 140.54 46.94 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.956 0.343 . . . . 0.0 111.868 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.4 m -77.08 112.3 13.58 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.426 HD21 ' OE1' ' A' ' 34' ' ' GLN . 90.1 mt . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.02 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.582 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.1 tp60 . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.1 p -80.55 162.02 24.51 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.756 0.789 . . . . 0.0 111.604 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -66.04 133.22 50.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 74.5 12.54 3.84 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.841 0.856 . . . . 0.0 112.485 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.582 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -101.76 169.55 20.26 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.629 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.4 tt0 -81.42 127.41 32.75 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.773 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -110.36 8.7 23.44 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.22 80.15 0.2 Allowed Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 116.862 -2.59 . . . . 0.0 114.317 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.84 179.64 30.22 Favored Glycine 0 C--N 1.284 -2.358 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 170.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 66.7 mt -62.46 111.04 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 117.984 0.892 . . . . 0.0 110.733 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.92 2.28 45.74 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.032 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -91.27 109.53 20.8 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.186 -0.597 . . . . 0.0 109.659 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -97.03 12.48 32.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.393 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.55 -165.78 41.62 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.613 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.03 115.18 2.38 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.937 2.425 . . . . 0.0 112.079 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -102.82 -8.53 20.71 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.939 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.54 108.92 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 85.6 m -71.34 155.8 40.23 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.39 138.05 56.82 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.2 m -57.54 128.13 35.49 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.84 23.9 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.6 p -108.23 146.44 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.7 p -107.68 131.31 54.54 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 121.263 -0.175 . . . . 0.0 110.879 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.47 103.26 4.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -103.56 116.14 31.82 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.214 0.53 . . . . 0.0 111.29 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.3 t -72.13 107.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.549 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' HD22 ' A' ' 29' ' ' ASN . 95.9 mt -93.73 -33.84 13.46 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.273 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -139.27 165.04 34.67 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 175.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.25 -30.61 93.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.723 1.615 . . . . 0.0 112.562 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.606 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.0 m-85 -105.36 -25.49 12.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.932 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 32.2 t80 -95.23 114.35 26.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -130.67 136.86 49.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.6 tt0 -132.37 137.25 47.29 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 118.304 0.502 . . . . 0.0 111.938 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -75.89 113.08 12.98 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.807 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.892 179.52 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.554 HE21 ' HA3' ' A' ' 6' ' ' GLY . 58.0 tp60 . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.7 p -75.75 158.87 31.7 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.186 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.447 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 18.7 t-160 -65.4 134.88 54.45 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 73.63 9.26 4.96 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.106 0.962 . . . . 0.0 111.584 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -97.29 161.2 21.46 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.675 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -74.95 123.57 25.36 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.2 p -107.03 16.03 24.64 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 75.49 0.31 Allowed Glycine 0 CA--C 1.483 -1.911 0 C-N-CA 117.044 -2.503 . . . . 0.0 114.705 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.15 -178.92 30.25 Favored Glycine 0 C--N 1.29 -1.986 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 169.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.4 119.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.0 -23.64 27.03 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.259 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.77 110.18 20.79 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -107.54 8.58 29.37 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.308 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.9 -162.3 25.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.881 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.64 117.83 4.57 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.202 2.601 . . . . 0.0 112.964 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 p -100.88 -13.38 18.38 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.831 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -92.53 109.58 21.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 81.8 m -73.26 159.72 32.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.277 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 138.98 58.71 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.5 m -51.94 117.93 3.09 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.448 0.467 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -2.88 28.7 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.749 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.8 p -123.98 142.21 51.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 p -109.54 131.93 54.61 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.378 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -74.18 103.66 4.69 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -103.87 113.73 27.47 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.637 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.23 104.78 4.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.03 -45.86 9.83 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.846 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.445 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -128.47 167.28 19.62 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.27 -34.86 99.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 121.545 1.497 . . . . 0.0 112.374 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.557 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.4 m-85 -100.86 -26.8 13.63 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.646 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 25.4 t80 -96.62 114.57 26.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -131.7 136.04 47.33 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' OE1' HD21 ' A' ' 36' ' ' LEU . 30.9 tt0 -136.09 137.0 40.6 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 118.671 0.669 . . . . 0.0 112.125 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.74 109.14 9.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.422 HD21 ' OE1' ' A' ' 34' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.287 -2.139 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.516 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.7 tp60 . . . . . 0 N--CA 1.426 -1.665 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.0 p -78.56 170.5 16.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.581 0.705 . . . . 0.0 111.88 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.479 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.5 t-160 -76.14 135.7 39.81 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 73.59 9.29 4.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.03 0.932 . . . . 0.0 111.963 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.516 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.85 166.88 25.15 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.058 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.1 tt0 -76.86 130.12 37.16 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.7 p -118.42 10.14 12.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.55 74.57 0.03 OUTLIER Glycine 0 CA--C 1.474 -2.479 0 C-N-CA 116.348 -2.834 . . . . 0.0 114.129 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.47 169.62 21.6 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 172.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 75.2 mt -59.55 113.49 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 117.574 0.687 . . . . 0.0 109.551 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.79 -18.75 36.93 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.323 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -73.38 114.32 11.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 109.737 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -109.67 20.28 18.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.694 0.759 . . . . 0.0 110.274 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.61 -162.45 35.02 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.079 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.85 115.92 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.702 2.268 . . . . 0.0 111.512 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -102.35 -4.13 26.03 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.945 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.31 109.65 26.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 79.1 m -71.8 152.17 42.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.724 0.409 . . . . 0.0 110.734 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.41 122.08 11.07 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -53.23 131.71 37.6 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.523 0.677 . . . . 0.0 110.806 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.15 -9.55 26.96 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -170.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -123.97 150.23 45.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -113.7 137.53 51.49 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.632 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -79.62 103.81 9.79 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.464 HE21 ' HB2' ' A' ' 36' ' ' LEU . 47.2 mt-30 -102.5 117.79 35.47 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.301 0.572 . . . . 0.0 111.679 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.8 t -74.48 108.41 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.518 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.5 mt -93.03 -40.08 10.73 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.627 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 43.7 m-80 -138.98 165.79 29.66 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -55.46 -36.86 94.99 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.981 1.787 . . . . 0.0 113.301 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.677 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -104.06 -25.89 12.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.264 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.5 t80 -95.51 114.53 26.3 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.7 139.44 50.3 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -132.3 137.52 47.49 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.785 0.721 . . . . 0.0 112.452 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -75.2 109.81 9.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.464 ' HB2' HE21 ' A' ' 26' ' ' GLN . 98.1 mt . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.611 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.6 tp60 . . . . . 0 N--CA 1.439 -1.01 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -77.04 160.43 29.1 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.577 0.703 . . . . 0.0 112.438 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.455 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 20.4 t-160 -67.14 133.49 49.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 77.03 5.27 3.29 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.119 0.968 . . . . 0.0 112.125 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.611 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.65 161.21 22.85 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.751 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -73.36 128.72 36.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.4 p -112.48 19.25 17.74 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.64 78.38 0.56 Allowed Glycine 0 CA--C 1.479 -2.198 0 C-N-CA 117.44 -2.314 . . . . 0.0 114.478 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.96 172.59 24.73 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 106.891 -2.484 . . . . 0.0 106.891 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.479 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 70.5 mt -58.25 113.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 118.006 0.903 . . . . 0.0 109.317 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.04 -8.22 33.34 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.193 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -95.67 110.05 22.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 m -97.9 0.98 47.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.064 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.04 -158.99 11.68 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.544 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.57 114.05 2.21 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.703 2.935 . . . . 0.0 112.466 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.1 p -101.34 -13.73 17.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -88.9 110.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 73.3 m -72.07 155.63 40.09 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.986 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.11 140.26 58.85 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 125.19 16.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 123.507 0.505 . . . . 0.0 110.538 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -12.48 30.04 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.9 p -116.78 146.96 42.49 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -111.73 137.4 49.69 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.951 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.4 t -80.83 100.77 8.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -102.12 115.8 31.32 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.755 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -79.76 94.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.403 ' C ' HD22 ' A' ' 29' ' ' ASN . 81.6 mt -76.5 -37.56 56.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.855 -175.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -138.01 163.7 45.99 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.47 -35.61 92.53 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.319 2.013 . . . . 0.0 112.712 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.6 m-85 -100.61 -25.6 14.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.456 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -96.24 113.88 25.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.636 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.7 m -129.89 135.33 48.23 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.03 138.24 42.0 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.287 0.494 . . . . 0.0 111.794 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -75.62 109.09 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--N 1.294 -1.812 0 C-N-CA 123.209 0.604 . . . . 0.0 110.388 -179.521 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.538 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.0 tp60 . . . . . 0 N--CA 1.416 -2.14 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.0 p -70.18 162.42 28.38 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 122.292 1.044 . . . . 0.0 112.745 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -72.4 129.72 39.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 77.43 7.16 2.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.766 0.826 . . . . 0.0 112.169 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.538 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.7 164.9 24.32 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.692 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.6 tt0 -75.59 128.19 34.72 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -111.3 8.98 21.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -174.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.43 66.88 0.06 OUTLIER Glycine 0 CA--C 1.48 -2.134 0 C-N-CA 116.83 -2.605 . . . . 0.0 113.807 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.83 173.15 25.41 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' H ' ' HA ' ' A' ' 31' ' ' TYR . 76.6 mt -65.75 122.51 16.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.69 4.06 57.08 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.32 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.421 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 48.3 t80 -105.89 110.25 22.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 m -99.76 6.01 45.54 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.25 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.34 -165.59 41.21 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.96 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.24 125.86 17.31 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.834 3.023 . . . . 0.0 112.979 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 p -106.2 -2.98 21.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.02 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.57 109.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 71.3 m -73.19 149.13 43.14 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.396 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.67 152.82 34.29 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.22 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 m -58.98 119.98 8.24 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.302 0.572 . . . . 0.0 110.57 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.47 -11.61 30.68 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.627 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.0 p -114.27 142.61 46.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.901 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 p -112.53 133.47 54.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.172 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.513 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.27 105.07 7.11 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.13 115.15 29.9 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.966 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.61 98.92 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -81.68 -37.7 27.01 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.206 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -143.28 163.4 37.45 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.42 -38.24 89.46 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.437 2.092 . . . . 0.0 113.132 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -101.89 -26.44 13.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.921 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -96.73 114.75 26.41 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -129.46 138.79 51.62 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.7 tt0 -132.95 137.07 46.46 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 118.896 0.771 . . . . 0.0 112.098 -175.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.1 m -78.29 108.62 11.75 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.289 -2.032 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.712 177.798 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.54 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p -78.94 165.75 23.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.965 0.888 . . . . 0.0 112.194 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -72.31 128.24 35.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.693 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 75.85 16.0 2.46 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.232 1.013 . . . . 0.0 111.947 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.54 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -103.0 162.75 16.08 Favored Glycine 0 N--CA 1.414 -2.789 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -75.71 127.98 34.21 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 26.8 p -112.24 3.7 17.32 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.01 72.37 0.04 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 116.43 -2.795 . . . . 0.0 114.498 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 170.18 23.03 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.588 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.7 mt -58.39 122.63 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 117.828 0.814 . . . . 0.0 108.947 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -27.06 19.17 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -84.93 115.59 22.88 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.8 m -115.8 17.68 15.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.081 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 -156.46 18.06 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.459 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.08 113.81 1.74 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.21 2.607 . . . . 0.0 111.246 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -109.78 -1.61 17.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.451 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.67 110.5 31.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.523 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 85.8 m -69.16 158.04 35.69 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 159.64 20.98 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.517 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -63.86 118.21 8.05 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.25 0.548 . . . . 0.0 110.415 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.64 29.13 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.5 p -108.3 144.01 36.38 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.418 -0.46 . . . . 0.0 110.442 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.9 p -109.81 136.29 49.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.36 100.5 5.18 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -99.42 112.43 24.62 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.638 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.65 101.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.82 -39.88 17.84 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.622 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 34.9 m-80 -140.18 165.86 27.58 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.15 -35.87 95.73 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.059 1.839 . . . . 0.0 113.508 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.621 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.0 m-85 -106.62 -25.42 11.79 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.262 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 41.2 t80 -95.92 114.43 26.15 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 177.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.595 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -130.81 137.91 49.64 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -133.91 138.33 45.47 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 118.262 0.483 . . . . 0.0 112.15 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -76.37 111.56 11.96 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.911 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.285 -2.228 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.329 179.53 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.514 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.0 tp60 . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 120.597 0.237 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.4 p -80.13 164.54 23.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.681 0.753 . . . . 0.0 111.869 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.436 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 11.4 t-160 -71.89 135.46 46.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 73.7 4.35 4.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.271 1.028 . . . . 0.0 111.886 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.514 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -88.26 162.94 32.55 Favored Glycine 0 N--CA 1.421 -2.301 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.8 tt0 -79.07 120.72 24.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.0 p -99.8 15.43 26.95 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.53 86.92 0.72 Allowed Glycine 0 CA--C 1.482 -1.981 0 C-N-CA 117.64 -2.219 . . . . 0.0 114.824 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 179.2 29.17 Favored Glycine 0 C--N 1.287 -2.194 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 170.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -64.42 114.04 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 118.0 0.9 . . . . 0.0 109.153 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.82 -13.65 29.49 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.342 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -87.31 112.1 21.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 m -96.87 -4.31 40.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.878 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 -164.52 17.2 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.754 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.8 123.01 12.12 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.401 2.734 . . . . 0.0 112.422 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -105.5 -17.99 14.24 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.13 109.56 18.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -69.17 146.46 52.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 123.263 0.352 . . . . 0.0 111.165 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.64 133.96 54.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.411 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 m -47.29 127.89 11.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.631 0.729 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.71 -19.72 25.59 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.774 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.4 p -113.8 153.03 29.79 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 122.429 -0.454 . . . . 0.0 109.917 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -113.54 138.33 50.3 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.895 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -83.09 110.24 17.83 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -108.46 114.5 28.38 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.63 97.82 2.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.78 -38.16 29.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.417 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -142.64 168.66 12.67 Favored Pre-proline 0 C--N 1.297 -1.692 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.59 -35.16 98.9 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.826 1.684 . . . . 0.0 113.198 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.608 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.1 m-85 -108.6 -25.46 10.88 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.493 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -96.14 115.25 27.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -132.89 141.03 48.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -136.27 139.56 42.77 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.741 0.7 . . . . 0.0 112.229 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.1 m -78.05 113.35 15.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.434 175.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.289 -2.039 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.908 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.552 ' OE1' ' HG2' ' A' ' 16' ' ' PRO . 52.0 tp60 . . . . . 0 N--CA 1.433 -1.298 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.8 p -80.62 167.69 19.75 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.067 0.937 . . . . 0.0 112.759 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -71.89 128.48 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.999 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 76.19 6.87 3.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.453 1.101 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.524 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.72 161.7 22.05 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.6 tt0 -77.85 121.44 24.12 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.713 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.1 p -106.76 16.19 24.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 123.93 76.64 0.32 Allowed Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 116.354 -2.832 . . . . 0.0 114.885 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.79 176.33 28.39 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 170.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.6 mt -60.47 113.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 118.177 0.988 . . . . 0.0 110.666 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.4 -11.56 21.68 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.167 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.481 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 51.5 t80 -91.97 132.23 36.68 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.1 m -128.49 13.32 6.51 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.84 -142.16 10.6 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.638 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -71.76 113.94 3.8 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.25 1.967 . . . . 0.0 111.282 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -102.79 -0.59 31.22 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.855 0.836 . . . . 0.0 112.098 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -106.96 118.99 55.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 74.2 m -73.29 160.24 32.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.4 0.619 . . . . 0.0 112.2 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 144.9 56.09 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.104 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -62.44 124.77 21.81 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.63 -14.55 27.21 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -173.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.2 p -119.59 147.73 44.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -113.76 138.08 50.75 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.881 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.8 t -78.86 98.17 6.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.3 mt-30 -96.89 113.85 25.43 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.64 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.4 96.26 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' C ' HD22 ' A' ' 29' ' ' ASN . 82.0 mt -79.92 -38.36 32.64 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.049 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.431 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -135.48 165.02 39.43 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -55.86 -34.31 91.12 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.809 1.673 . . . . 0.0 113.187 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.61 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.7 m-85 -106.04 -25.25 12.15 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.274 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 28' ' ' LEU . 44.8 t80 -95.09 115.06 26.95 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -130.84 134.54 46.91 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -133.41 137.44 45.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 118.446 0.566 . . . . 0.0 111.974 -175.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.8 m -76.8 110.03 11.07 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.999 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.286 -2.183 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.555 HE21 ' HA3' ' A' ' 6' ' ' GLY . 52.0 tp60 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -76.65 159.16 30.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.736 0.779 . . . . 0.0 112.283 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.4 t-160 -66.49 134.53 52.62 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 76.34 0.32 3.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.163 0.985 . . . . 0.0 112.72 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -89.31 161.81 30.36 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -75.18 123.39 25.17 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.754 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -105.63 11.46 32.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.53 88.36 0.84 Allowed Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 116.926 -2.559 . . . . 0.0 114.937 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.56 -178.03 31.14 Favored Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 169.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.4 113.27 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 118.12 0.96 . . . . 0.0 109.099 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.81 -16.37 28.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -82.77 110.26 17.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 m -98.8 2.55 46.94 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.571 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.18 -164.66 13.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.154 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.62 116.53 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.88 2.387 . . . . 0.0 111.873 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.9 p -104.84 -4.81 21.8 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.098 0.475 . . . . 0.0 112.042 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.33 109.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.511 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.8 m -65.29 154.09 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 123.762 0.825 . . . . 0.0 112.35 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 146.9 52.31 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.417 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -50.21 122.74 7.25 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.107 0.963 . . . . 0.0 111.684 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.81 -20.12 24.88 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.132 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 78.7 p -108.31 159.68 16.45 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 122.463 -0.433 . . . . 0.0 111.178 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -119.66 142.27 48.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.9 t -82.23 110.31 17.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -107.7 117.58 34.49 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.93 101.78 3.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.44 ' C ' HD22 ' A' ' 29' ' ' ASN . 90.3 mt -86.85 -39.75 15.56 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.859 0.837 . . . . 0.0 109.62 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -133.34 162.93 54.66 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -57.98 -27.26 78.49 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.858 1.705 . . . . 0.0 113.137 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.51 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.5 m-85 -110.36 -25.19 10.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.321 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.443 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 39.5 t80 -94.51 114.02 25.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.02 139.55 51.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' OE1' HD21 ' A' ' 36' ' ' LEU . 30.2 tt0 -134.47 137.79 44.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 117.967 0.349 . . . . 0.0 111.448 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -74.03 116.31 14.51 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.418 HD21 ' OE1' ' A' ' 34' ' ' GLN . 89.9 mt . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.009 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.452 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.0 p -73.07 166.1 23.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.51 1.148 . . . . 0.0 113.15 -174.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -75.2 134.02 41.29 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 75.08 7.62 4.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.876 0.871 . . . . 0.0 111.081 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.452 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -93.5 167.61 28.79 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -81.72 135.39 35.5 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.692 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.2 p -124.74 8.2 8.19 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.35 68.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 116.337 -2.84 . . . . 0.0 115.198 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.04 169.77 22.17 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.6 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.8 mt -58.95 111.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 117.492 0.646 . . . . 0.0 109.492 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.86 -1.8 52.07 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.067 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -84.09 109.84 18.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 117.282 0.541 . . . . 0.0 110.393 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.5 m -93.92 7.01 46.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.48 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.37 -176.36 48.69 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.471 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.12 125.1 14.01 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.581 2.188 . . . . 0.0 110.662 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -99.23 -8.31 25.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.57 0.7 . . . . 0.0 111.006 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.91 109.49 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 58.9 m -76.13 160.69 29.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.052 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.7 121.08 11.36 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 m -53.68 136.68 38.98 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.608 0.718 . . . . 0.0 111.547 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.28 -20.39 23.47 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.2 p -108.53 147.49 31.65 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -107.06 132.04 53.41 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.352 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.9 t -76.0 106.67 7.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.436 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -105.48 115.77 30.82 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.29 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -73.85 104.71 2.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.67 -45.23 9.0 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.804 -175.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -130.01 167.5 20.36 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' O ' HG13 ' A' ' 11' ' ' ILE . 49.1 Cg_exo -60.63 -28.7 87.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.566 1.511 . . . . 0.0 113.198 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.647 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 32.3 m-85 -110.25 -26.04 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -95.17 114.64 26.46 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.1 m -131.31 136.64 48.31 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.475 ' OE1' HD21 ' A' ' 36' ' ' LEU . 32.3 tt0 -131.52 139.43 49.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 118.601 0.637 . . . . 0.0 112.457 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 38.1 m -78.56 109.25 12.59 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.533 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.475 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.3 mt . . . . . 0 C--N 1.294 -1.82 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.491 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.9 p -68.5 158.16 34.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.945 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -64.46 132.83 51.09 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 76.49 4.06 3.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.015 0.926 . . . . 0.0 112.35 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.52 154.18 24.78 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -71.17 124.42 24.42 Favored 'General case' 0 C--O 1.202 -1.434 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.1 p -106.17 14.73 27.25 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -173.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.3 80.71 0.46 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 116.828 -2.606 . . . . 0.0 114.963 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.66 177.45 29.36 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 106.881 -2.487 . . . . 0.0 106.881 170.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.11 114.2 2.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 118.27 1.035 . . . . 0.0 108.971 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.51 -6.49 26.38 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.748 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -97.37 109.82 22.5 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.366 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -100.89 18.74 18.76 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.498 0.666 . . . . 0.0 110.765 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.63 -165.27 38.43 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -58.18 114.9 2.18 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.904 2.403 . . . . 0.0 111.915 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -104.55 -2.83 24.65 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.847 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.6 113.29 43.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 81.7 m -70.91 156.26 39.81 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 154.1 38.39 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.499 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -54.77 118.79 4.53 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.021 0.528 . . . . 0.0 110.831 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.84 26.26 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.139 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.6 p -108.78 143.83 37.41 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.456 -0.438 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.6 p -110.78 145.32 38.34 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.862 -0.154 . . . . 0.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.5 t -84.76 110.51 18.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -107.38 111.89 24.44 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.814 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.6 100.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.427 HD12 ' CE1' ' A' ' 32' ' ' TYR . 79.9 mt -82.78 -40.74 20.04 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.028 -174.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -136.07 162.94 53.74 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.06 -28.14 68.14 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.02 1.813 . . . . 0.0 113.463 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 40.9 m-85 -111.34 -25.51 9.62 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.617 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' CE1' HD12 ' A' ' 28' ' ' LEU . 38.8 t80 -96.6 115.0 26.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -129.95 140.01 50.99 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -133.05 138.82 46.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 118.903 0.774 . . . . 0.0 112.034 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.1 m -76.21 114.24 14.66 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.064 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.286 -2.16 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.879 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.547 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.4 tp60 . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.3 p -75.69 162.43 28.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.982 0.896 . . . . 0.0 112.13 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -68.77 133.44 48.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 74.35 6.84 4.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.987 0.915 . . . . 0.0 112.19 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.547 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.61 160.89 22.78 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.5 tt0 -74.4 129.54 37.97 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.9 p -111.58 5.12 19.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.13 82.77 0.1 Allowed Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 116.78 -2.629 . . . . 0.0 114.51 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.25 174.52 26.29 Favored Glycine 0 N--CA 1.417 -2.605 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 170.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.505 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.3 mt -59.55 118.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 117.788 0.794 . . . . 0.0 109.61 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.41 63.07 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.487 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -76.87 111.54 12.52 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.28 -0.541 . . . . 0.0 110.488 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -94.65 2.98 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.938 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.1 -174.28 50.27 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.525 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -62.32 127.84 22.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.177 2.585 . . . . 0.0 112.617 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 p -105.96 -5.67 19.42 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -99.29 109.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 99.4 m -66.44 154.52 40.0 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.64 0.587 . . . . 0.0 112.304 -178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 150.1 45.07 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.389 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -59.72 124.37 19.92 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.247 0.546 . . . . 0.0 110.822 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.23 -18.42 28.19 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.8 p -108.32 149.98 27.94 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.8 p -114.43 140.41 48.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -80.73 103.37 10.52 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.66 114.24 28.3 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.172 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -73.16 106.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.8 mt -92.38 -33.29 14.63 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.961 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 36.2 m-80 -143.97 161.85 43.6 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.09 -31.32 89.94 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.891 1.727 . . . . 0.0 112.87 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.573 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 64.8 m-85 -105.71 -26.08 11.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.938 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' CE2' HD12 ' A' ' 28' ' ' LEU . 51.5 t80 -96.69 114.56 26.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -132.75 136.47 46.37 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -131.02 138.29 49.58 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -75.72 109.11 9.04 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--N 1.293 -1.868 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.834 178.935 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.536 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.0 tp60 . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.1 p -76.03 160.98 29.28 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.075 0.941 . . . . 0.0 112.858 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -66.06 133.04 49.92 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 76.9 3.61 3.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.243 1.017 . . . . 0.0 111.591 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.536 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -93.75 163.44 25.91 Favored Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -77.05 123.83 26.93 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.828 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 19.4 p -105.64 6.98 32.51 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -175.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.34 85.4 0.42 Allowed Glycine 0 CA--C 1.476 -2.388 0 C-N-CA 116.512 -2.756 . . . . 0.0 114.909 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.73 -176.87 31.0 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 107.019 -2.432 . . . . 0.0 107.019 169.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.09 118.24 6.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.854 0.827 . . . . 0.0 109.577 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.5 9.0 59.31 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.293 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -80.56 115.32 20.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.393 0.597 . . . . 0.0 110.508 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -84.63 -3.45 58.5 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.923 0.889 . . . . 0.0 113.326 -176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.06 -167.23 33.03 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.245 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.52 130.06 21.45 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.381 2.721 . . . . 0.0 112.098 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -104.4 -6.47 20.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.917 0.865 . . . . 0.0 111.866 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.57 109.04 22.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 87.9 m -68.45 156.22 38.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 123.612 0.57 . . . . 0.0 112.423 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 148.22 43.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.943 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -59.06 120.72 9.65 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -13.65 28.09 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.84 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.5 p -116.88 150.48 38.36 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.371 -0.488 . . . . 0.0 110.077 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -116.58 144.48 44.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.1 t -79.2 112.17 16.15 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.1 mt-30 -106.45 116.61 32.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.333 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -73.01 111.08 6.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 32' ' ' TYR . 94.1 mt -97.0 -31.61 12.43 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.56 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -149.63 166.14 15.93 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.32 -36.22 96.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.19 1.927 . . . . 0.0 113.627 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.61 -25.73 12.15 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.281 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CE1' HD12 ' A' ' 28' ' ' LEU . 58.3 t80 -95.93 114.96 26.73 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.2 m -129.33 143.55 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.7 tt0 -132.04 137.51 47.84 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.688 0.676 . . . . 0.0 111.952 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.828 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -74.93 111.64 10.34 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.042 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.502 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.0 mt . . . . . 0 C--N 1.291 -1.969 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.531 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.4 tp60 . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.1 p -73.6 167.87 20.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.045 0.926 . . . . 0.0 112.722 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -73.49 132.96 43.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.506 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 75.35 2.76 3.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.29 1.036 . . . . 0.0 112.135 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.531 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -91.43 161.81 27.73 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.4 tt0 -75.68 123.32 25.36 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.817 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.4 p -103.63 -3.62 24.91 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 137.74 83.57 0.12 Allowed Glycine 0 CA--C 1.479 -2.183 0 C-N-CA 116.334 -2.841 . . . . 0.0 114.966 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -173.25 29.89 Favored Glycine 0 C--N 1.284 -2.34 0 N-CA-C 107.925 -2.07 . . . . 0.0 107.925 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 78.6 mt -64.41 116.37 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.2 54.77 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.025 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 53.5 t80 -91.91 109.73 21.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.159 177.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 m -89.47 -5.6 57.19 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.839 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.15 -160.23 26.64 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.41 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.506 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 39.9 Cg_endo -72.14 131.53 18.12 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.1 2.533 . . . . 0.0 112.59 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.0 p -107.57 3.07 24.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -105.59 109.71 28.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 75.5 m -67.62 150.38 48.84 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.815 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 156.06 24.02 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.165 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -58.52 119.34 6.84 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.458 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -11.9 30.3 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.907 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.1 p -118.62 146.27 44.78 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.512 -0.404 . . . . 0.0 110.345 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 p -114.22 142.17 46.61 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.5 t -79.88 112.17 16.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.437 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 73.6 mt-30 -110.59 114.22 27.45 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.235 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 t -77.49 104.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD12 ' CE2' ' A' ' 32' ' ' TYR . 86.6 mt -89.57 -34.16 16.45 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.528 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 37.2 m-80 -143.42 167.41 15.79 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.91 -41.5 74.37 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.149 1.899 . . . . 0.0 113.62 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.512 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.4 m-85 -101.7 -25.04 13.99 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.199 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 41.7 t80 -95.04 115.42 27.41 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.7 m -131.5 140.04 49.45 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -134.31 138.4 44.93 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.244 0.475 . . . . 0.0 111.839 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.817 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.0 m -76.86 107.44 9.18 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.951 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.437 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.2 mt . . . . . 0 C--N 1.282 -2.339 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.555 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.1 p -77.27 168.01 20.76 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 112.145 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -71.21 135.28 47.44 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 73.71 9.7 4.85 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.954 0.901 . . . . 0.0 112.651 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.19 154.17 22.22 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.845 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.7 tt0 -70.14 123.27 21.2 Favored 'General case' 0 C--O 1.205 -1.241 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.726 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.9 p -102.21 13.01 35.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -171.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.71 63.22 0.18 Allowed Glycine 0 CA--C 1.48 -2.114 0 C-N-CA 117.047 -2.502 . . . . 0.0 114.876 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -85.19 173.24 48.22 Favored Glycine 0 N--CA 1.421 -2.317 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 63.9 mt -56.73 111.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 117.919 0.86 . . . . 0.0 109.951 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.82 -13.72 34.83 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.8 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -85.51 109.15 18.29 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 m -107.43 30.24 6.43 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.422 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.06 -160.67 28.46 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.06 118.68 5.58 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.944 2.429 . . . . 0.0 111.014 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -107.55 0.56 22.75 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.415 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.48 109.55 28.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 68.9 m -71.38 155.75 40.28 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 123.158 0.583 . . . . 0.0 112.051 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.54 147.63 50.91 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.046 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.7 m -57.6 122.62 13.17 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -10.08 30.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.3 p -118.67 141.84 48.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -108.35 129.12 55.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.422 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.84 98.54 3.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -98.94 117.03 32.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.268 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.4 t -78.43 93.95 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.3 -41.97 32.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.875 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 39.8 m-80 -139.91 166.53 23.23 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.04 -43.03 63.32 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.265 1.976 . . . . 0.0 112.866 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.634 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -99.64 -26.37 14.09 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.009 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 31.9 t80 -94.94 113.95 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.456 0.646 . . . . 0.0 111.722 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -135.49 137.18 41.89 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -137.05 141.3 42.43 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.872 0.76 . . . . 0.0 111.75 -172.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.9 m -78.96 107.12 11.47 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.276 -2.602 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.202 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.505 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.4 tp60 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 172.68 13.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.011 0.91 . . . . 0.0 112.189 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -78.58 133.46 37.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 74.04 6.34 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.909 0.884 . . . . 0.0 111.818 -175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.505 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.78 160.45 25.29 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.638 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.1 tt0 -78.84 127.41 32.0 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.793 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.0 p -106.68 9.37 31.25 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.65 80.57 0.48 Allowed Glycine 0 CA--C 1.489 -1.576 0 C-N-CA 117.252 -2.404 . . . . 0.0 115.207 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.24 -179.15 30.08 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 168.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.433 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 71.4 mt -62.78 114.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 117.854 0.827 . . . . 0.0 108.859 175.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.74 2.43 32.38 Favored Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.664 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -98.08 133.3 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -117.86 10.68 13.28 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.097 0.475 . . . . 0.0 111.133 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.08 -164.6 35.15 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.069 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.37 124.66 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.174 2.582 . . . . 0.0 112.159 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.8 p -106.09 -7.83 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.771 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -99.33 111.9 30.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 82.2 m -73.53 159.93 32.44 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.521 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 151.52 43.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.77 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -60.6 121.54 12.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.018 0.437 . . . . 0.0 109.861 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -19.81 24.77 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.586 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.7 p -107.62 140.77 40.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 27.6 p -105.24 136.33 44.95 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.359 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.1 t -79.91 99.03 7.38 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -98.55 116.73 31.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.588 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.92 93.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.51 -34.22 58.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.542 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -142.92 165.28 27.14 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 -32.51 93.65 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 121.453 1.435 . . . . 0.0 112.557 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.553 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.0 m-85 -107.76 -26.83 10.61 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.411 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -96.68 115.24 27.09 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -124.63 142.47 51.35 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -135.7 141.06 44.88 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 118.762 0.71 . . . . 0.0 112.334 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -82.03 107.46 14.75 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.073 176.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.488 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 85.6 mt . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.389 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.563 HE21 ' HA3' ' A' ' 6' ' ' GLY . 59.9 tp60 . . . . . 0 N--CA 1.41 -2.445 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.2 p -79.08 172.28 14.02 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.922 0.867 . . . . 0.0 111.163 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -72.66 135.07 45.36 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.259 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 73.77 6.38 4.92 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.319 1.048 . . . . 0.0 112.075 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.563 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.15 166.8 29.92 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.662 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.619 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -79.81 128.66 33.71 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.797 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 16.2 p -110.57 15.48 22.05 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.63 84.42 0.51 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 117.109 -2.472 . . . . 0.0 114.412 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.32 -179.4 29.89 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 169.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.66 109.62 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 117.826 0.813 . . . . 0.0 109.199 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.65 -11.12 32.77 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.12 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -79.12 110.15 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.025 0.441 . . . . 0.0 109.904 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 p -93.78 0.61 56.4 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.936 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.42 -168.55 40.65 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.305 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.86 122.37 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.845 2.364 . . . . 0.0 112.511 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 p -102.6 -15.72 16.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.657 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.43 108.97 20.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 77.9 m -68.92 153.11 44.37 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.094 0.473 . . . . 0.0 111.587 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.61 146.94 47.35 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -60.66 120.49 10.14 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.944 0.402 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.58 -10.66 30.43 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 71.1 p -114.31 143.83 44.24 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -108.7 132.72 53.65 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.227 0.329 . . . . 0.0 110.634 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.1 t -78.81 100.75 7.28 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -100.2 110.89 23.15 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.59 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.32 102.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.71 -39.4 16.04 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.437 -177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -139.41 162.79 49.66 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.7 -32.88 85.66 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.108 1.872 . . . . 0.0 113.041 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.7 m-85 -106.28 -26.16 11.64 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.491 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -96.79 114.45 26.08 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -131.74 139.35 48.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.3 tt0 -135.08 138.36 43.77 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 118.55 0.614 . . . . 0.0 112.45 -174.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -79.41 107.63 12.32 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.291 -1.966 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.235 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 120.718 0.294 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.51 HE21 ' HA3' ' A' ' 6' ' ' GLY . 49.5 tp60 -74.21 145.28 44.27 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.7 p -77.31 171.41 14.9 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 111.821 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.441 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.6 t-160 -78.01 134.46 37.8 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 74.81 11.79 3.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.924 0.89 . . . . 0.0 111.596 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.51 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -101.37 163.82 17.91 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.642 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -77.28 122.38 25.02 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.8 p -106.8 14.96 26.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.96 85.98 0.6 Allowed Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 116.954 -2.546 . . . . 0.0 114.889 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 177.27 28.16 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 168.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.433 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 67.0 mt -65.09 111.85 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 118.129 0.965 . . . . 0.0 109.138 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.58 -9.52 21.87 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.91 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -106.42 108.57 20.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -112.62 11.64 19.64 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.943 0.401 . . . . 0.0 111.091 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.59 -147.44 1.8 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.552 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.04 98.66 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.061 2.507 . . . . 0.0 112.093 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 p -98.7 -14.78 19.64 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.036 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.49 110.93 23.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.531 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 70.8 m -69.44 157.09 37.76 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.657 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.68 147.49 49.34 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 m -60.9 126.65 28.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.524 0.678 . . . . 0.0 110.54 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.79 -20.29 24.72 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.2 p -108.14 143.25 37.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 122.403 -0.469 . . . . 0.0 109.803 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 p -107.72 137.15 46.25 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.477 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.7 t -82.08 102.22 10.88 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.96 117.96 36.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.321 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.9 t -76.63 117.91 22.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.459 HD12 ' CE1' ' A' ' 32' ' ' TYR . 83.9 mt -101.7 -42.15 6.3 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.559 0.695 . . . . 0.0 109.598 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 40.8 m-80 -135.62 165.03 39.24 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.25 -27.58 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.032 1.822 . . . . 0.0 113.313 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.607 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.1 m-85 -112.49 -26.08 8.87 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.294 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CE1' HD12 ' A' ' 28' ' ' LEU . 40.7 t80 -95.2 115.06 26.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -131.96 141.78 49.42 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 33.7 tt0 -134.42 138.24 44.65 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 118.535 0.607 . . . . 0.0 112.307 -175.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.0 m -77.32 114.7 16.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.745 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.494 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 C--O 1.241 0.647 0 CA-C-O 120.871 0.367 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.515 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.1 tp60 -70.87 142.57 51.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.966 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -79.32 157.49 27.67 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.74 0.781 . . . . 0.0 112.167 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.416 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.7 t-160 -67.15 132.03 46.99 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 75.44 6.05 4.07 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.975 0.91 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.515 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.75 166.78 29.18 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -78.63 130.32 35.75 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.779 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.7 p -115.23 7.0 15.15 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -173.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.82 75.26 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 117.026 -2.511 . . . . 0.0 114.458 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.94 174.06 26.19 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 172.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.2 mt -59.2 110.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 117.588 0.694 . . . . 0.0 109.694 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.9 43.68 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.815 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -89.21 109.45 20.32 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -105.23 17.62 23.71 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.165 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.25 -163.22 37.87 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.53 114.47 2.14 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.763 2.309 . . . . 0.0 111.597 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -103.28 0.33 31.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.205 0.526 . . . . 0.0 112.036 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.81 109.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 73.4 m -69.44 155.43 40.47 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.053 0.541 . . . . 0.0 111.469 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.46 147.11 49.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.046 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -57.73 123.75 16.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -14.43 28.98 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 65.3 p -117.53 145.5 44.2 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.448 -0.443 . . . . 0.0 110.117 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -111.35 138.25 48.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.504 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.9 t -78.49 109.63 12.85 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.6 mt-30 -106.28 112.5 25.55 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 99.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.47 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.2 mt -84.27 -39.23 19.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.334 -173.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.422 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -134.96 164.65 42.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.14 -34.68 88.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.818 1.679 . . . . 0.0 113.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.642 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.6 m-85 -107.46 -24.96 11.62 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CE2' HD12 ' A' ' 28' ' ' LEU . 43.8 t80 -94.98 114.39 26.2 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -128.53 139.08 52.49 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 31.8 tt0 -133.3 137.17 45.87 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.451 0.569 . . . . 0.0 111.885 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -75.68 109.39 9.22 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.48 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.28 -2.444 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.554 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.3 tp60 -70.84 140.3 51.11 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -77.03 166.68 22.98 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.72 0.772 . . . . 0.0 111.874 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -71.22 135.76 47.68 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 73.72 8.6 4.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.801 0.84 . . . . 0.0 112.161 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.08 155.75 21.16 Favored Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.0 tt0 -69.96 125.44 26.76 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.76 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -107.52 11.33 28.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.35 72.83 0.23 Allowed Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 117.278 -2.391 . . . . 0.0 114.741 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.31 179.52 30.86 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 171.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 68.0 mt -57.93 116.28 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 118.041 0.921 . . . . 0.0 110.327 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.27 -28.5 9.62 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.608 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -78.3 111.98 14.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.91 0.386 . . . . 0.0 110.189 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -102.15 -0.32 33.46 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.925 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -163.15 10.46 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.942 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.44 123.92 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.515 2.81 . . . . 0.0 112.649 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 p -109.74 -1.57 17.89 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.377 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.24 110.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.3 m -70.64 164.61 24.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.557 0.694 . . . . 0.0 112.761 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.97 160.41 31.95 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.017 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -63.4 116.58 5.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 123.363 0.665 . . . . 0.0 110.032 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.74 -14.33 34.95 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.871 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 60.6 p -108.17 142.83 37.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.573 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 p -106.85 137.68 44.44 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.51 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.0 t -79.56 100.36 7.73 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -98.56 118.95 36.4 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.927 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.87 98.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.2 -35.68 28.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.581 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 37.9 m-80 -146.28 165.12 21.32 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.26 -37.42 94.43 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.155 1.903 . . . . 0.0 113.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.534 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 36.3 m-85 -101.13 -26.24 13.75 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.913 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 19.9 t80 -95.59 114.3 26.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.329 0.585 . . . . 0.0 112.334 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.9 m -132.78 135.14 45.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' OE1' HD21 ' A' ' 36' ' ' LEU . 32.8 tt0 -133.84 140.54 46.94 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.956 0.343 . . . . 0.0 111.868 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.4 m -77.08 112.3 13.58 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.426 HD21 ' OE1' ' A' ' 34' ' ' GLN . 90.1 mt . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.02 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.467 ' H3 ' ' HA3' ' A' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.44 -0.962 0 CA-C-O 120.85 0.357 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.582 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.1 tp60 -77.7 141.01 39.6 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 174.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.1 p -80.55 162.02 24.51 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.756 0.789 . . . . 0.0 111.604 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -66.04 133.22 50.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 74.5 12.54 3.84 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.841 0.856 . . . . 0.0 112.485 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.582 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -101.76 169.55 20.26 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.629 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.4 tt0 -81.42 127.41 32.75 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.773 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -110.36 8.7 23.44 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.22 80.15 0.2 Allowed Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 116.862 -2.59 . . . . 0.0 114.317 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.84 179.64 30.22 Favored Glycine 0 C--N 1.284 -2.358 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 170.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 66.7 mt -62.46 111.04 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 117.984 0.892 . . . . 0.0 110.733 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.92 2.28 45.74 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.032 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -91.27 109.53 20.8 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.186 -0.597 . . . . 0.0 109.659 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -97.03 12.48 32.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.393 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.55 -165.78 41.62 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.613 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.03 115.18 2.38 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.937 2.425 . . . . 0.0 112.079 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -102.82 -8.53 20.71 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.939 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.54 108.92 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 85.6 m -71.34 155.8 40.23 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.39 138.05 56.82 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.2 m -57.54 128.13 35.49 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.84 23.9 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.6 p -108.23 146.44 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.7 p -107.68 131.31 54.54 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 121.263 -0.175 . . . . 0.0 110.879 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.47 103.26 4.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -103.56 116.14 31.82 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.214 0.53 . . . . 0.0 111.29 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.3 t -72.13 107.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.549 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' HD22 ' A' ' 29' ' ' ASN . 95.9 mt -93.73 -33.84 13.46 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.273 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -139.27 165.04 34.67 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 175.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.25 -30.61 93.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.723 1.615 . . . . 0.0 112.562 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.606 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.0 m-85 -105.36 -25.49 12.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.932 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 32.2 t80 -95.23 114.35 26.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -130.67 136.86 49.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.6 tt0 -132.37 137.25 47.29 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 118.304 0.502 . . . . 0.0 111.938 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -75.89 113.08 12.98 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.807 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.892 179.52 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.247 0.967 0 CA-C-O 120.575 0.226 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.554 HE21 ' HA3' ' A' ' 6' ' ' GLY . 58.0 tp60 -70.43 138.06 50.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.7 p -75.75 158.87 31.7 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.186 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.447 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 18.7 t-160 -65.4 134.88 54.45 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 73.63 9.26 4.96 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.106 0.962 . . . . 0.0 111.584 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -97.29 161.2 21.46 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.675 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.3 tt0 -74.95 123.57 25.36 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.2 p -107.03 16.03 24.64 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 75.49 0.31 Allowed Glycine 0 CA--C 1.483 -1.911 0 C-N-CA 117.044 -2.503 . . . . 0.0 114.705 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.15 -178.92 30.25 Favored Glycine 0 C--N 1.29 -1.986 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 169.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.4 119.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.0 -23.64 27.03 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.259 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.77 110.18 20.79 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -107.54 8.58 29.37 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.308 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.9 -162.3 25.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.881 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.64 117.83 4.57 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.202 2.601 . . . . 0.0 112.964 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 p -100.88 -13.38 18.38 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.831 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -92.53 109.58 21.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.469 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 81.8 m -73.26 159.72 32.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.277 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 138.98 58.71 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.5 m -51.94 117.93 3.09 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.448 0.467 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -2.88 28.7 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.749 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.8 p -123.98 142.21 51.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 p -109.54 131.93 54.61 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.378 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -74.18 103.66 4.69 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -103.87 113.73 27.47 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.637 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.23 104.78 4.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.03 -45.86 9.83 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.846 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.445 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -128.47 167.28 19.62 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.27 -34.86 99.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 121.545 1.497 . . . . 0.0 112.374 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.557 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.4 m-85 -100.86 -26.8 13.63 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.646 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.445 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 25.4 t80 -96.62 114.57 26.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -131.7 136.04 47.33 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' OE1' HD21 ' A' ' 36' ' ' LEU . 30.9 tt0 -136.09 137.0 40.6 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 118.671 0.669 . . . . 0.0 112.125 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.74 109.14 9.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.422 HD21 ' OE1' ' A' ' 34' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.287 -2.139 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.516 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.7 tp60 -84.25 145.34 28.37 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.0 p -78.56 170.5 16.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.581 0.705 . . . . 0.0 111.88 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.479 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.5 t-160 -76.14 135.7 39.81 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 73.59 9.29 4.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.03 0.932 . . . . 0.0 111.963 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.516 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.85 166.88 25.15 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.058 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.1 tt0 -76.86 130.12 37.16 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.7 p -118.42 10.14 12.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.55 74.57 0.03 OUTLIER Glycine 0 CA--C 1.474 -2.479 0 C-N-CA 116.348 -2.834 . . . . 0.0 114.129 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.47 169.62 21.6 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 172.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 75.2 mt -59.55 113.49 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 117.574 0.687 . . . . 0.0 109.551 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.79 -18.75 36.93 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.323 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -73.38 114.32 11.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 109.737 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -109.67 20.28 18.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.694 0.759 . . . . 0.0 110.274 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.61 -162.45 35.02 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.079 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.85 115.92 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.702 2.268 . . . . 0.0 111.512 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -102.35 -4.13 26.03 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.945 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.31 109.65 26.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 79.1 m -71.8 152.17 42.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.724 0.409 . . . . 0.0 110.734 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.41 122.08 11.07 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -53.23 131.71 37.6 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.523 0.677 . . . . 0.0 110.806 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.15 -9.55 26.96 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -170.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -123.97 150.23 45.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -113.7 137.53 51.49 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.632 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -79.62 103.81 9.79 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.464 HE21 ' HB2' ' A' ' 36' ' ' LEU . 47.2 mt-30 -102.5 117.79 35.47 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.301 0.572 . . . . 0.0 111.679 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.8 t -74.48 108.41 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.518 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.5 mt -93.03 -40.08 10.73 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.627 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 43.7 m-80 -138.98 165.79 29.66 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -55.46 -36.86 94.99 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.981 1.787 . . . . 0.0 113.301 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.677 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -104.06 -25.89 12.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.264 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.5 t80 -95.51 114.53 26.3 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.7 139.44 50.3 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -132.3 137.52 47.49 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.785 0.721 . . . . 0.0 112.452 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -75.2 109.81 9.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' HB2' HE21 ' A' ' 26' ' ' GLN . 98.1 mt . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.611 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.6 tp60 -76.04 141.36 42.11 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.077 0.551 . . . . 0.0 110.172 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -77.04 160.43 29.1 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.577 0.703 . . . . 0.0 112.438 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.455 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 20.4 t-160 -67.14 133.49 49.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 77.03 5.27 3.29 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.119 0.968 . . . . 0.0 112.125 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.611 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.65 161.21 22.85 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.751 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -73.36 128.72 36.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.4 p -112.48 19.25 17.74 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.64 78.38 0.56 Allowed Glycine 0 CA--C 1.479 -2.198 0 C-N-CA 117.44 -2.314 . . . . 0.0 114.478 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.96 172.59 24.73 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 106.891 -2.484 . . . . 0.0 106.891 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.479 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 70.5 mt -58.25 113.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 118.006 0.903 . . . . 0.0 109.317 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.04 -8.22 33.34 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.193 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -95.67 110.05 22.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 m -97.9 0.98 47.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.064 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.04 -158.99 11.68 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.544 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.57 114.05 2.21 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.703 2.935 . . . . 0.0 112.466 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.1 p -101.34 -13.73 17.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -88.9 110.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 73.3 m -72.07 155.63 40.09 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.986 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.11 140.26 58.85 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 125.19 16.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 123.507 0.505 . . . . 0.0 110.538 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -12.48 30.04 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.9 p -116.78 146.96 42.49 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -111.73 137.4 49.69 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.951 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.4 t -80.83 100.77 8.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -102.12 115.8 31.32 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.755 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -79.76 94.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.403 ' C ' HD22 ' A' ' 29' ' ' ASN . 81.6 mt -76.5 -37.56 56.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.855 -175.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -138.01 163.7 45.99 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.47 -35.61 92.53 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.319 2.013 . . . . 0.0 112.712 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.6 m-85 -100.61 -25.6 14.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.456 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -96.24 113.88 25.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.636 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.7 m -129.89 135.33 48.23 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.03 138.24 42.0 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.287 0.494 . . . . 0.0 111.794 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -75.62 109.09 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--N 1.294 -1.812 0 C-N-CA 123.209 0.604 . . . . 0.0 110.388 -179.521 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.438 -1.048 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.538 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.0 tp60 -82.5 138.35 34.35 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 174.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.0 p -70.18 162.42 28.38 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 122.292 1.044 . . . . 0.0 112.745 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -72.4 129.72 39.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 77.43 7.16 2.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.766 0.826 . . . . 0.0 112.169 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.538 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.7 164.9 24.32 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.692 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.6 tt0 -75.59 128.19 34.72 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -111.3 8.98 21.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -174.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.43 66.88 0.06 OUTLIER Glycine 0 CA--C 1.48 -2.134 0 C-N-CA 116.83 -2.605 . . . . 0.0 113.807 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.83 173.15 25.41 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' H ' ' HA ' ' A' ' 31' ' ' TYR . 76.6 mt -65.75 122.51 16.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.69 4.06 57.08 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.32 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.421 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 48.3 t80 -105.89 110.25 22.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 m -99.76 6.01 45.54 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.25 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.34 -165.59 41.21 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.96 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.24 125.86 17.31 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.834 3.023 . . . . 0.0 112.979 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 p -106.2 -2.98 21.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.02 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.57 109.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 71.3 m -73.19 149.13 43.14 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.396 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.67 152.82 34.29 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.22 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 m -58.98 119.98 8.24 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.302 0.572 . . . . 0.0 110.57 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.47 -11.61 30.68 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.627 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.0 p -114.27 142.61 46.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.901 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 p -112.53 133.47 54.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.172 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.513 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.27 105.07 7.11 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.13 115.15 29.9 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.966 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.61 98.92 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -81.68 -37.7 27.01 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.206 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -143.28 163.4 37.45 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.42 -38.24 89.46 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.437 2.092 . . . . 0.0 113.132 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 33.8 m-85 -101.89 -26.44 13.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.921 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -96.73 114.75 26.41 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -129.46 138.79 51.62 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.7 tt0 -132.95 137.07 46.46 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 118.896 0.771 . . . . 0.0 112.098 -175.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.1 m -78.29 108.62 11.75 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.289 -2.032 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.712 177.798 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 120.943 0.401 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.54 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 -76.63 140.97 41.19 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.562 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p -78.94 165.75 23.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.965 0.888 . . . . 0.0 112.194 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -72.31 128.24 35.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.693 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 75.85 16.0 2.46 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.232 1.013 . . . . 0.0 111.947 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.54 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -103.0 162.75 16.08 Favored Glycine 0 N--CA 1.414 -2.789 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.2 tt0 -75.71 127.98 34.21 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 26.8 p -112.24 3.7 17.32 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.01 72.37 0.04 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 116.43 -2.795 . . . . 0.0 114.498 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 170.18 23.03 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.588 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.7 mt -58.39 122.63 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 117.828 0.814 . . . . 0.0 108.947 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -27.06 19.17 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -84.93 115.59 22.88 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.8 m -115.8 17.68 15.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.081 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 -156.46 18.06 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.459 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.08 113.81 1.74 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.21 2.607 . . . . 0.0 111.246 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -109.78 -1.61 17.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.451 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.67 110.5 31.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.523 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 85.8 m -69.16 158.04 35.69 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 159.64 20.98 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.517 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -63.86 118.21 8.05 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.25 0.548 . . . . 0.0 110.415 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.64 29.13 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.5 p -108.3 144.01 36.38 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.418 -0.46 . . . . 0.0 110.442 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.9 p -109.81 136.29 49.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.6 t -76.36 100.5 5.18 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -99.42 112.43 24.62 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.638 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.65 101.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.82 -39.88 17.84 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.622 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 34.9 m-80 -140.18 165.86 27.58 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.15 -35.87 95.73 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.059 1.839 . . . . 0.0 113.508 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.0 m-85 -106.62 -25.42 11.79 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.262 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 41.2 t80 -95.92 114.43 26.15 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 177.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.595 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -130.81 137.91 49.64 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -133.91 138.33 45.47 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 118.262 0.483 . . . . 0.0 112.15 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -76.37 111.56 11.96 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.911 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.285 -2.228 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.329 179.53 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.519 ' H3 ' ' HA3' ' A' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.514 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.0 tp60 -77.9 143.08 38.01 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.597 0.237 . . . . 0.0 110.652 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.4 p -80.13 164.54 23.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.681 0.753 . . . . 0.0 111.869 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.436 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 11.4 t-160 -71.89 135.46 46.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 73.7 4.35 4.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.271 1.028 . . . . 0.0 111.886 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.514 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -88.26 162.94 32.55 Favored Glycine 0 N--CA 1.421 -2.301 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.8 tt0 -79.07 120.72 24.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.0 p -99.8 15.43 26.95 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.53 86.92 0.72 Allowed Glycine 0 CA--C 1.482 -1.981 0 C-N-CA 117.64 -2.219 . . . . 0.0 114.824 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.56 179.2 29.17 Favored Glycine 0 C--N 1.287 -2.194 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 170.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -64.42 114.04 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 118.0 0.9 . . . . 0.0 109.153 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.82 -13.65 29.49 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.342 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -87.31 112.1 21.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 m -96.87 -4.31 40.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.878 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 -164.52 17.2 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.754 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.8 123.01 12.12 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.401 2.734 . . . . 0.0 112.422 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -105.5 -17.99 14.24 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.13 109.56 18.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -69.17 146.46 52.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 123.263 0.352 . . . . 0.0 111.165 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.64 133.96 54.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.411 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 m -47.29 127.89 11.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.631 0.729 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.71 -19.72 25.59 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.774 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.4 p -113.8 153.03 29.79 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 122.429 -0.454 . . . . 0.0 109.917 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -113.54 138.33 50.3 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.895 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -83.09 110.24 17.83 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -108.46 114.5 28.38 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.63 97.82 2.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.78 -38.16 29.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.417 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -142.64 168.66 12.67 Favored Pre-proline 0 C--N 1.297 -1.692 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.59 -35.16 98.9 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.826 1.684 . . . . 0.0 113.198 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.608 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.1 m-85 -108.6 -25.46 10.88 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.493 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -96.14 115.25 27.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -132.89 141.03 48.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -136.27 139.56 42.77 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.741 0.7 . . . . 0.0 112.229 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.1 m -78.05 113.35 15.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.434 175.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.289 -2.039 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.908 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.451 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.552 ' OE1' ' HG2' ' A' ' 16' ' ' PRO . 52.0 tp60 -86.51 144.43 27.25 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.8 p -80.62 167.69 19.75 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.067 0.937 . . . . 0.0 112.759 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -71.89 128.48 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.999 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 76.19 6.87 3.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.453 1.101 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.524 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.72 161.7 22.05 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.6 tt0 -77.85 121.44 24.12 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.713 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.1 p -106.76 16.19 24.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 123.93 76.64 0.32 Allowed Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 116.354 -2.832 . . . . 0.0 114.885 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.79 176.33 28.39 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 170.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.6 mt -60.47 113.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 118.177 0.988 . . . . 0.0 110.666 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.4 -11.56 21.68 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.167 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.481 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 51.5 t80 -91.97 132.23 36.68 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.1 m -128.49 13.32 6.51 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.84 -142.16 10.6 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.638 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -71.76 113.94 3.8 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.25 1.967 . . . . 0.0 111.282 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -102.79 -0.59 31.22 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.855 0.836 . . . . 0.0 112.098 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -106.96 118.99 55.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 74.2 m -73.29 160.24 32.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.4 0.619 . . . . 0.0 112.2 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 144.9 56.09 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.104 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -62.44 124.77 21.81 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.63 -14.55 27.21 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -173.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.2 p -119.59 147.73 44.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -113.76 138.08 50.75 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.881 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.8 t -78.86 98.17 6.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.3 mt-30 -96.89 113.85 25.43 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.64 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.4 96.26 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' C ' HD22 ' A' ' 29' ' ' ASN . 82.0 mt -79.92 -38.36 32.64 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.049 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.431 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -135.48 165.02 39.43 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -55.86 -34.31 91.12 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.809 1.673 . . . . 0.0 113.187 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.61 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.7 m-85 -106.04 -25.25 12.15 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.274 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 28' ' ' LEU . 44.8 t80 -95.09 115.06 26.95 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -130.84 134.54 46.91 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -133.41 137.44 45.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 118.446 0.566 . . . . 0.0 111.974 -175.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.8 m -76.8 110.03 11.07 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.999 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.286 -2.183 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.438 -1.072 0 CA-C-O 120.639 0.257 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.555 HE21 ' HA3' ' A' ' 6' ' ' GLY . 52.0 tp60 -74.03 138.82 44.32 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 123.192 0.597 . . . . 0.0 109.663 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -76.65 159.16 30.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.736 0.779 . . . . 0.0 112.283 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.4 t-160 -66.49 134.53 52.62 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 76.34 0.32 3.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.163 0.985 . . . . 0.0 112.72 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -89.31 161.81 30.36 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -75.18 123.39 25.17 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.754 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -105.63 11.46 32.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.53 88.36 0.84 Allowed Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 116.926 -2.559 . . . . 0.0 114.937 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.56 -178.03 31.14 Favored Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 169.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.4 113.27 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 118.12 0.96 . . . . 0.0 109.099 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.81 -16.37 28.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -82.77 110.26 17.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 m -98.8 2.55 46.94 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.571 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.18 -164.66 13.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.154 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.62 116.53 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.88 2.387 . . . . 0.0 111.873 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.9 p -104.84 -4.81 21.8 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.098 0.475 . . . . 0.0 112.042 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.33 109.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.511 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.8 m -65.29 154.09 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 123.762 0.825 . . . . 0.0 112.35 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 146.9 52.31 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.417 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -50.21 122.74 7.25 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.107 0.963 . . . . 0.0 111.684 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.81 -20.12 24.88 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.132 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 78.7 p -108.31 159.68 16.45 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 122.463 -0.433 . . . . 0.0 111.178 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -119.66 142.27 48.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.9 t -82.23 110.31 17.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -107.7 117.58 34.49 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.93 101.78 3.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.44 ' C ' HD22 ' A' ' 29' ' ' ASN . 90.3 mt -86.85 -39.75 15.56 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.859 0.837 . . . . 0.0 109.62 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -133.34 162.93 54.66 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -57.98 -27.26 78.49 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.858 1.705 . . . . 0.0 113.137 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.51 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.5 m-85 -110.36 -25.19 10.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.321 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.443 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 39.5 t80 -94.51 114.02 25.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.3 m -130.02 139.55 51.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' OE1' HD21 ' A' ' 36' ' ' LEU . 30.2 tt0 -134.47 137.79 44.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 117.967 0.349 . . . . 0.0 111.448 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -74.03 116.31 14.51 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.418 HD21 ' OE1' ' A' ' 34' ' ' GLN . 89.9 mt . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.009 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.615 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 56.5 tp60 -79.19 141.77 36.89 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.0 p -73.07 166.1 23.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.51 1.148 . . . . 0.0 113.15 -174.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -75.2 134.02 41.29 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 75.08 7.62 4.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.876 0.871 . . . . 0.0 111.081 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -93.5 167.61 28.79 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.4 tt0 -81.72 135.39 35.5 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.692 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.2 p -124.74 8.2 8.19 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.35 68.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 116.337 -2.84 . . . . 0.0 115.198 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.04 169.77 22.17 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.6 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.8 mt -58.95 111.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 117.492 0.646 . . . . 0.0 109.492 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.86 -1.8 52.07 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.067 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -84.09 109.84 18.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 117.282 0.541 . . . . 0.0 110.393 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.5 m -93.92 7.01 46.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.48 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.37 -176.36 48.69 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.471 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.12 125.1 14.01 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.581 2.188 . . . . 0.0 110.662 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -99.23 -8.31 25.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.57 0.7 . . . . 0.0 111.006 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.91 109.49 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 58.9 m -76.13 160.69 29.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.052 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.7 121.08 11.36 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 m -53.68 136.68 38.98 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.608 0.718 . . . . 0.0 111.547 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.28 -20.39 23.47 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.2 p -108.53 147.49 31.65 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -107.06 132.04 53.41 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.352 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.9 t -76.0 106.67 7.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.436 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -105.48 115.77 30.82 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.29 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -73.85 104.71 2.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.67 -45.23 9.0 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.804 -175.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -130.01 167.5 20.36 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' O ' HG13 ' A' ' 11' ' ' ILE . 49.1 Cg_exo -60.63 -28.7 87.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.566 1.511 . . . . 0.0 113.198 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.647 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 32.3 m-85 -110.25 -26.04 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -95.17 114.64 26.46 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.1 m -131.31 136.64 48.31 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' OE1' HD21 ' A' ' 36' ' ' LEU . 32.3 tt0 -131.52 139.43 49.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 118.601 0.637 . . . . 0.0 112.457 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 38.1 m -78.56 109.25 12.59 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.533 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.475 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.3 mt . . . . . 0 C--N 1.294 -1.82 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.491 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.615 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 120.791 0.329 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.419 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 18.2 tp60 -98.01 133.9 41.85 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.9 p -68.5 158.16 34.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.945 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -64.46 132.83 51.09 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 76.49 4.06 3.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.015 0.926 . . . . 0.0 112.35 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.52 154.18 24.78 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -71.17 124.42 24.42 Favored 'General case' 0 C--O 1.202 -1.434 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.1 p -106.17 14.73 27.25 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -173.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.3 80.71 0.46 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 116.828 -2.606 . . . . 0.0 114.963 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.66 177.45 29.36 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 106.881 -2.487 . . . . 0.0 106.881 170.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.11 114.2 2.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 118.27 1.035 . . . . 0.0 108.971 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.51 -6.49 26.38 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.748 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -97.37 109.82 22.5 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.366 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -100.89 18.74 18.76 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.498 0.666 . . . . 0.0 110.765 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.63 -165.27 38.43 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -58.18 114.9 2.18 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.904 2.403 . . . . 0.0 111.915 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -104.55 -2.83 24.65 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.847 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.6 113.29 43.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 81.7 m -70.91 156.26 39.81 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 154.1 38.39 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.499 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -54.77 118.79 4.53 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.021 0.528 . . . . 0.0 110.831 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.84 26.26 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.139 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.6 p -108.78 143.83 37.41 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.456 -0.438 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.6 p -110.78 145.32 38.34 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.862 -0.154 . . . . 0.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.5 t -84.76 110.51 18.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -107.38 111.89 24.44 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.814 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.6 100.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.427 HD12 ' CE1' ' A' ' 32' ' ' TYR . 79.9 mt -82.78 -40.74 20.04 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.028 -174.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -136.07 162.94 53.74 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.06 -28.14 68.14 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.02 1.813 . . . . 0.0 113.463 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 40.9 m-85 -111.34 -25.51 9.62 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.617 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' CE1' HD12 ' A' ' 28' ' ' LEU . 38.8 t80 -96.6 115.0 26.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -129.95 140.01 50.99 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -133.05 138.82 46.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 118.903 0.774 . . . . 0.0 112.034 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.1 m -76.21 114.24 14.66 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.064 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.286 -2.16 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.879 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.419 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 120.885 0.374 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.547 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.4 tp60 -85.9 139.77 30.95 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.3 p -75.69 162.43 28.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.982 0.896 . . . . 0.0 112.13 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -68.77 133.44 48.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 74.35 6.84 4.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.987 0.915 . . . . 0.0 112.19 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.547 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.61 160.89 22.78 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.5 tt0 -74.4 129.54 37.97 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.9 p -111.58 5.12 19.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.13 82.77 0.1 Allowed Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 116.78 -2.629 . . . . 0.0 114.51 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.25 174.52 26.29 Favored Glycine 0 N--CA 1.417 -2.605 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 170.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.505 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.3 mt -59.55 118.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 117.788 0.794 . . . . 0.0 109.61 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.41 63.07 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.487 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -76.87 111.54 12.52 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.28 -0.541 . . . . 0.0 110.488 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -94.65 2.98 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.938 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.1 -174.28 50.27 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.525 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -62.32 127.84 22.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.177 2.585 . . . . 0.0 112.617 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 p -105.96 -5.67 19.42 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -99.29 109.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 99.4 m -66.44 154.52 40.0 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.64 0.587 . . . . 0.0 112.304 -178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 150.1 45.07 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.389 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -59.72 124.37 19.92 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.247 0.546 . . . . 0.0 110.822 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.23 -18.42 28.19 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.8 p -108.32 149.98 27.94 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.8 p -114.43 140.41 48.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -80.73 103.37 10.52 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.66 114.24 28.3 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.172 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -73.16 106.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.8 mt -92.38 -33.29 14.63 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.961 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 36.2 m-80 -143.97 161.85 43.6 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.09 -31.32 89.94 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.891 1.727 . . . . 0.0 112.87 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.573 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 64.8 m-85 -105.71 -26.08 11.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.938 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.445 ' CE2' HD12 ' A' ' 28' ' ' LEU . 51.5 t80 -96.69 114.56 26.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -132.75 136.47 46.37 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -131.02 138.29 49.58 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -75.72 109.11 9.04 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--N 1.293 -1.868 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.834 178.935 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.536 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.0 tp60 -87.29 137.05 32.68 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.1 p -76.03 160.98 29.28 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.075 0.941 . . . . 0.0 112.858 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -66.06 133.04 49.92 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 76.9 3.61 3.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.243 1.017 . . . . 0.0 111.591 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.536 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -93.75 163.44 25.91 Favored Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -77.05 123.83 26.93 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.828 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 19.4 p -105.64 6.98 32.51 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -175.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.34 85.4 0.42 Allowed Glycine 0 CA--C 1.476 -2.388 0 C-N-CA 116.512 -2.756 . . . . 0.0 114.909 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.73 -176.87 31.0 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 107.019 -2.432 . . . . 0.0 107.019 169.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.09 118.24 6.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.854 0.827 . . . . 0.0 109.577 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.5 9.0 59.31 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.293 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -80.56 115.32 20.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.393 0.597 . . . . 0.0 110.508 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -84.63 -3.45 58.5 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.923 0.889 . . . . 0.0 113.326 -176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.06 -167.23 33.03 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.245 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.52 130.06 21.45 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.381 2.721 . . . . 0.0 112.098 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -104.4 -6.47 20.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.917 0.865 . . . . 0.0 111.866 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.57 109.04 22.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 87.9 m -68.45 156.22 38.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 123.612 0.57 . . . . 0.0 112.423 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 148.22 43.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.943 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -59.06 120.72 9.65 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.38 -13.65 28.09 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.84 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.5 p -116.88 150.48 38.36 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.371 -0.488 . . . . 0.0 110.077 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -116.58 144.48 44.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.1 t -79.2 112.17 16.15 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.1 mt-30 -106.45 116.61 32.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.333 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -73.01 111.08 6.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 32' ' ' TYR . 94.1 mt -97.0 -31.61 12.43 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.56 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -149.63 166.14 15.93 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.32 -36.22 96.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.19 1.927 . . . . 0.0 113.627 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.61 -25.73 12.15 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.281 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CE1' HD12 ' A' ' 28' ' ' LEU . 58.3 t80 -95.93 114.96 26.73 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.2 m -129.33 143.55 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.7 tt0 -132.04 137.51 47.84 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.688 0.676 . . . . 0.0 111.952 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.828 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -74.93 111.64 10.34 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.042 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.502 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.0 mt . . . . . 0 C--N 1.291 -1.969 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.428 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.438 -1.071 0 CA-C-O 120.821 0.343 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.531 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.4 tp60 -85.07 141.92 29.91 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.1 p -73.6 167.87 20.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.045 0.926 . . . . 0.0 112.722 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -73.49 132.96 43.49 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.506 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 75.35 2.76 3.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.29 1.036 . . . . 0.0 112.135 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.531 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -91.43 161.81 27.73 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.4 tt0 -75.68 123.32 25.36 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.817 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.4 p -103.63 -3.62 24.91 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 137.74 83.57 0.12 Allowed Glycine 0 CA--C 1.479 -2.183 0 C-N-CA 116.334 -2.841 . . . . 0.0 114.966 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -173.25 29.89 Favored Glycine 0 C--N 1.284 -2.34 0 N-CA-C 107.925 -2.07 . . . . 0.0 107.925 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 78.6 mt -64.41 116.37 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.2 54.77 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.025 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 53.5 t80 -91.91 109.73 21.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.159 177.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 m -89.47 -5.6 57.19 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.839 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.15 -160.23 26.64 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.41 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.506 ' HG2' ' OE1' ' A' ' 2' ' ' GLN . 39.9 Cg_endo -72.14 131.53 18.12 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.1 2.533 . . . . 0.0 112.59 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.0 p -107.57 3.07 24.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -105.59 109.71 28.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 75.5 m -67.62 150.38 48.84 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.815 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 156.06 24.02 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.165 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -58.52 119.34 6.84 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.458 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -11.9 30.3 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.907 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.1 p -118.62 146.27 44.78 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.512 -0.404 . . . . 0.0 110.345 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 p -114.22 142.17 46.61 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.5 t -79.88 112.17 16.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.437 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 73.6 mt-30 -110.59 114.22 27.45 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.235 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 t -77.49 104.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD12 ' CE2' ' A' ' 32' ' ' TYR . 86.6 mt -89.57 -34.16 16.45 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.528 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 37.2 m-80 -143.42 167.41 15.79 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.91 -41.5 74.37 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.149 1.899 . . . . 0.0 113.62 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.512 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 26.4 m-85 -101.7 -25.04 13.99 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.199 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 41.7 t80 -95.04 115.42 27.41 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.7 m -131.5 140.04 49.45 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -134.31 138.4 44.93 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.244 0.475 . . . . 0.0 111.839 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.817 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.0 m -76.86 107.44 9.18 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.951 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.437 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.2 mt . . . . . 0 C--N 1.282 -2.339 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.42 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.555 HE21 ' HA3' ' A' ' 6' ' ' GLY . 56.5 tp60 -69.48 142.4 53.76 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.1 p -77.27 168.01 20.76 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 112.145 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -71.21 135.28 47.44 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 73.71 9.7 4.85 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.954 0.901 . . . . 0.0 112.651 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.19 154.17 22.22 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.845 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.7 tt0 -70.14 123.27 21.2 Favored 'General case' 0 C--O 1.205 -1.241 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.726 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.9 p -102.21 13.01 35.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -171.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.71 63.22 0.18 Allowed Glycine 0 CA--C 1.48 -2.114 0 C-N-CA 117.047 -2.502 . . . . 0.0 114.876 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -85.19 173.24 48.22 Favored Glycine 0 N--CA 1.421 -2.317 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 63.9 mt -56.73 111.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 117.919 0.86 . . . . 0.0 109.951 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.82 -13.72 34.83 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.8 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -85.51 109.15 18.29 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 m -107.43 30.24 6.43 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.422 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.06 -160.67 28.46 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.06 118.68 5.58 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.944 2.429 . . . . 0.0 111.014 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -107.55 0.56 22.75 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.415 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.48 109.55 28.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 68.9 m -71.38 155.75 40.28 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 123.158 0.583 . . . . 0.0 112.051 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.54 147.63 50.91 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.046 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.7 m -57.6 122.62 13.17 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.69 -10.08 30.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.3 p -118.67 141.84 48.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -108.35 129.12 55.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.422 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.5 t -74.84 98.54 3.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -98.94 117.03 32.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.268 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.4 t -78.43 93.95 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.3 -41.97 32.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.875 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 39.8 m-80 -139.91 166.53 23.23 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.04 -43.03 63.32 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.265 1.976 . . . . 0.0 112.866 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.634 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -99.64 -26.37 14.09 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.009 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 31.9 t80 -94.94 113.95 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.456 0.646 . . . . 0.0 111.722 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -135.49 137.18 41.89 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -137.05 141.3 42.43 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.872 0.76 . . . . 0.0 111.75 -172.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.9 m -78.96 107.12 11.47 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.276 -2.602 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.202 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.409 ' H5 ' HE22 ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.241 0.641 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.552 ' NE2' ' H3 ' ' A' ' 101' ' ' MAN . 54.4 tp60 -68.42 141.88 55.55 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 172.68 13.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.011 0.91 . . . . 0.0 112.189 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -78.58 133.46 37.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 74.04 6.34 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.909 0.884 . . . . 0.0 111.818 -175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.505 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.78 160.45 25.29 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.638 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.1 tt0 -78.84 127.41 32.0 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.793 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 25.0 p -106.68 9.37 31.25 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.65 80.57 0.48 Allowed Glycine 0 CA--C 1.489 -1.576 0 C-N-CA 117.252 -2.404 . . . . 0.0 115.207 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.24 -179.15 30.08 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 168.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.433 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 71.4 mt -62.78 114.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 117.854 0.827 . . . . 0.0 108.859 175.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.74 2.43 32.38 Favored Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.664 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -98.08 133.3 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -117.86 10.68 13.28 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.097 0.475 . . . . 0.0 111.133 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.08 -164.6 35.15 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.069 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.37 124.66 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.174 2.582 . . . . 0.0 112.159 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.8 p -106.09 -7.83 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.771 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -99.33 111.9 30.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 82.2 m -73.53 159.93 32.44 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.521 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 151.52 43.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.77 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -60.6 121.54 12.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.018 0.437 . . . . 0.0 109.861 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -19.81 24.77 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.586 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.7 p -107.62 140.77 40.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 27.6 p -105.24 136.33 44.95 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.359 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.1 t -79.91 99.03 7.38 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -98.55 116.73 31.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.588 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.92 93.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.51 -34.22 58.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.542 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -142.92 165.28 27.14 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 -32.51 93.65 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 121.453 1.435 . . . . 0.0 112.557 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.553 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.0 m-85 -107.76 -26.83 10.61 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.411 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -96.68 115.24 27.09 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -124.63 142.47 51.35 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -135.7 141.06 44.88 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 118.762 0.71 . . . . 0.0 112.334 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -82.03 107.46 14.75 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.073 176.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.488 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 85.6 mt . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.389 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.552 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.438 -1.059 0 CA-C-O 121.203 0.525 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.563 HE21 ' HA3' ' A' ' 6' ' ' GLY . 59.9 tp60 -96.7 144.99 26.2 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.2 p -79.08 172.28 14.02 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.922 0.867 . . . . 0.0 111.163 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -72.66 135.07 45.36 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.259 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 73.77 6.38 4.92 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.319 1.048 . . . . 0.0 112.075 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.563 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -92.15 166.8 29.92 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.662 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.619 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -79.81 128.66 33.71 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.797 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 16.2 p -110.57 15.48 22.05 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.63 84.42 0.51 Allowed Glycine 0 CA--C 1.478 -2.24 0 C-N-CA 117.109 -2.472 . . . . 0.0 114.412 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.32 -179.4 29.89 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 169.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.66 109.62 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 117.826 0.813 . . . . 0.0 109.199 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.65 -11.12 32.77 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.12 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -79.12 110.15 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.025 0.441 . . . . 0.0 109.904 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 p -93.78 0.61 56.4 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.936 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.42 -168.55 40.65 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.305 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.86 122.37 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.845 2.364 . . . . 0.0 112.511 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 p -102.6 -15.72 16.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.657 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 1' ' ' THR . 47.2 t -90.43 108.97 20.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -176.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 77.9 m -68.92 153.11 44.37 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.094 0.473 . . . . 0.0 111.587 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.61 146.94 47.35 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -60.66 120.49 10.14 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.944 0.402 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.58 -10.66 30.43 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 71.1 p -114.31 143.83 44.24 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -108.7 132.72 53.65 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.227 0.329 . . . . 0.0 110.634 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.1 t -78.81 100.75 7.28 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -100.2 110.89 23.15 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.59 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.32 102.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.71 -39.4 16.04 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.437 -177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -139.41 162.79 49.66 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.7 -32.88 85.66 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.108 1.872 . . . . 0.0 113.041 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.7 m-85 -106.28 -26.16 11.64 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.491 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -96.79 114.45 26.08 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -131.74 139.35 48.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.3 tt0 -135.08 138.36 43.77 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 118.55 0.614 . . . . 0.0 112.45 -174.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -79.41 107.63 12.32 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.291 -1.966 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.235 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.464 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_